





















Queen Mary University of London 
 
 
Thesis submitted for the degree of Doctor of Philosophy 














I would like to thank the Biotechnology and Biological Sciences Research 
Council and Barts and The London Charity for funding. 
 
I would like to express my thanks towards my supervisor Prof. Tanya Parish for 
her close supervision, guidance and expertise. I would also like to thank my 
second supervisor, Dr Richard Waite for his constant support. 
 
I particularly want to thank Dr. Amanda Brown for all her advice over the years 
and getting all my questions answered, and the members of the TB Group 
(Dorothee, Julian, Lise, Melanie, Paul, and Pavitra) for their help. 
 
I would also like to thank members of the ‘TB DISCO’ for making me feel 
welcome during my time in Seattle and more specifically thanks to Dr David 
Roberts, Dr Julianne Ollinger and Mai Ann Bailey for their teaching and help. 
 
Special thanks go to Luisa, for her patience during the writing and for simply 







Caseinolytic (Clp) proteases are the most widespread energy-dependent 
proteases in bacteria. They are involved in protein quality control by degrading 
misfolded and aggregated proteins and have a role in regulatory proteolysis. 
The main group of substrates of the Clp proteases is the SsrA-tagged proteins, 
which arise in the presence of defective translation. SsrA tagging is carried out 
by tmRNA, encoded by ssrA, together with a protein partner SmpB. While most 
organisms have only one ClpP, Mycobacterium tuberculosis has two ClpP 
protease subunits (ClpP1 and ClpP2) with at least one of them essential for 
growth. Co-expression of clpP1 and clpP2 was demonstrated showing that 
clpP1 and clpP2 are not expressed under different conditions. The promoter 
region of clpP1P2 was identified, together with the potential ClgR binding site. 
A reporter system to assay ClpP1 and ClpP2 enzymatic activities was 
developed based on LacZ incorporating SsrA tag sequences. This showed that 
both ClpP1 and ClpP2 degrade SsrA-tagged LacZ, whilst only ClpP2 degrades 
untagged proteins. This suggests different pattern recognition for the two ClpP 
proteins with substrate recognition by ClpP1 dependent on the last three 
residues of the C-terminus of the tag sequence. Mutagenesis analysis of the 
accessory components demonstrated that ssrA is essential but SmpB deletion 
is viable. SmpB is not required for aerobic growth but the smpBΔ mutant strain 
was more sensitive to antibiotics targeting the ribosome as compared to wild-
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1 General Introduction 
1.1 Mycobacteria  
Mycobacteria are members of the bacterial order Actinomycetales along with 
the genera Corynebacterium and Streptomyces. The Mycobacterium genus 
includes over a hundred species that are found in soil, water or associated with 
plants, animals or humans; and the majority of these species are non 
pathogenic (Primm et al., 2004; Tortoli, 2006). Mycobacteria are aerobic, rod-
shaped, acid-fast bacteria (McMurray, 1996). They possess a GC-rich genome 
and a thick, waxy cell wall unique among prokaryotes containing peptidoglycan, 
arabinogalactan, mycolic acid, and complex lipids (Brennan and Nikaido, 1995; 
Clark-Curtiss et al., 1985; Hett and Rubin, 2008). Based on 16S rRNA 
sequences, mycobacteria are divided into two taxonomic groups which also 
exhibit different growth rates (Stahl and Urbance, 1990); ‘fast growing’ 
mycobacteria, such as Mycobacterium smegmatis, form colonies within seven 
days; while ‘slow growers’, which includes most of the pathogenic 
mycobacteria, such as Mycobacterium tuberculosis, Mycobacterium leprae and 
Mycobacterium bovis, take weeks to months to form colonies.  
 
The M. tuberculosis complex (MTC) of tuberculosis (TB)-causing mycobacteria 
comprises the species M. tuberculosis, M. bovis, Mycobacterium africanum, 
Mycobacterium canetti and Mycobacterium microti. Members of the MTC differ 
in morphology, host preference, virulence and disease patterns (Brosch et al., 
2002). While M. microti mainly causes TB in small rodents such as voles (Wells 
and Oxon, 1937), the host range of M. bovis is broad; it can cause TB in 
various domestic or wild animals like cattle or goats, as well as in humans 
(Ayele et al., 2004). M. africanum is a major cause of human TB in West Africa 
while M. canetti is prevalent in the horn of Africa (Kallenius et al., 1999; Miltgen 
et al., 2002). The natural habitat of M. tuberculosis is humans, but it can also 
infect animals that are in contact with humans (Ocepek et al., 2005). 
1.2 Tuberculosis 
1.2.1 History and current situation 
Tuberculosis (TB) is an infectious disease that commonly affects the lungs 
(pulmonary TB), but it can also affect other parts of the body such as the 




(McMurray, 1996). TB is an ancient disease claiming victims throughout much 
of known human history (Donoghue, 2009); archaeological evidence of bone 
TB has been identified in Egyptian mummies and skeletal remains from the Iron 
Age (Taylor et al., 2005; Zink et al., 2003). However, it was not until 1882 that 
Robert Koch established that TB was a communicable disease caused by M. 
tuberculosis (with the publication of an article in the German journal Berliner 
Klinische Wochenschrift on 10th April 1882) (Kaufmann, 2000). With 1.2-1.5 
million people dying from TB in 2010, TB is second only to HIV as the leading 
infectious killer of adults worldwide (WHO, 2011). Annually, approximately nine 
million new cases of TB are reported globally and about one third of the world’s 
population is estimated to be latently infected (WHO, 2011), and of these 
individuals two to ten percent will develop active disease at some point in their 
life (Marks et al., 2000). 
 
In the UK, the incidence of tuberculosis has increased steadily over the past 
two decades. However in 2010, a decrease of 4.9% was reported in the number 
of cases (8,483 cases) compared to the previous year (HPA, 2010). London 
accounts for 39% of all TB cases in the UK and rates in some parts of the 
region are over 80 per 100,000, which are similar to those reported in high 
incidence countries in South America, Asia and North Africa (WHO, 2011). 
1.2.2 Pathogenesis and immune response 
Tuberculosis is caused by a complex interaction between M. tuberculosis and 
its host that can last for decades. Primary TB infection begins with inhalation of 
tubercle bacilli. When the bacteria reach pulmonary alveoli, they are ingested 
by macrophages and reside in a vacuole called the phagosome (Russell, 
2001). If normal phagosomal maturation cycle occurs, i.e. phagosome-
lysosome fusion, these bacteria encounter a very hostile environment that 
includes acid pH, reactive oxygen intermediates, lysosomal enzymes and toxic 
peptides. However, M. tuberculosis can prevent fusion of the phagosome with 
lysosomes, thus escaping exposure to the hostile environment (Brown et al., 
1969; Clemens and Horwitz, 1995). The infection of macrophages constitutes 
the early stage of the disease, generally occurring within the first three weeks 
post-infection and most patients remain asymptomatic or only present mild flu-
like symptoms during this stage. M. tuberculosis then spreads to the lymph 
nodes in the lung via the lymphatic system and forms a lesion, known as the 




which activate macrophages and cause them to form a compact cluster or 
granuloma around the site of infection (Hu and Coates, 2003). The formation of 
the granuloma is usually sufficient to arrest the primary infection, and 
surrounding fibroblasts produce a dense scar tissue which encloses the lesion 
(Saunders and Cooper, 2000). Tuberculous granulomas are often caseous due 
to necrosis at the centre of the lesion but can also be fibrotic and calcified. M. 
tuberculosis is located within macrophages of granulomas and in large 
numbers within the central caseous region (Bouley et al., 2001; Dannenberg, 
1993). Granulomas are thought to limit bacterial growth by restricting access to 
oxygen and nutrients as well as exposing the bacteria to host factors such as 
nitric oxide and acidic pH (Gomes et al., 1999; Schaible et al., 1998; 
Schnappinger et al., 2003; Via et al., 2008). However, the bacilli are not 
necessarily eradicated and surviving bacteria are considered to enter a phase 
of non-replicating persistence (Parrish et al., 1998; Wayne, 1994). Bacterial 
persistence during latent tuberculosis is not fully understood although latency is 
central to the prolonged presence of the pathogen in the host with the potential 
to give rise to reactivation disease (Grange, 1992). The bacterial and host 
factors implicated in reactivation of the disease remain to be determined but 
weakening of the immune system (for example by co-infection with HIV, 
malnutrition or ageing) is strongly associated with the onset of active 
tuberculosis (Dolin et al., 1994; Swaminathan et al., 2000).  
1.2.3 The molecular response to hypoxia 
Of the different conditions M. tuberculosis is believed to be exposed to inside 
the host hypoxia is probably the best studied. The main model of hypoxia was 
developed by Wayne, in which M. tuberculosis cultures are gradually depleted 
of oxygen and enter in a non-replicating state (Wayne, 1977; Wayne and Lin, 
1982; Wayne and Hayes, 1996). Two distinct stages are observed: Non-
Replicating Persistence stage 1 (NRP1), which occurs under microaerophilic 
conditions (at an oxygen concentration around 1%), and Non-Replicating 
Persistence stage 2 (NRP2), which happens at the onset of anaerobic 
conditions (oxygen concentration below 0.06%) (Wayne and Hayes, 1996). 
NRP1 is characterised by cell enlargement due to thickening of the cell wall, 
termination of DNA synthesis, a significant decrease in RNA synthesis and 
protein synthesis, and termination of cell division (Cunningham and 
Spreadbury, 1998; Hu et al., 1998; Muttucumaru et al., 2004; Wayne and 




susceptibility profile of the cells changes (Wayne and Hayes, 1996). Under 
anaerobic conditions M. tuberculosis rapidly reduces or completely stops 
protein synthesis in order to shutdown cellular metabolic activities (Hu et al., 
1998). However M. tuberculosis is not completely dormant during its state of 
persistence as approximately 50% of its transcriptome is active (Ehlers, 2009) 
and treatment with isoniazid, which is only active against replicating 
mycobacteria, is effective in preventing active disease in humans (Comstock, 
1999; Diel et al., 2005). This activity can only be explained if at least a fraction 
of the mycobacterial population are replicating at least from time to time. 
 
The DosR (also called DevR) regulon is critically involved in the adaptation to 
hypoxia, it comprises of a set of about 50 genes that are highly induced by 
hypoxia, nitric oxide and during infection of macrophages, which are regulated 
by the DosR-DosS two-component regulatory system (Dasgupta et al., 2000; 
Kumar et al., 2007; Ohno et al., 2003; Park et al., 2003; Sherman et al., 2001; 
Voskuil et al., 2004). In response to hypoxia, expression of most of the genes of 
the DosR regulon is only transiently induced as about half of the regulon is no 
longer induced after 24 hours of exposure to hypoxic conditions (Rustad et al., 
2008). A second transcriptional response, the enduring hypoxic response 
(EHR), consists of more than 200 genes that are not initially induced but are 
upregulated after four to seven days of hypoxia. Unlike the DosR regulon, these 
genes overlap with genes that are upregulated under conditions of nutrient 
starvation suggesting that the EHR contributes to the adaptation to and 
maintenance of a non-replicating state (Rustad et al., 2008; Rustad et al., 
2009a).  
1.2.4 TB vaccination and treatment 
M. bovis Bacillus Calmette-Guerin (BCG) is the only licensed TB vaccine and 
the oldest vaccine currently in use; it has been given four billion times over the 
last 90 years (Parida and Kaufmann, 2010). Although BCG is effective against 
childhood TB, its efficacy among adolescents and young adults is highly 
variable, especially in TB endemic areas (Antas and Castello-Branco, 2008; 
Fine, 1995). There are a number of hypotheses for the varying efficacy of BCG 
including genetic variability between different strains of BCG, exposure to 
environmental mycobacteria and other infections, as well as genetic and 
nutritional differences in human populations, and trial methods (Liu et al., 




particularly those with HIV, the development of a new vaccine is essential if TB 
is to be controlled and ultimately eradicated. A total of 11 vaccine candidates 
against TB have entered clinical trials within the last several years (Kaufmann, 
2010) but a better alternative to BCG has yet to be produced.   
 
TB chemotherapy takes typically upwards of six months of daily treatment, and 
has two phases known as the intensive and the continuation phase. The 
intensive phase regimen consists of four drugs (isoniazid, rifampicin, 
ethambutol and pyrazinamide) to be taken daily for two months, this is then 
followed by the continuation phase where two drugs (isoniazid and rifampicin) 
are taken for a further four months. DOTS (Directly Observed Treatment Short 
course) is the internationally recommended strategy for TB control and was 
reported by the WHO in 2007 to have an 85% global success rate. However, 
due to inadequate therapy, poor follow-up and outdated TB control strategies, 
drug-resistant strains have emerged and are now widespread. Two main 
categories of resistance are encountered: multidrug-resistant TB (MDR-TB) is 
resistant to isoniazid and rifampicin and extensively drug-resistant TB (XDR-
TB) is resistant to isoniazid and rifampicin plus any fluoroquinolone and at least 
one of the second-line anti-TB injectable drugs (amikacin, kanamycin and 
capreomycin). There were an estimated 650,000 cases of MDR-TB in 2010 and 
there are thought to be 25,000 cases of XDR-TB emerging every year; by July 
2010 58 countries reported at least one case of XDR-TB (WHO, 2011). Cure 
rates for patients with XDR are relatively low, especially if patients are co-
infected with HIV. For example, in an outbreak of XDR-TB in KwaZulu-Natal, 
South Africa, 98% of infected patients died within three weeks of diagnosis 
(Gandhi et al., 2006). Virtually incurable isolates, extremely drug resistant TB 
(XXDR-TB) have now appeared and underline the need for new drugs (Migliori 
et al., 2007; Velayati et al., 2009).  
1.3 Drug discovery and validation 
The discovery and development of new drugs is a complex, lengthy and 
expensive process. The drug discovery pipeline starts with target identification, 
then followed by target validation, assay development and high-throughput 
screening, confirming hits to leads through to lead optimisation and 
development of a candidate which can then enter into the clinical trials phase 
(Showalter and Denny, 2008). Appropriate drug targets are genes that encode 




infection or persistence. Potential targets for new drugs need to be identified in 
the context of their essentiality for survival in vitro and in vivo since a gene may 
be required for growth during an infection but dispensable for mycobacterial 
survival in defined medium and vice versa (Sassetti and Rubin, 2003). Thus, in 
order to identify new drug targets, essential genes need to be selected, their 
function identified and then validated as potential drug targets. In addition to 
essentiality, other properties relevant to the drug discovery process such as 
selectivity, suitability for structural studies and ability to monitor inhibition in 
whole cells are important factors to assess the value of a target for drug 
development (Showalter and Denny, 2008).  
 
Essential genes, by definition, cannot be deleted from the chromosome and 
their identification is not an easy task. The construction of a library of tagged 
mutants using transposon mutagenesis can be used to screen large pools of 
mutants for essential genes: genes that are disrupted are non-essential genes 
while genes that cannot be mutated by transposon insertion can be predicted to 
be essential. Transposon mutants can be detected by mapping the insertion 
sites of individual mutants by sequencing (Lamichhane et al., 2003) or by using 
transposon site hybridisation (TraSH) (Sassetti et al., 2003). This technique has 
been used to look at the essentiality of genes under defined growth conditions, 
such as growth on specific media, in macrophages, and in a mouse infection 
model (Rengarajan et al., 2005; Sassetti et al., 2003; Sassetti and Rubin, 
2003). Another method called DeADMAn (Designer Arrays for Defined Mutant 
Analysis), where collections of archived mutants are pooled and assessed 
simultaneously under a particular stress condition, has been used to study 
essential genes during in vivo infections in mice (Lamichhane et al., 2005), 
guinea pigs (Jain et al., 2007) and macaques (Dutta et al., 2010) .  
 
Validation is a crucial step in the drug discovery process. For a molecular 
target to be validated, it requires demonstration that it is critically involved in the 
disease process and that its modulation will have a therapeutic effect. This can 
be achieved by the use of several strategies such as the creation of specific 
gene deletion mutants, use of site-specific recombination systems, antisense 
oligonucleotides and regulated promoters. It is important to determine under 
which conditions the gene is essential for growth, for example assay growth in 
vitro in the presence of different media, carbon sources, or exposure to 




examining virulence and survival in vivo. In vitro models of nutrient starvation, 
oxygen deprivation (for example the Wayne model of hypoxia), as well as 
prolonged stationary phase can be used to replicate conditions that are 
believed to occur during persistence (Betts et al., 2002; Hu et al., 2000; 
Shleeva et al., 2002; Sun and Zhang, 1999; Wayne and Hayes, 1996; Wayne 
and Sohaskey, 2001; Zhang et al., 2001). For in vivo studies, the mouse model 
is widely used but TB granulomas in mice are not especially hypoxic (Aly et al., 
2006) and mice are not as sensitive to TB as other animals (Gupta and Katoch, 
2005). Alternative animal models are more expensive and require larger 
facilities; TB models to date include the use of guinea pigs, rabbits and non-
human primates (Dharmadhikari and Nardell, 2008). Besides essentiality, 
another important criteria for a good drug target is vulnerability which 
represents how much a protein or enzyme has to be inactivated before a 
therapeutic effect can be seen. This can be achieved by creating conditional 
knockdown mutants, where the native promoter of a target gene is replaced by 
one which is tightly regulated and inducible, for example (Carroll et al., 2005; 
Ehrt et al., 2005; Gandotra et al., 2007). Once a drug has been designed, 
understanding its mechanisms of action is critical and selecting drugs that 
inhibit a broad spectrum of essential biochemical pathways is useful in order to 
minimise the appearance of resistant strains. The use of combination therapy 
also reduces the development of resistance and cures patients more rapidly. 
Thus, another challenge for drug development is the selection of optimal 
targets that may be inhibited without drug-drug antagonism. 
 
Most drugs act by blocking the action of a particular protein whose function is 
essential in the cell. Proteins are involved in virtually every cellular function and 
most proteins must fold into defined three-dimensional structures to gain 
functional activity so, accordingly, cells contain some quality controls.  
1.4 Protein quality control and proteases 
Environmental conditions such as oxidative stress or extreme pH may cause 
proteins to misfold. Misfolded proteins expose hydrophobic polypeptide 
stretches, normally buried within the core of globular protein, that can coagulate 
and form aggregates (Alberts et al., 2002a). Aggregated proteins are 
biologically inactive and can be toxic for the cells. Protein quality control 
systems contribute to the maintenance of proteome homeostasis and two 




stabilise protein conformations or refold misfolded proteins; however if a protein 
cannot be refolded by chaperones it will be degraded by specialised proteases 
that are often induced during adverse conditions (Dougan et al., 2002; Hartl 
and Hayer-Hartl, 2002). Accumulation of damaged or incorrectly folded proteins 
also occurs during normal growth conditions with approximately 20% of newly 
synthesised polypeptides being degraded by proteases and a similar proportion 
associated with chaperones (Wickner and Maurizi, 1999). The correct balance 
between protein folding and degradation is critical for cell viability and multiple 
chaperones and proteases are present. In E. coli, the DnaK chaperone with its 
DnaJ and GrpE co-chaperones and the GroEL–GroES chaperone complex 
have central functions in the refolding of misfolded proteins (Hartl and Hayer-
Hartl, 2002).  
 
Proteases are enzymes that catalyse the hydrolysis of peptide bonds in 
polypeptides. Based on their catalytic mechanism, proteases are divided into 
seven groups: aspartic acid proteases, cysteine proteases, glutamic acid 
proteases, metalloproteases, serine proteases, threonine proteases, and the 
seventh group, which constitutes a number of proteases that cannot yet be 
assigned to any particular catalytic type (Wladyka and Pustelny, 2008). Serine 
proteases are one of the most abundant groups of proteolytic enzymes found in 
all kingdoms of life (Tripathi and Sowdhamini, 2008). The number of proteases 
is variable between organisms; for example E. coli has a large number of 
proteases (398), M. leprae has only 69 while M. tuberculosis encodes 142 
proteases (Rawlings et al., 2010). In bacteria most intracellular proteolysis is 
performed by four energy-dependent proteases: Lon, Clp, HslV, and FtsH 
(Gottesman, 1996). Lon is responsible for more than half of all energy-
dependent proteolysis in E. coli (Laskowska et al., 1996; Maurizi, 1992) but is 
absent in M. tuberculosis. M. tuberculosis also lacks homologs of HslV but 
contains the proteasome which is absent in most bacterial species, FtsH, and 
two ClpPs.  
1.4.1 The proteasome 
Proteasomes are present in eukaryotes and archaea but are only found in 
some bacteria of the order actinomycetales, including M. tuberculosis. The 
eukaryotic proteasome is comprised of two complexes: the 20S core, where 
proteins are degraded, and the 19S regulatory cap that binds substrates to be 




including six AAA (ATPases Associated with various Activities) ATPases, is 
involved in the recognition, unfolding, and translocation of proteins into the 
proteasome core (Pickart and Cohen, 2004). The M. tuberculosis 20S core is 
composed of seven α-type and seven β-type subunits (encoded by prcA and 
prcB respectively) forming a barrel shaped structure which contains the active 
sites (Hu et al., 2006; Pickart and Cohen, 2004); however only limited 
peptidase activity has been observed for the core particle alone. PrcA and PrcB 
are predicted to be essential or required for optimal growth (Darwin et al., 2003; 
Sassetti et al., 2003) and are essential for pathogenesis in M. tuberculosis 
(Darwin et al., 2003; Gandotra et al., 2007; Lamichhane et al., 2006), although 
deletion of prcBA did not severely impact bacterial growth in M. smegmatis 
(Knipfer and Shrader, 1997).  The M. tuberculosis proteasome system requires 
at least two co-factors, Mpa (Mycobaterium proteasomal ATPase) and PafA 
(proteasome accessory factor A). Mpa has ATPase activity (Darwin et al., 
2005) and directly interacts with the 20S core protease (Wang et al., 2009) 
while PafA attaches a small protein, Pup (prokaryotic ubiquitin-like protein), to 
substrates targeted for degradation (Pearce et al., 2006; Striebel et al., 2010). 
The accessory proteins MpA and PafA are not essential for growth but are 
essential for virulence and resistance to nitric oxide (Pearce et al., 2006). To 
date, seven proteasome substrates have been identified: FabD, PanB, MpA, 
PhoH2, Icl, MtrA and Ino1 (Festa et al., 2010; Pearce et al., 2006). 
1.4.2 The Clp proteases 
Caseinolytic (Clp) proteases are highly conserved serine proteases present in a 
wide range of bacteria as well as in plants and mammals (Gottesman et al., 
1990; Porankiewicz et al., 1999). The Clp holoenzyme is structurally similar to 
the eukaryotic 26S proteasomal complex and is composed of a catalytic and a 
regulatory subunit. The term ‘Clp protease’ refers to the active Clp protease 
complex which consists of two protease heptamers and two ATPase hexamers 
(Licht and Lee, 2008).  
 
The central proteolytic core assembles into a tetradecamer of ClpP subunits 
consisting of two heptameric rings stacked on top of each other forming a cavity 
where protein degradation occurs (Flanagan et al., 1995; Kessel et al., 1995; 




active site, which is formed by a Ser-His-Asp catalytic triad typical of serine 
proteases (Ingvarsson et al., 2007; Wang et al., 1997). This chamber is 51 Å in 
diameter and can accommodate proteins up to approximately 50 kDa (Wang et 
al., 1997). Axial pores of 1–2 nm are present at either end of the ClpP 
tetradecamer where substrates enter (Baker and Sauer, 2006). These pores 
are only large enough for small polypeptides and unfolded proteins to enter, 
thus cytoplasmic proteins appear to be protected from accidental degradation 
(Inobe and Matouschek, 2008). ClpP by itself displays limited peptidase activity; 
it can degrade small peptides and is capable of hydrolysing proteins but at a 
very slow rate (Jennings et al., 2008; Porankiewicz et al., 1999; Woo et al., 
1989). In order to function as an effective protease ClpP associates with Clp 
ATPases, at either one or both ends, to make an active complex.  
 
The Clp ATPases belong to the AAA+ superfamily of ATPase (Ogura and 
Wilkinson, 2001). These proteins share a common ATPase domain, the AAA 
domain, with a conserved sequence of 230-250 amino acid residues, 
containing Walker A and Walker B nucleotide binding and recognition motifs, 
and a C-terminal α–helical domain (Snider et al., 2008; Zhang et al., 2000). Clp 
ATPases can function both as molecular chaperones to promote protein 
remodelling and reactivation or as regulatory components of Clp proteases for 
degradation by ClpP (Wawrzynow et al., 1996). The Clp ATPases are 
ubiquitous and highly conserved but their number and types can vary even 
between closely related genera (Frees et al., 2007). Clp ATPases are divided 
into two classes based on the number of AAA domains present. Class I 
proteins, including ClpA, ClpB and ClpC, contain two AAA domains; whilst class 
II proteins, including ClpX, contain only one (Schirmer et al., 1996). The first 
ATPase domain promotes hexamerisation of the Clp ATPase protein whereas 
the second ATPase domain, when present, is primarily responsible for ATP 
hydrolysis (Singh and Maurizi, 1994). The functional significance of having one 
versus two AAA+ domains for delivering substrates to ClpP is not yet known 
(Hanson and Whiteheart, 2005). In addition, Clp ATPases contain an N-
terminal domain (N-domain) and a linker domain (also called I-domain or M-
domain) but these domains are not conserved to the same degree as the AAA 
domain (Kojetin et al., 2009). 
 
ClpX is the most widespread Clp ATPase subunit (Kress et al., 2009); ClpC is 




Gram negative proteobacteria (Kress et al., 2009). ClpB is structurally similar to 
ClpA but does not associate with ClpP in any organisms. Thus ClpB is not 
involved in degradation; instead it functions exclusively as a molecular 
chaperone that reactivates denatured and aggregated proteins with the help of 
other chaperones such as DnaK or DnaJ (Motohashi et al., 1999; Zolkiewski, 
1999). Notably, ClpB has a heptameric ring structure (Kim et al., 2000a) while 
the others Clp ATPases assemble into hexamers. 
1.4.2.1 Protein degradation  
Protein degradation by the Clp proteases is a three step-process: substrate 
recognition, unfolding and translocation into ClpP, degradation and peptide 
release (Fig 1.1). Substrate recognition by the Clp ATPases must be highly 
specific in order to protect cells from uncontrolled proteolysis. Clp ATPases 
recognise and bind to a target protein via their sensor and substrate 
discrimination (SSD) domain (Smith et al., 1999) and a simple strategy for 
different ATPases to recognise specific substrates is the presence of extra 
domains in their N-terminal region which are missing in other ATPases (Smith 
et al., 1999). Substrate recognition and selection by the Clp ATPase may be 
assisted by adaptor proteins which bind simultaneously to the substrate and to 
the Clp ATPase (Baker and Sauer, 2006; Kirstein et al., 2006). Misfolded or 
aggregated proteins are recognised by exposed hydrophobic patches at their 
surface, whilst specific substrate proteins are recognised via degradation tags 
termed degrons (Varshavsky, 1991). 
 
Following substrate recognition, the Clp ATPase unfolds and translocates the 
selected protein into the proteolytic cavity using energy generated by ATP 
hydrolysis. Clp ATPases exhibit three key structural elements for this process: 
a narrow gate that restricts passage of a structured protein sequence into their 
central channel, a long inert central channel, and ATP hydrolysis powered 
loops positioned along their channel that are in contact with the engaged 
protein (Hinnerwisch et al., 2005; Martin et al., 2008). Depending on the size of 
the protein, denaturation can require 20 to 500 molecules of ATP (Baker and 
Sauer, 2006). The entry of substrates into ClpP is normally blocked by the ClpP 
N-terminal loops that change conformation only when interacting with the Clp 






Figure 1.1 Protein degradation by the Clp proteases 
In presence of ATP, ClpP and Clp ATPases form a complex. Clp ATPases recognise 
and bind to substrate proteins. The protein is unfolded and translocated into ClpP for 
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Proteolysis is catalysed by the active sites that line the inner surface of the 
internal chamber formed by ClpP (Kim et al., 2000b). ClpP rapidly degrades 
proteins in a processive manner, peptide products have an average length of 
about six to eight residues (Choi and Licht, 2005; Licht and Lee, 2008; Yu and 
Houry, 2007), and ClpP alone controls the length of the peptide products 
(Jennings et al., 2008). It is unclear how the peptide products are released from 
the chamber, the peptides may be released through the axial pores or more 
likely through a set of equatorial pores that open transiently at the interface of 
the two heptameric ClpP rings (Geiger et al., 2011; Kimber et al., 2010; Licht 
and Lee, 2008; Sprangers et al., 2005). 
1.4.2.2 Interaction between ClpP and Clp ATPase 
ClpP is made of heptameric rings while Clp ATPases form hexamers, thus a 
symmetry mismatch takes place (Bewley et al., 2006; Kessel et al., 1995); it 
has been considered that this asymmetry may facilitate rotation of the Clp 
ATPases for a processive degradation of substrate proteins (Beuron et al., 
1998). Different structural features mediate the interaction of ClpP with a Clp 
ATPase partner. The first involves surface loops in the Clp ATPase protein, 
termed the ClpP binding loops, with a highly conserved tripeptide motif 
[LIVMP]-G-[FL] which dock into deep hydrophobic pockets on the surface of 
ClpP (Bewley et al., 2006; Kim et al., 2001; Kim and Kim, 2003). Each of the six 
IGF loops in a ClpX hexamer are required for strong ClpP binding and for 
efficient ClpXP proteolysis (Martin et al., 2007). Clp ATPases that lack the 
tripeptide motif do not form a complex with the ClpP protease, and 
transplanting the ClpA IGL loop to ClpB allows ClpB to interact with ClpP 
(Weibezahn et al., 2004). ClpP N-terminal loops mediate a second critical 
interaction between ClpP and the ATPases. N-terminal truncations of E. coli 
ClpP prevents the interaction between ClpP and its ATPase partner and 
alignment of multiple ClpP sequences shows a very high degree of 
conservation in the N-terminus (Gribun et al., 2005). Additionally, interaction 
occurs between the pore-2 loops present at the bottom of E. coli ClpX and the 
N-terminal loops of ClpP; this interaction is weak but allows fine-tuning of ClpX-
ClpP transactions via changes in ATP-hydrolysis rates during substrate 






1.5 ClpPs and Clp ATPases in M. tuberculosis 
M. tuberculosis clpP1 (Rv2461c) and clpP2 (Rv2460c) are co-located and 
presumed to form an operon. clpP1 was recently demonstrated to be essential 
(Ollinger et al., 2011) and clpP2 is predicted to be essential using high-density 
transposon mutagenesis (Sassetti et al., 2003). A ClpP1-ClpP2 knockdown 
strain was constructed using a tetracycline inducible system and was unable to 
grow in absence of tetracycline confirming that the operon is essential (Carroll 
et al., 2005; Carroll et al., 2011). This knockdown strain showed reduced 
growth and virulence in a macrophage infection model, confirming the 
importance of ClpP1 and ClpP2 for growth and infection (Carroll et al., 2011). 
clpP1 and clpP2 are highly expressed in both aerobic and hypoxic 
environments and are further up-regulated during reaeration from anaerobic 
conditions suggesting they are important for survival during latency and 
reactivation (Muttucumaru et al., 2004; Sherrid et al., 2010). ClpP1 and ClpP2 
are similar in size (22 kDa and 23.5 kDa respectively) and in sequence (43% 
amino acid similarity). They both contain predicted active sites formed by a Ser-
His-Asp catalytic triad typical of serine proteases (Rawlings et al., 2010). ClpP 
monomers can be divided into a globular domain (the head domain), and an 
elongated domain (the handle domain), which constitutes the equatorial wall of 
the tetradecamer (Wang et al., 1997). The structure of M. tuberculosis ClpP1 
revealed that the first ten residues of the handle domain are disordered which 
affects the formation and configuration of the tetradecamer: the equatorial 
pores (hypothesised to be used for peptide exit) are larger as compared to 
ClpP from other species (Ingvarsson et al., 2007). Disorder in the handle 
domain has also been described for other ClpP structures (Gribun et al., 2005). 
The N-terminal residues of mature ClpP proteins are highly conserved, but the 
N-terminus sequence of M. tuberculosis ClpP1 significantly deviates from the 
consensus sequence and exhibits an extended αA helix which is unique 
(Ingvarsson et al., 2007). The active site containing the catalytic triad Ser98, 
His123 and Asp172 is situated at the base of the head domain at the interface 
with the handle domain. However, the conformation of the active site of ClpP1 
is consistent with an inactive enzyme, and peptidase activity was not detected 
(Ingvarsson et al., 2007).  
 
M. tuberculosis has three potential Clp ATPases: ClpC1 (Rv3596c), ClpC2 




ATPase (AAA) domains while ClpX contains only one AAA domain and is 
classified as Class II protein. ClpX and ClpC1 are predicted to be essential for 
optimal growth of M. tuberculosis (Sassetti et al., 2003). ClpC1 is required for 
survival in macrophages and was recently identified as a drug target 
(Rengarajan et al., 2005; Schmitt et al., 2011). ClpC1 exhibits chaperone 
activity; it has two repeat sequences at its N-terminus but only one of them is 
required for the chaperone activity (Kar et al., 2008). Contrary to the other Clp 
ATPases, clpC2 is predicted to be non-essential in M. tuberculosis although it is 
up-regulated during nutrient starvation (Betts et al., 2002). The predicted ClpC2 
protein is smaller than other Clp ATPases, does not contain any AAA domain 
and the purified ClpC2 did not have any ATPase activity (Benaroudj et al., 
2011), suggesting that this protein might not be functional. Additionally this 
protein is not conserved in M. leprae. ClpX was found to interact with FtsZ 
(Dziedzic et al., 2010). 
1.6 Gene regulation 
1.6.1 Bacterial promoter and RNA polymerase 
Prokaryotic promoters consist of two short sequences centred typically 10 and 
35 base pairs upstream of the transcriptional start site; the E. coli consensus 
sequence consists of two hexamers: the Pribnow box (TATAAT) at -10 and 
TTGACA at -35 (Alberts et al., 2002a). The frequency of transcription initiation 
events defines the strength of a promoter; E. coli genes with strong promoters 
are typically transcribed every two seconds whereas weak promoters are 
transcribed only about once in ten minutes (Stryer et al., 2002). The bacterial 
RNA polymerase is a multisubunit complex composed of five subunits: 2α, β, β' 
and ω (Stryer et al., 2002). In order to bind tightly to promoter sequences the 
polymerase recruits another subunit called the sigma (σ) factor. Different σ 
factors recognise specific sequences and respond to environmental conditions; 
for example sigma factor σ32 responds to heat shock while sigma factor σS 
controls expression of stationary phase genes (Watson, 2004). M. tuberculosis 
encodes 13 sigma factors (Cole et al., 1998) and sigma A is the principal sigma 
factor of M. tuberculosis (Gomez et al., 1998).  
  
Promoters are commonly identified and characterised by means of reporter 
genes such as lacZ or gfp (Blokpoel et al., 2003; Carroll et al., 2005; Ehrt et al., 




and very diverse (Gomez and Smith, 2000). They are classified into three 
groups: group A has a -10 and -35 motif similar to the E. coli σ70	  consensus, 
group B is characterised by the presence of a -10 hexamer similar to the 
consensus while group C has no resemblance to the consensus in either 
elements (Gomez and Smith, 2000).  
1.6.2 ClpP expression 
In E. coli the alternative sigma factor σ32 (RpoH) associates with RNA 
polymerase to activate transcription of the clp genes (Kroh and Simon, 1990). 
In several Gram positive bacteria clpP transcription is stress dependent; for 
example in B. subtilis, Lactococcus lactis and Streptococcus mutans, ClpP is 
negatively regulated by the transcriptional regulator CtsR during normal growth 
conditions (Derre et al., 1999; Kruger et al., 2001; Lemos and Burne, 2002; 
Varmanen et al., 2000) while during stress conditions, such as heat shock, 
CtsR is degraded by the ClpCP complex to increase clpP expression (Kruger et 
al., 2001). In Streptococcus salivarius clpP expression is also regulated by 
CtsR and a second repressor named HrcA (Chastanet and Msadek, 2003). 
  
In actinobacteria, including C. glutamicum and Strep. lividans, the clpP1P2 
operon is controlled by the transcriptional activator ClgR (clp gene Regulator) 
(Bellier et al., 2006; Bellier and Mazodier, 2004; Engels et al., 2004). ClgR both 
induces and is degraded by the Clp proteases in these organisms, this 
degradation is mediated by two C-terminal alanine residues of the ClgR protein 
sequence (Bellier et al., 2006; Engels et al., 2004). ClgR is not involved in the 
heat-triggered activation of clpP1P2 expression in C. glutamicum, indicating 
that the corresponding promoter can be recognised by different sigma factors; 
one active at ambient temperatures and requiring ClgR, and the other activated 
by severe heat stress and acting independently of ClgR (Engels et al., 2004). 
clgR homologs are present in all actinomycete genomes, except M. leprae, at a 
conserved genomic location downstream of the ftsK and pgsA3 genes, 
although the identity and number of genes inserted between ftsK, pgsA3 and 
clgR varies to some degree (Engels et al., 2004). The M. tuberculosis clgR 
gene has been shown to replace its counterpart in C. glutamicum for activating 
clpP1P2 expression, suggesting a conserved role for ClgR actinomycetes 
(Engels et al., 2004). Upon binding to ClgR, it has been suggested that DNA 
undergoes considerable bending which is an important feature for transcription 




allowed the deduction of a consensus motif in C. glutamicum 
(WNNWMGCYNNNRGCGWWS, where M=A or C; R = A or G; S= C, T or G; W 
= A or T; Y = C or T and N stands for any nucleotide) (Engels et al., 2005).  
 
M. tuberculosis ClgR homologue (Rv2745c) binds upstream of the clpP1P2 
promoter and directly activates transcription of the ClpP proteases (Mehra and 
Kaushal, 2009; Sherrid et al., 2010). Disruption of the M. smegmatis ClgR 
homologue prevents up-regulation of clpP1P2 upon exposure to vancomycin, 
suggesting ClgR also controls clpP1P2 expression in M. smegmatis (Barik et 
al., 2009). A ClgR deletion mutant confirmed that ClgR was activating the 
expression of clpP1 and clpP2 in M. tuberculosis and this strain exhibited a 
reduced capacity to replicate in macrophages compared to the wild-type 
organism (Estorninho et al., 2010). Microarray analyses showed that ClgR was 
induced after heat shock (Stewart et al., 2002), starvation (Betts et al., 2002) 
and under anaerobic conditions (Muttucumaru et al., 2004) in M. tuberculosis. 
Moreover ClgR is involved in the reaeration response as it is induced during the 
transition of M. tuberculosis from bacteriostasis to growth (Sherrid et al., 2010). 
At least ten genes have been proposed to be directly regulated by ClgR in M. 
tuberculosis, with the majority involved in protein stabilisation, disassembly or 
degradation (Estorninho et al., 2010). 
1.7 ClpP activators 
A novel class of compounds, the acyldepsipeptides (ADEPs), which target 
ClpP, are active against M. tuberculosis and also have potent activity against 
various Gram positive bacteria, including multidrug resistant isolates such as 
methicilin-resistant Staphylococcus aureus (MRSA) (Brotz-Oesterhelt et al., 
2005; Ollinger et al., 2011; Socha et al., 2010). Unusually, ADEPs are 
activators rather than inhibitors of the protease function of ClpP (Brotz-
Oesterhelt et al., 2005). ADEPs prevent the interaction of ClpP with its ATPase 
partner by competing for the same binding site and trigger a conformational 
change in ClpP that widens the entrance pores (Lee et al., 2010; Li et al., 
2010). ADEPs induce oligomerisation of ClpP monomers and activate the 
resulting tetradecamer to bind and degrade unfolded, nascent polypeptides 
(Kirstein et al., 2009). This unregulated proteolysis by the protease ultimately 
leads to cell death, which could be caused by the shortage of essential cellular 
proteins or by the accumulation of considerable amounts of diverse protein 




prevents the formation of FtsZ rings, thus inhibiting cell division in Gram 
positive bacteria (Sass et al., 2011). Gram negative bacteria are resistant to 
ADEP due to efflux pumps that remove the drug from the cell; this has been 
demonstrated as the deletion of those efflux pumps or the use of permeabilising 
agents made them susceptible to ADEP treatment (Brotz-Oesterhelt et al., 
2005). ADEPs activity against M. tuberculosis is enhanced by the addition of 
efflux pump inhibitors, demonstrating that export occurs as seen with Gram 
negative bacteria (Ollinger et al., 2011). Resistance strains can arise by 
deletion of the clpP gene in species where clpP is not essential such as B. 
subtilis (Brotz-Oesterhelt et al., 2005). Resistance was also observed in S. 
lividans which contains five ClpP proteins, ClpP3 is insensitive to ADEP and 
can substitute for ClpP1; other resistance mechanisms are also involved but 
remain to be characterised (Gominet et al., 2011). Since both of the ClpP 
proteases may be essential in M. tuberculosis (Ollinger et al., 2011) targeting 
ClpP activity may be an attractive choice for new antimycobacterial drugs. 
1.8 Role of the Clp proteases  
The number of Clp proteases varies between organisms; while most bacteria 
such as E. coli, B. subtilis, and Y. enterocolitica (Gottesman et al., 1993; 
Pederson et al., 1997; Volker et al., 1994) have a single clpP gene, other 
organisms such Bacillus thuringiensis and Corynobacterium glutamicum have 
two ClpP (Engels et al., 2004; Fedhila et al., 2002). Four clpP genes are 
present in the cyanobacterium Synechococcus (Schelin et al., 2002) and most 
Streptomyces species have five ClpP (Viala et al., 2000).  
 
Clp proteases participate in protein quality control, by degrading misfolded and 
aggregated proteins potentially toxic for the cell, which contributes to cellular 
protein homeostasis (Frees and Ingmer, 1999; Kruger et al., 2000; Thomsen et 
al., 2002). Degradation of these non-functional proteins is useful to protect the 
cell but also serve as a way to efficiently recycle the cell limited resources 
(Keiler et al., 1996). During periods of stress levels of proteins such as heat 
shock proteins are adjusted to allow the cell to adapt to hostile environmental 
conditions. Protein levels can be adjusted by modulating the rate of synthesis 
or the rate of degradation; regulation by proteolysis is more rapid than 
transcriptional induction since continuous proteolysis can be inhibited quickly 




regulatory processes via controlled proteolysis of key regulatory proteins (Frees 
et al., 2007; Inobe and Matouschek, 2008).  
1.8.1 Role of the Clp proteases in E. coli, B. subtilis and 
virulence 
More than 50 Clp substrate proteins have been identified in E. coli (Flynn et al., 
2003). Several substrates are transcriptional regulators including FnR 
(fumarate-nitrate reductase) and an iron-sulfur cluster regulator (IscR), while 
others are involved in cell division (GTPase, and FtsZ). The ClpXP complex 
degrades the stationary phase sigma factor σs and six proteins (Fnr, IscR, IscU, 
AcnB, MoaA, and LipA) which are sensors of oxidative stress. Six ribosomal 
proteins were identified as ClpXP substrates suggesting that the ClpXP 
complex may degrade ribosomes when nutrients become limiting, releasing 
amino acids for new protein synthesis. Nearly all identified proteins reside in the 
cytoplasm except one outer membrane protein (OmpA) and one inner 
membrane protein (RseA).  
 
Bacterial toxin–antitoxin (TA) systems are diverse and widespread in 
prokaryotes. They typically consist of a complex including a small stable toxin 
and an unstable antitoxin that neutralises the toxin. Reduction of antitoxin levels 
releases its associated toxin, which can then interfere with a specific cellular 
target such as mRNA or DNA helicase. TA complexes are used by low-copy or 
antibiotic resistance plasmids for example to ensure their maintenance (Hayes, 
2003). Clp proteases have been implicated in the degradation of antitoxins of 
several TA complexes. In E. coli the ClpAP complex degrades the antitoxin 
MazE (Aizenman et al., 1996) while the ClpXP complex degrades the antitoxin 
Phd (Lehnherr and Yarmolinsky, 1995). Additionally, in Staph. aureus the 
ClpCP complex degrades antitoxins of mazEF, axe1-txe1 and axe2-txe2 TA 
systems (Donegan et al., 2009). 
 
General protein turnover in B. subtilis depends almost exclusively on the Clp 
protease (Kock et al., 2004). In response to environmental conditions B. subtilis 
undertakes complex developmental processes that either lead to the 
manifestation of competence (i.e. the ability to be genetically transformed) or to 
the formation of endospores (Msadek et al., 1998). To decide which of these 
processes occurs and to ensure their correct relative timing, cells have to 




ClpP proteolysis is crucial in the information processing of both developmental 
pathways since strains lacking clpP fail to develop competence and display 
defects in sporulation (Msadek et al., 1998). The ClpCP complex controls 
sporulation by degrading the anti-sigma factor SpoIIAB, which prevents 
expression of sigma factor F (Pan et al., 2001). Additionally B. subtilis ClpP 
mutants are unable to grow at high temperature and are non-motile (Msadek et 
al., 1998). Spx, a global transcriptional regulator of oxidative stress in several 
Gram positive bacteria, is a substrate of the ClpXP protease in B. subtilis 
(Nakano et al., 2002). Additionally, a microarray study showed that ClpP has an 
impact on multiple central regulons of B. subtilis involved in virulence, oxidative 
stress response, metal homeostasis, and SOS DNA repair (Michel et al., 2006). 
The number of regulators whose activity is controlled by ClpP mediated 
proteolysis might therefore be underestimated at present. In contrast to B. 
subtilis, B. thuringiensis contains two ClpP homologs which control different 
cellular regulatory pathways: ClpP1 is essential for normal cell division at low 
temperature, whereas ClpP2 is required for motility and sporulation (Fedhila et 
al., 2002). 
 
Clp proteases have been linked to virulence and pathogenesis in many 
organisms. For example, ClpP is essential for intracellular survival and 
replication of Listeria monocytogenes and modulates the expression of 
listeriolysin O, a major virulence factor required to escape from the 
phagosomes of macrophages (Gaillot et al., 2000). ClpP is important for 
Salmonella typhimurium to grow under various stress conditions, such as low 
pH, elevated temperature, and high salt concentrations (Thomsen et al., 2002). 
In Staph. aureus ClpP has an impact on several regulons involved in virulence, 
heat shock response, oxidative stress response, DNA repair, autolysis, and 
anaerobic growth (Frees et al., 2003; Michel et al., 2006; Savijoki et al., 2003). 
Loss of clpP in Strept. pneumoniae results in attenuation in virulence 
(Robertson et al., 2002) and ClpP regulates expression of the virulence factors 
pneumolysin and pneumococcal surface antigen A (Kwon et al., 2003).  
 
Additionally, ClpP is also involved in biofilm formation in various species such 
as Pseudomonas fluorescens and Staphylococcus epidermidis (O'Toole and 
Kolter, 1998; Wang et al., 2007). Either enhancement or diminution of biofilm 
formation can be observed in clp mutants. In Staph. aureus, biofilm formation is 




(Frees et al., 2004). Conversely Strept. mutans strains lacking ClpP, but not 
strains lacking ClpC, have a reduced capacity to form biofilms (Lemos and 
Burne, 2002). ClpP therefore may act by controlling the stability or activity of 
transcriptional regulators of biofilm maturation.  
1.8.2 Role of the Clp proteases in actinobacteria 
Corynebacterium glutamicum contains two clpP genes arranged in an apparent 
operon and are predicted to be essential (Engels et al., 2004). ClpP1 and 
ClpP2 are induced upon heat and osmotic stress suggesting a role in stress 
conditions (Engels et al., 2004). ClpCP and ClpXP complexes degrade GlnK, a 
protein involved in nitrogen control (Strosser et al., 2004).  
 
In addition to the clpP1P2 operon most Streptomyces species have three other 
clpP genes: clpP3 and clpP4 are arranged in an operon, and clpP5 is 
monocistronic. ClpP1 degrades the transcriptional activator PopR; PopR is the 
activator of the clpP3P4 operon, so when clpP1 is present this operon is not 
expressed (Viala et al., 2000). ClpP3 however does not fully perform the role of 
ClpP1 as clpP1 deletion mutants fail to form aerial mycelium on various media 
(de Crecy-Lagard et al., 1999). The role of ClpP5 is, as yet, unknown (Gominet 
et al., 2011). Streptomyces have a complex growth cycle with three major 
stages: substrate mycelium, aerial mycelium, and sporulation. Disruption of the 
clpP1 gene in S. lividans and S. coelicolor blocks differentiation at the substrate 
mycelium step, while over-expression of clpP1 and clpP2 accelerates aerial 
mycelium formation in S. lividans, S. albus and S. coelicolor, indicating that 
clpP genes are involved in the formation of aerial mycelium (de Crecy-Lagard 
et al., 1999). In S. lividans strains lacking ClpP1, cell cycle progression is 
blocked at the early stages of growth (Viala and Mazodier, 2003). 
Overproduction of ClpX activates production of the antibiotic actinorhodin in S. 
lividans and accelerates its production in S. coelicolor (de Crecy-Lagard et al., 
1999). Altogether Clp proteases regulate morphological and metabolic 
differentiation in Streptomyces species.  
 
To date, only one substrate protein has been identified in M. tuberculosis: 
RseA, the SigE anti-sigma factor (Barik et al., 2009). SigE regulates expression 
of genes important for virulence and for responding to environmental stresses 
and its expression is linked to RseA. In the presence of vancomycin, RseA 




RseA so SigE becomes activated. This cleavage is specific to the 
phosphorylated state of the protein, as degradation was blocked when the 
protein was dephosphorylated, and exclusive to the ClpC1P2 complex as 
ClpP1 could not substitute ClpP2 and ClpX could not substitute ClpC1 (Barik et 
al., 2009). 
1.9 Recognition signals 
The Clp proteases degrade a large range of proteins, however substrate 
proteins possess recognition signals also called degradation tags or degrons 
(Varshavsky, 1991). Two main degradation tags are found in the cell: the SsrA 
tag which is added to the C-terminus of proteins during the process of trans-
translation, and the N-degron.  
1.9.1 Trans-translation 
In bacteria, ribosome stalling is a serious issue for cell survival since cells need 
to maintain a pool of active ribosomes for translation, and the release of 
incomplete proteins may be toxic for the cell. Transfer-messenger RNA 
(tmRNA), encoded by the ssrA gene, liberates stalled ribosomes and tag 
incomplete nascent proteins for degradation (Fig 1.2). Trans-translation is an 
effective system to release stalled ribosomes at the end of a truncated mRNA 
that lacks a stop codon, at stretches of rare codons, or at inefficient termination 
codons (Keiler et al., 1996; Li et al., 2006; Roche and Sauer, 1999). tmRNA is a 
large molecule (260 to 430 nucleotides depending on bacterial species) with 
both tRNA and mRNA activities. It contains a tRNA like domain, a series of 
pseudoknots and a short internal open reading frame (mRNA like domain) of 8-
35 codons ending with a stop codon (Keiler et al., 1996; Williams and Bartel, 
1996). A two-piece tmRNA is present in Caulobacter crescentus and some 
cyanobacteria as a result of gene permutation and rearrangement and displays 
a reduction in pseudoknot number and a linear tag reading frame (Gaudin et 
al., 2002; Keiler et al., 2000; Williams, 2002). tmRNA is one of the most 
abundant RNAs in the cell and its half-life exceeds the doubling time of the 
bacterium in E. coli (Hallier et al., 2004). E. coli has 500-1000 copies of tmRNA 
per cell, corresponding to one tmRNA for every ten to 20 ribosomes (Moore 
and Sauer, 2005); tmRNA levels in M. smegmatis are equivalent to E. coli, 
which suggests a high rate of trans-translation in mycobacteria (Andini and 





Figure 1.2 The trans-translation model of tmRNA activity 
Transfer-messenger RNA (tmRNA) enters in the vacant A site of the stalled ribosome 
with small protein B (SmpB). The defective mRNA is released and the mRNA region of 
tmRNA becomes the template for translation until a stop codon is reached. The 
ribosome is subsequently released and the protein now harbouring an 11 amino acids 



















about 0.4% of all proteins terminates with tagging during normal exponential 
growth (Moore and Sauer, 2005) 
1.9.1.1 The trans-translation model 
The majority of tmRNA is believed to be in a complex with the small basic 
protein B (SmpB) wich binds tmRNA with high affinity (Keiler, 2008). tmRNA 
can be charged with alanine by alanyl-tRNA synthetase, the tmRNAala-SmpB 
complex is recognised by elongation factor Tu (EF-Tu) and GTP to form a 
complex that recognises stalled ribosomes. GTP is hydrolysed, EF-Tu is 
released and the tRNA domain of tmRNA enters the unoccupied A site of a 
stalled ribosome. tmRNA first functions as a tRNA to transfer its pre-charged 
alanine to the nascent polypeptide in a transpeptidation reaction. The defective 
mRNA is then replaced by the mRNA region of tmRNA so translation resumes. 
Ribosomal protein S1 binds tmRNA with high affinity to the mRNA domain and 
is possibly required for switching the reading frame from the original mRNA to 
the mRNA domain of tmRNA (Wower et al., 2000). Termination of translation 
occurs at the stop codon of the new mRNA and the ribosome is released. The 
nascent protein, now harbouring a C-terminal tag, usually 10-11 amino acids 
long, is degraded by proteases.  
 
SmpB is an essential component for trans-translation. SmpB is important for 
tmRNA stability (Hallier et al., 2004; Hanawa-Suetsugu et al., 2002; Moore et 
al., 2003); in C. crescentus SmpB protects tmRNA from degradation in vitro and 
the in vivo levels of SmpB during the cell cycle correlate with tmRNA stability 
(Hong et al., 2005). Additionally SmpB enhances tmRNA aminoacylation by 
making contacts with alanyl-tRNA synthetase (Hanawa-Suetsugu et al., 2002; 
Shimizu and Ueda, 2002) and is required for stable association of tmRNA with 
the ribosome, it overcomes the absence of codon-anticodon interactions 
(Felden and Gillet, 2011; Nonin-Lecomte et al., 2009). 
 
The SsrA tag does not affect the structure or thermodynamic stability of 
attached proteins, suggesting that it causes degradation simply by providing a 
recognition site for protease binding (Karzai et al., 2000). Five different 
protease complexes (Tsp, FtsH, ClpXP, ClpAP and Lon) degrade SsrA-tagged 
proteins in E. coli (Choy et al., 2007; Gottesman et al., 1998; Herman et al., 
1998; Spiers et al., 2002). However the ClpXP complex is thought to be the 




the adaptor protein SspB which binds to ClpX and a part of the tag (Lies and 
Maurizi, 2008; Wiegert and Schumann, 2001). SspB binds to the first seven 
amino acids of the tag sequence while ClpX binds to the terminal three 
residues and enhances ClpXP degradation while inhibiting degradation by 
ClpAP (Farrell et al., 2005; Flynn et al., 2001; Levchenko et al., 2000). No 
similar adaptors have been identified in Gram positive bacteria, and in 
Streptococcus pneumoniae SsrA-tagged proteins were found to be degraded 
by ClpXP without the participation of an adaptor protein (Ahlawat and Morrison, 
2009). 
1.9.1.2 Functions of the tmRNA pathway 
SmpB and tmRNA have been identified in all bacterial genomes including those 
with reduced genome sizes (Mao et al., 2009; Williams, 2002b) suggesting a 
conserved role amongst bacteria. However, tmRNA is not required for growth 
under normal conditions of many bacteria including E. coli (Oh and Apirion, 
1991), B. subtilis (Muto et al., 2000), C. crescentus (Keiler and Shapiro, 2003), 
Salmonella enterica (Julio et al., 2000) and Yersinia pseudotuberculosis (Okan 
et al., 2006); but it does play an important role in cell growth and resistance to 
adverse conditions. For example E. coli ssrA deletion cells recover more slowly 
from carbon starvation, have reduced motility, are more sensitive to sublethal 
concentrations of antibiotics that inhibit protein synthesis and display a 
constitutive heat shock response (Abo et al., 2002; Komine et al., 1994). B. 
subtilis ssrA deletion strains have growth defects in high temperature, low 
temperature and sporulation (Muto et al., 2000). Disruption of ssrA in Y. 
pseudotuberculosis and Sal. enterica reduces their virulence and in 
Streptomyces ssrA and smpB mutant cells show growth and sporulation 
defects and are more sensitive to hygromycin (Yang and Glover, 2009). In 
contrast, ssrA is essential in Neisseria gonorrhoeae (Huang et al., 2000) 
Helicobacter pylori (Thibonnier et al., 2008) and is predicted to be essential in 
Mycoplasma pneumoniae, Mycoplasma genitalium and Haemophilus 
influenzae (Akerley et al., 2002; Hutchison et al., 1999).  
 
The tmRNA-SmpB system mainly serves two functions: it releases stalled 
ribosomes and provides a general quality control system that promotes the 
degradation of incomplete proteins. A tmRNA variant which mediates the 
addition of a peptide tag (tmRNA-DD) that does not result in degradation can 




deletion mutants; from this it has been identified that it is the ribosomal 
recycling and not the proteolysis tagging function that is required for viability in 
N. gonorrhoeae (Huang et al., 2000; Withey and Friedman, 1999). In addition, 
the tmRNA system may have a regulatory role since some phenotypes 
generated by mutations in tmRNA can relate to misregulation of individual 
substrates. For example, Y. pseudotuberculosis cells lacking tmRNA display a 
defect in the secretion of virulence factors possibly resulting from the 
misregulation of the transcriptional factor VirF that controls synthesis of the 
secretion apparatus (Okan et al., 2006) and tmRNA regulates synthesis of the 
stress sigma factor RpoS in E. coli (Ranquet and Gottesman, 2007). 
Additionally tmRNA was shown to act as an antisense RNA to regulate 
expression of CrtM/N and influence the pigment synthesis of Staph. aureus (Liu 
et al., 2010).  
1.9.1.3 The tmRNA pathway in M. tuberculosis 
M. tuberculosis contains ssrA (Tyagi and Kinger, 1992) and smpB genes 
confirming the presence of tmRNA tagging system in this species. smpB is not 
predicted to be essential whilst there are no data available for ssrA (Sassetti et 
al., 2003). The M. tuberculosis SsrA tag is 12 residues long: 
(A)ADSHQRDYALAA and this sequence is conserved in most mycobacterial 
species. smpB was found to be down-regulated in a SenX3-RegX3 deletion 
mutant strain; smpB expression levels are therefore predicted to be controlled 
by this two-component system (Parish et al., 2003). As the tmRNA pathway is 
absent from eukaryotes it may be a promising drug target. Recently 
pyrazinamide was found to target a component of trans-translation. 
Pyrazinamide is a pro-drug, which is currently used in TB chemotherapy, and 
requires conversion into its active form pyrazinoic acid (POA) by the bacterial 
pyrazinamidase. POA was found to bind to RpsA, which is involved in tmRNA 
tagging system, suggesting that pyrazinamide is effective due to its effect on 
the tmRNA system (Shi et al., 2011) and confirming that the tmRNA pathway is 
an attractive drug target for novel antibacterial.  
1.9.1.4 Alternative ribosome rescue pathways 
Several bacteria have some tmRNA-independent rescue pathways to recycle 
stalled ribosomes. For example in the absence of tmRNA, ArfA (for Alternative 
Ribosome rescue Factor; former YhdL) is required for the growth of E. coli cells 




subunit of ribosomes and enhances the hydrolysis of peptidyl-tRNA residing in 
the stalled ribosome, although the molecular mechanism of how it rescues 
ribosomes is still unknown. Moreover, ArfA synthesis is regulated by tmRNA 
tagging and proteolysis so ArfA-mediated ribosome rescue is increased in 
response to decreased tmRNA activity (Chadani et al., 2011a). The 
combination of ssrA and arfA mutations is lethal; however over-expression of 
the YaeJ protein supports growth of cells lacking ssrA and arfA (Chadani et al., 
2011b). YaeJ was shown to rescue stalled ribosomes independently of SsrA 
and ArfA demonstrating a third alternative ribosome rescue system. 
1.9.2  N-end rule pathway 
The N-degron is a second degradation tag present in eukaryotes and 
prokaryotes. The N-end rule states that the stability of a protein is determined 
by the identity of its N-terminal residue, with proteins commencing with large 
residues preferred for degradation (Bachmair et al., 1986; Varshavsky, 1996). 
E. coli destabilising residues are organised into two levels: primary and 
secondary. The primary destabilising residues are aromatic amino acids 
(tryptophan, phenylalanine, and tyrosine) and leucine, while secondary 
destabilising residues are basic amino acids arginine and lysine (Tobias et al., 
1991). In bacteria protein synthesis starts with formyl-methionine (fMet) 
considered to be a stabilising residue, thus the generation of a N-degron 
requires some post-translational modifications. Several different models have 
been proposed for the generation of N-degron in vivo (Dougan et al., 2010). 
The first model involves the removal of the N-terminal fMet on the target protein 
to reveal the N-degron. Alternatively, the N-terminal fMet is untouched but a 
primary destabilising residue is attached to the N-terminus of the protein. The 
remaining model involves processing of a pre-N-degron (containing a stabilising 
N-terminal residue) by an unknown endopeptidase resulting in exposure of a 
primary destabilising residue or resulting in exposure of a secondary residue 
onto which a primary residue is attached (Dougan et al., 2010). 
 
The N-end rule pathway has largely been defined using artificial substrates but 
two natural substrates have been identified in E. coli: DpS (DNA protection 
during starvation) and putrescine-aminotransferase (PATase) (Schmidt et al., 
2009). DpS, as the name suggests, protects DNA during starvation and also 
oxidative stress, whilst PATase is involved in the catabolism of putrescine. 




protease complex which targets the first residues of the N-terminal segment 
(Schmidt et al., 2009).  
 
The protein ClpS is an essential component of the E. coli N-end rule pathway. 
In E. coli ClpS specifically binds to destabilising N-terminal residues and 
mediates degradation of the selected substrate by the ClpAP complex (Erbse et 
al., 2006; Schmidt et al., 2009). Structurally ClpS is a ‘cone-shaped’ molecule 
with a coiled N-terminal extension; the N-degron binding site is located at the 
base of the cone, while the tip docks to the N-domains of ClpA (Guo et al., 
2002; Zeth et al., 2002). ClpS binding to ClpAP prevents recognition and 
degradation of other types of substrates by ClpAP (Dougan et al., 2002). ClpS 
binds more tightly to ClpA in presence of N-end substrates so it does not 
prevent degradation of other proteins in absence of such substrates (Roman-
Hernandez et al., 2011). M. tuberculosis has the adaptor protein ClpS (Rv1331) 
suggesting the N-end rule pathway is present in mycobacteria. ClpS is 
predicted non essential for mycobacterial growth (Sassetti et al., 2003) but is 
predicted to be required for survival in primary murine macrophages 
(Rengarajan et al., 2005).  
1.10  M. smegmatis and M. marinum as model organisms  
Despite the recent advancements in genetic tools available for studying M. 
tuberculosis, it remains a difficult organism to work with. Related mycobacteria 
such as M. smegmatis and M. marinum, are frequently used as model 
organisms to study the biology of M. tuberculosis (Stinear et al., 2008). M. 
smegmatis was first isolated in 1824 by Lustgarten and in 1885 was isolated 
from human smegma by Alvarez and Tavel (Alvarez and Tavel, 1885). The 
genome of M. smegmatis is about 1.7 times bigger than that of M. tuberculosis. 
It is a fast-growing non-pathogenic mycobacterium and has a generation time 
of three to four hours compared to 24 hours for M. tuberculosis. It does not 
infect humans and it does not require ACDP Hazard Group 3 containment. 
However, because it is saprophytic and not pathogenic, it cannot be used as a 
model for pathogenesis (Reyrat and Kahn, 2001). 
 
M. marinum can infect more than 150 species of fish and is an occasional 
zoonotic human pathogen, with transmission to humans occurring through 
direct skin inoculation. M. marinum has more than 85% nucleotide identity with 




al., 2008). M. marinum is a slow growing organism with a generation time of ten  
to 12 hours but its optimal growth temperature is 30°C (Shiloh and DiGiuseppe 
Champion, 2009).   
 
M. smegmatis and M. marinum have a total of 153 and 125 proteases 
respectively including the cytoplasmic Lon protease, which is absent in M. 
tuberculosis (Rawlings et al., 2010). M. smegmatis and M. marinum have two 
clpP homologues arranged in tandem similarly to M. tuberculosis (Kapopoulou 
et al., 2011). The ATPase subunits ClpX, ClpC1, and ClpC2 are also present in 
both organisms, as well as the adaptor protein ClpS and the tmRNA tagging 
components ssrA and SmpB, in both organisms. Thus these two organisms 
appear to be good models for unravelling the role of the Clp proteins in 
mycobacteria.  
1.11  Aims and objectives 
Bacterial species have evolved multiple proteolytic systems, and the genome of 
M. tuberculosis encodes over 140 proteases including the proteasome, which is 
absent from most bacteria. While most bacteria  have a single clpP gene, M. 
tuberculosis has two ClpP protease subunits (ClpP1 and ClpP2), with at least 
one of them essential for growth and activators of ClpP activity have been 
shown to have activity against M. tuberculosis (Ollinger et al., 2011). Although 
Clp proteases have been extensively studied in organisms such as E. coli and 
B. subtilis, little is known regarding their function in mycobacteria and in M. 
tuberculosis in particular.  
 
The aim of this project was to determine why M. tuberculosis has two ClpP 
proteases and why they are essential for mycobacterial growth, although other 
systems such as the proteasome are present. We hypothesised that ClpP1 and 
ClpP2 perform different functions, as in other bacteria with multiple ClpP 
proteases (Fedhila et al., 2002), or may be active under different conditions. 
 
The objectives of this project were to determine: 
- the mechanism of activation of the ClpP proteases in M. tuberculosis and 
identify the conditions that influence their expression  
 






- the effect of the ClpP proteases over-expression on the transcriptome of M. 
tuberculosis 
  
- the specificity of ClpP1 and ClpP2 substrate recognition  
 





2 Materials and methods 
Unless otherwise stated all chemical reagents were obtained from Sigma-
Aldrich.  
2.1 Bacterial growth 
2.1.1 Media 
E. coli  DH5α  and E. coli  BTH101 (Karimova et al., 1998) were grown at 37°C 
with shaking at 225 rpm in Luria-Bertani (LB) broth or in M63 medium (2 g L-1 
(NH4)2SO4, 13.6 g L-1 KH2PO4, 0.5 mg L-1 FeSO4.7H2O and 1 mg L-1 vitamin 
B1, pH 7.0) for liquid cultures or with Bacto agar (15g L-1) for solid media. 
Ampicillin was used at 100 mg L-1,, kanamycin at 50 mg L-1, isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 0.5 mM and 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal)  at 50 mg L-1 where required. 
M. smegmatis mc2155 (Snapper et al., 1990) and M. smegmatis ΔHisA (O'Hare 
et al., 2008) were grown at 37°C with shaking at 160 rpm in Lemco medium (10 
g L-1 peptone, 5 g L-1 Lemco powder, 5 g L-1 NaCl) containing 0.05% w/v Tween 
80 for liquid cultures or with Bacto agar (15g L-1) for solid media. For Split-Trp 
growth assays, M. smegmatis ΔHisA was grown on 7H9 agar (5 g L-1 DifcoTM 
Middlebrook 7H9 powder (Becton Dickinson), 15 g L-1 agar) supplemented with 
0.2% w/v glucose, 0.2% v/v glycerol and 60 mg L-1 histidine at 30°C. 
M. marinum strain M (ATCC BAA-535), was obtained from N. Andreu, Imperial 
College, London and grown at 30°C with shaking at 100 rpm in Middlebrook 
7H9 medium supplemented with 10% v/v oleic-albumin-dextrose-catalase 
(OADC) supplement (Becton Dickinson) and 0.05% w/v Tween80 (7H9-Tw-
OADC) or on Middlebrook 7H10 agar (Becton Dickinson) with 10% v/v OADC 
supplement.  
M. tuberculosis H37Rv was grown at 37°C in 7H9-Tw-OADC or in 7H9-Tween 
supplemented with AD (5% w/v bovine serum albumin fraction V, 2% w/v 
glucose) or on DifcoTM Middlebrook 7H10 agar supplemented with 10% v/v 
OADC. Cultures were grown without agitation in 50 mL tubes unless otherwise 
stated. For LacZ reporter system experiments M. tuberculosis was grown in 
7H9-tw supplemented with 10% v/v BSA and 0.1% w/v succinate with or 





For growth under hypoxic conditions, M. tuberculosis was grown in Dubos 
medium (Difco, Becton Dickinson) supplemented with Dubos Medium Albumin 
(Becton Dickinson) and 0.05% w/v Tween®80. 
Gentamicin was used at 10 mg L-1, hygromycin B at 100 mg L-1, kanamycin at 
20 mg L-1, streptomycin at 20 mg L-1 where required. 
2.1.2 Growth of mycobacteria  
Cultures of M. smegmatis and M. marinum were prepared as follows: a loopful 
of cells from a plate was used to inoculate 5 mL of medium and grown 
overnight; cultures were then inoculated 1/10 in 5 mL medium. 
 
All work involving M. tuberculosis was carried out in a Containment Level 3 
laboratory equipped for Advisory Committee on Dangerous Pathogens (ACDP) 
Hazard Group 3 work. To prepare seed cultures of M. tuberculosis, a loopful of 
cells from a plate was used to inoculate 10 mL medium containing 3 mL of 1 
mm glass beads (BioSpec Products Inc.) and incubated at 37°C without 
agitation for 14 d. 1 mL of this culture was used to inoculate 10 mL medium and 
grown without agitation for 7 d. 
 
To assay promoter activity, a seed culture was used to inoculate 10 mL 7H9-
Tw-AD medium to a starting OD580 of 0.1. Liquid cultures were grown until an 
OD580 of 0.6-0.8 was reached and cell-free extracts were prepared. For growth 
profile of promoter activity, 100 mL of medium in a 450 cm2 roller bottle was 
inoculated with 3 mL of a seed culture and incubated rolling at 37°C. The OD580 
of the roller culture was measured and cell-free extracts were prepared every 
day. 
 
To measure LacZ turnover in cells carrying the acetamidase promoter, a seed 
culture was used to set up 10 mL medium with an OD580 of 0.1. Liquid cultures 
were grown in 7H9-Tween-BSA with 0.1% w/v sodium succinate with or without 
0.1% w/v acetamide until an OD600 of 0.6-0.8 was reached and cell-free extracts 
were prepared. To measure LacZ turnover in cells carrying the tetracycline 
inducible promoter, a seed culture was used to set up 100 mL roller culture with 
an O.D of 0.025. Cultures were grown in 7H9-Tw-AD with or without 150 or 300 




10 mL of this culture, while 50 mL were spun, washed three times in 7H9 
medium and used to inoculate new 100 mL roller culture starting with an O.D of 
0.05.  
 
For growth in the Wayne model of hypoxia (Wayne and Hayes, 1996), liquid 
cultures were grown in DTA in 20 mm x 125 mm round bottom screw cap glass 
tubes. To create a theoretical starting OD580 of 0.004, 170 µL of a culture with 
an OD580 of 0.4 was used to inoculate 17 mL medium. Caps were tightly 
screwed on and sealed with parafilm. Cultures were grown stirring at 150 rpm 
with a 3 x 8 mm magnetic stirring bar. A control tube containing methylene blue 
(1.5 µg mL-1) was used as a visual indication of oxygen depletion. Fading of the 
methylene blue dye indicated onset of microaerophilic conditions (Non-
replicating Phase stage 1) and decolourisation signified onset of anaerobic 
conditions (Non-replicating Phase stage 2). For reaeration, 3 mL of hypoxic 
cultures were used to inoculate 100 mL of fresh medium in roller bottles and 
incubated with rolling at 37°C. 
 
Aerobic growth curves in M. tuberculosis were carried out in 4 mL 7H9-Tw-AD  
medium in 16 x 125 mm round bottom screw cap glass tubes with a starting 
OD580 of 0.02. Cultures were stirred with 3 x 8 mm magnetic stirring bars at 150 
rpm.  
2.2 Nucleic acid isolation 
2.2.1 Extraction and purification of genomic DNA 
M. tuberculosis cells were harvested by centrifugation for 10 min at 2700 x g, 
resuspended in 1 mL 10 mM Tris-Cl pH 7.5, and added to 2 mL lysing matrix B 
tubes (MP Biomedicals) on ice. Cells were disrupted using one 30 s cycle at 
speed 6.0 using a FP120 FastPrep (Qbiogene). Samples were spun at 16000 x 
g for 4 min and the supernatants were filter-sterilised through a 0.2 µm filter 
unit. Samples were incubated at 55°C for a minimum of 90 min with 0.2 vol of 
5% w/v sodium deoxycholate. An equal volume of phenol:chloroform:isoamyl 
acohol 25:24:1 was added, the mixture was vortexed for 30 s and spun at 
16000 x g for 2 min. The top layer was transferred to a new 1.5 mL 
microcentrifuge tube and the phenol-chloroform extraction was repeated 1-3 
times as required. An equal volume of chloroform was added to the samples 




layer was transferred to a new 1.5 mL tube and ethanol precipitation was 
carried out by adding 0.1 vol of 3 M sodium acetate buffer pH 5.2, and 2.5 vol 
of 100% ethanol. Samples were incubated at -80°C for a minimum of 1 h and 
spun at 16000 x g for 15 min. Supernatant was removed and the pellet was re-
suspended in 1 mL of ice cold 100% ethanol. Samples were centrifuged for 2 
min at 16000 x g and the supernatant was removed. The pellet was dried for 5 
min at 30°C in a vacuum concentrator and re-suspended in 50 µL SDW. DNA 
concentration was determined using a ND-1000 spectrophometer (NanoDrop). 
2.2.2 Extraction of mycobacterial DNA for colony PCR 
One loopful of cells from a plate was added to 1 mL Tris buffer and incubated 
for 10 min at 100°C. Samples were left to cool for 5 min and filter-sterilised 
through 0.2 µM filter units.  
2.2.3 Extraction and purification of mycobacterial RNA  
RNase and DNase-free filtered tips, water and microcentrifuge tubes were used 
for all RNA work. RNA was extracted as previously described (Rustad et al., 
2009b). Briefly, M. tuberculosis cells were harvested by centrifugation for 10 
min at 2700 x g. The pellets were resuspended in 1 mL TRI Reagent 
(Invitrogen) and added to 2 mL tubes containing lysing matrix B. Cells were 
disrupted using two 20 s cycles at speed 4 using a FastPrep, placed on ice for 
5 min, spun at 16000 x g for 4 min and filter-sterilised through a 0.2 µm filter 
unit. The solutions were added to 2 mL Heavy Phase Lock Gel (5 Prime) snap 
cap tubes containing 300 µL chloroform:isoamyl alcohol (24:1). Samples were 
mixed by inverting rapidly for 15 s and placed on ice. Once all samples were 
transferred, inverting was continued periodically for 2 min. Samples were spun 
for 5 min at 16000 x g and the aqueous layer (~540 µL) was transferred to a 1.5 
mL tube containing 270 µL ispopropanol and 270 µL high salt solution (0.8 M 
sodium citrate, 1.2 M NaCl). Tubes were inverted several times to mix. 
Samples were left to precipitate overnight at 4°C and centrifuged for 10 min at 
16000 x g to remove the supernatant. The pellets were then washed with 1 mL 
75% ethanol, tubes were inverted and spun for 5 min before decanting the 
ethanol. Pellets were resuspended in 100 µL RNase-free water. 
 
RNA was purified and DNase digested using the RNeasy Minikit (QIAGEN) 
protocol as follows. RLT buffer was prepared by adding 10 µL ß-




added to the sample and mixed. 265 µL of 95% ethanol was added and mixed 
by vortexing. The mixture was transferred to an RNeasy spin column, 
centrifuged for 15 s and transferred to a new 2 mL collection tube. 350 µL of 
buffer RW1 was added, the column spun for 15 s and the flow through was 
discarded. 70 µL of buffer RDD was added to a 10 µL aliquot of DNase I stock 
solution and pipetted directly onto the column membrane. Digestions were 
carried out at RT for 1 h. 350 µL buffer RW1 was added and the column spun 
for 15 s before adding 500 µL RPE buffer. The column was spun for 15 s and 
the flow through was discarded. An additional 500 µL RPE buffer was added 
and the column, centrifuged for 2 min and the flow through was discarded and 
the column spun for 1 min to dry completely. The column was transferred to a 
new 1.5 mL microcentrifuge tube and RNA eluted in 40 µL RNAse-free water. 
RNA concentrations were measured on a ND-1000 Spectrophometer. To check 
for RNA degradation, 1 µL of RNA sample was run on a 2% w/v agarose gel.  
2.3 Polymerase chain reaction (PCR) 
Reactions with GoTaq Green Master Mix (Promega) (containing Taq DNA 
polymerase, buffer, MgCl2 and dNTPs) were carried out in a total volume of 20 
µL with 10-100 ng of DNA template, 1 µL of each 10 µM primer, 10 µL 2x 
Master Mix and SDW. Reactions with Pfu high fidelity DNA polymerase 
(Promega) were carried out in a total volume of 50 µL containing 5 µL 10X 
buffer, 5 µL DMSO, 1 µL 10 mM dNTPs, 10-100 ng of DNA template, 2.5 µL of 
each 10 µM primer, 0.5 µL Pfu DNA polymerase and SDW. PCRs were carried 
out on a thermocycler TC-312 (Techne, Duxford, UK). For amplification of 
inserts, PCR program consisted of: initial denaturation at 94°C for 1 min, 
followed by 35 cycles of denaturation at 94°C for 30 s, annealing at optimal 
temperature for 30 s and extension at 72°C for 1 min/kb. Final extension at 
68°C for 5 min was followed by hold at 4°C. 
2.4 Limiting dilution RT-PCR 
SuperScript II reverse transcriptase (Invitrogen) was used for the preparation of 
cDNA according to the manufacturer’s instructions. Two tubes were prepared 
for each sample. In a total volume of 12 µL, 1 µg of RNA was mixed with 50 ng 
random primers (Invitrogen) and 1 µL of 10 mM deoxyribonucleotide 
triphosphates (dNTPs) mix (Promega). The mixture was heated at 65°C for 5 
min and quickly chilled on ice. 4 µL of 5X First Strand Buffer, 2 µL 0.1 M 




incubated at 25°C for 10 min. 1 µL of reverse transcriptase was added to one 
tube and 1 µL DNAse- and RNAse-free water was added to the negative 
control tube. Samples were mixed and incubated at 25°C for 10 min, 42°C for 
50 min and 70°C for 15 min.  
 
PCR was carried out using undiluted cDNA and serial four-fold dilutions (1:4, 
1:16, 1:64, 1:256, and 1:1,026) with GoTaq Green Master mix and primers 
listed in Appendix 1.  
2.5 Cloning PCR products into pSC-A and pSC-B vectors 
A-tailed PCR products were cloned into pSC-A while blunt PCR products were 
cloned into pSC-B using the StrataClone PCR cloning kit (Stratagene). A 
reaction mixture was set up using 3 µL buffer, 10 ng PCR product and 1 µL 
Strataclone vector mix. After 1 h of incubation at RT, the reaction was 
transformed into StrataClone SoloPack competent cells as follows. Cells were 
thawed on ice, 1 µL of the reaction was added and mixed gently. Cells were 
incubated on ice for 20 min, heat shocked at 42°C for 45 s and incubated on ice 
for 2 min. Cells were recovered in 250 µL pre-warmed SOC medium shaking at 
225 rpm at 37°C for 1 h. Samples of 100 µL, 50 µL, and 5 µL of cells were 
plated onto LB agar plates containing the appropriate selection antibiotic plus 
X-gal and incubated overnight. White or light blue colonies were picked. 
2.6 Cloning PCR products into pGEM vector 
A-tailed PCR products were cloned into pGEM T-Easy Vector System 
(Promega). A reaction mixture was set up using 5 µL ligation buffer, 1 µL 
vector, 1 µL T4 DNA ligase, 3 µL PCR product and SDW in a total volume of 
10µL. After 1 h of incubation at RT, the reaction was transformed into 
subcloning efficency DH5α competent cells (Invitrogen). Samples were plated 
onto LB plates containing the appropriate selection antibiotic plus X-gal and 
incubated overnight; white or light blue colonies were picked. 
2.7 Blunting of sticky-end DNA fragments 
Sticky ends of DNA fragments were converted to blunt ends by mixing 1 µL Pfu 
high fidelity DNA polymerase (Promega), 2 µL of 10X buffer, 0.5 µL 10 mM 
dNTPs with 100-500 ng DNA and SDW in a 20 µL reaction. The mix was 
incubated for 25 min at 72°C. Samples were purified using a clean and 





2.8 A-tailing of DNA fragments 
DNA fragments were A-tailed by mixing 4 µL of 5X buffer with 0.4 µL 1 mM 
deoxyadenosine triphosphates (dATPs) (Promega), 1 µL GoTaq DNA 
polymerase (Promega) and 100-500 ng DNA in a total volume of 20 µL. The 
mix was incubated for 25 min at 72°C. Samples were purified using a clean and 
concentrate kit (Zymo). 
2.9 Restriction enzyme digests 
For a 20 µL reaction, the digestion mixture contained 200 ng of plasmid DNA, 2 
µL of 10X enzyme buffer, 1-2 µL of enzyme and SDW. Digests were incubated 
at 37°C for 1-2 h. For a 50 µL reaction, the digestion mixture contained 1-5 µg 
of plasmid DNA, 5 µL of 10X enzyme buffer, 2-3 µL of enzyme and SDW. 
Where appropriate, 2 µL Alkaline Phosphatase (Promega) was added as well 
as 5 µL of 10X buffer. Digests were incubated at 37°C overnight. 
2.10 DNA extraction from agarose gels 
DNA fragments were separated on 0.8% w/v or 1% w/v agarose gels made with 
UltraPureTM agarose (Invitrogen) in 1X TAE (242 g L-1 Tris base, 37.2 g L-1 
Na2EDTA and 57.1 mL L-1 glacial acetic acid pH 8.3) with 0.5 µg mL-1 ethidium 
bromide. Orange G buffer (1X) was used to load samples (2.5 g L-1 Orange G 
sodium salt, 40% w/v glycerol, 60% w/v TE buffer).  
 
DNA was extracted from agarose gels using the QIAquick Gel Extraction Kit 
(QIAGEN) according to the manufacturer’s instructions. The DNA fragment was 
excised using a scalpel and dissolved in 3 vol of buffer QG for 10 min at 50°C. 
1 gel vol of isopropanol was added and the mixture was transferred to a 
QIAquick spin column. The DNA was bound to the column by centrifugation at 
16000 x g for 1 min followed by a wash with 750 µL buffer PE and a 
centrifugation at 16000 x g for 1 min. DNA was eluted by adding 20 µL of SDW 
to the column and centrifugation for 1 min. 
2.11  Cleaning and concentrating of DNA 
Small quantities of DNA (≤5 µg) were cleaned and concentrated using the 
“Zymo 5” DNA Clean and Concentrator-5 kit (Zymo Research Corporation) 
while large quantities of DNA (between 5 µg and 25 µg) were cleaned and 




according to the manufacturer’s instructions. Briefly, in a 1.5 mL 
microcentrifuge tube, 2 vol of DNA binding buffer was added to each vol of 
DNA sample and mixed briefly by vortexing. The mixture was transferred to a 
Zymo-Spin Column in a collection tube. The tubes were centrifuged at 16000 x 
g for 30 s and the flow-through discarded. 200 µL of wash buffer was added to 
the column, spun at 16000 x g for 30 s, and the wash step was repeated. Small 
quantities of DNA were eluted by applying in 10 µL of SDW to the column while 
large quantities of DNA were eluted in 20-35 µL of SDW. DNA concentrations 
were measured on a ND-1000 spectrophometer. 
2.12  Ligation of DNA fragments 
Ligations were performed using the Rapid DNA Dephos & Ligation kit (Roche) 
according to the manufacturer’s instructions with a vector:insert ratio of 1:3. 
Reactions were carried out in a total volume of 20 µL containing 50 ng of 
linearised vector, a corresponding amount of insert, 2 µL of 5X dilution buffer 
and SDW and 10 µL of 2X ligation buffer. 1 µL of DNA ligase was added and 
the ligation reaction was incubated at RT for 1 h before transformation into 
competent E. coli cells. 
2.13  Transformation of E. coli 
Subcloning efficency DH5α competent cells (Invitrogen) were used for cloning. 
DNA (1-10 ng) was added to 50 µL of cells thawed on ice and mixed gently. 
Cells were incubated on ice for 30 min, heat shocked for 20 s at 42°C and 
placed on ice for 2 min. Cells were diluted into pre-warmed 0.9 mL of LB 
medium and incubated with shaking at 225 rpm at 37°C for 1 h; 100 µL of cells 
and the pellet were plated onto an LB agar plate containing the appropriate 
selection antibiotic and grown overnight at 37°C.  
2.14  Preparation of plasmid DNA 
Small scale plasmid DNA preparations were carried out using the Wizard Plus 
SV Minipreps DNA Purification Systems kit (Promega) according to the 
manufacturer’s instructions as follows. A 5 mL overnight culture was pelleted by 
centrifugation and the pellet was resuspended in 250 µL cell resuspension 
solution. 250 µL of cell lysis solution was added and mixed by inversion; 10 µL 
of alkaline protease was added, mixed by inversion, and incubated at RT for 5 
min. To stop the reaction, 350 µL of neutralisation buffer was added and mixed 




lysate was transferred into a spin column and spun at 16000 x g for 1 min. The 
column was washed by adding 750 µL of wash solution and spun at 16000 x g 
for 1 min. The wash step was repeated with 250 µL wash solution and the 
column spun for 2 min. DNA was eluted in 50 µL of SDW and stored at -20°C. 
 
Large scale plasmid DNA preparations were carried out using the HiSpeed 
Plasmid purification kit (QIAGEN) according to the manufacturer’s instructions 
as follows. A 100 mL overnight culture was pelleted by centrifugation (2700x g 
for 10 min) and the pellet was resuspended in 6 mL of buffer P1 containing 
RNase A. 6 mL of buffer P2 was added, mixed by inversion and the mixture 
was incubated at RT for 5 min. To stop the reaction, 6 mL of buffer P3 was 
added and mixed by inversion. The lysate was transferred into a QIAfilter 
cartridge, incubated for 10 min at RT and filtered into a HiSpeed tip pre-
equilibrated with 4 mL of buffer QBT. The HiSpeed tip was then washed with 20 
mL buffer QC and DNA was eluted with 5 mL of buffer QF. 3.5 mL isopropanol 
were added to precipitate the DNA and the mixture was incubated at RT for 5 
min. The solution was filtered through a QIAprecipitor and washed with 2 mL of 
70% ethanol. DNA was eluted in 1 mL of SDW and stored at -20°C.  
2.15  Site directed mutagenesis 
Site directed mutagenesis (SDM) was carried out in 50 µL total volume 
containing 2.5 units PfuUltra Hot Start high fidelity DNA polymerase 
(Stratagene), 1X buffer, 0.5 mM dNTPs, 125 ng of mutagenic primers and 10 
ng plasmid template. The PCR program consisted of: 95°C for 30 s, followed by 
18 cycles of 95°C for 30 s, 60°C for 1 min and 1 min/kb at 68°C. Template DNA 
was degraded using 10 units of DpnI at 37°C for 2 h. Samples were purified 
using a clean and concentrate kit (Zymo) and 2 µL were used to transform 
Subcloning DH5α competent cells. Recombinant plasmids were isolated and 
sequence-verified. Primers used for SDM experiments are listed in Appendices 
2 and 3. 
2.16  Construction of plasmids 
For testing promoter activity, the upstream regions of the predicted translational 
start site were PCR-amplified using the primers listed in Appendix 2. ScaI 
restriction sites were incorporated into the primers where required and the 
amplified regions were cloned into the PCR cloning vector pSC-A, from which 




the mycobacteriophage L5-derived promoter probe vector pSM128 (Dussurget 
et al., 1999). Successful cloning was confirmed by restriction enzyme digest 
and sequence verification. Lists of plasmids used in this study are provided in 
Appendix 4.  
 
Protein tags AADENYA-ASV and AADENYA-LAA, added to the C-terminal end 
of lacZ in pSM128, were provided by Dr D. Schuessler (NIMR). AADENYA-ASV 
was mutated to AADENYA-GGG by site directed mutagenesis using primers 
listed in Appendix 13. To construct AADSHQRDYA-LAA protein tag, LacZ was 
excised with HindIII, PCR amplified with a primer harbouring the tag and cloned 
into pSC-A. The tagged LacZ was cut out of pSC-A and cloned into pSM128. 
The acetamidase promoter (Pami) (Parish et al., 1997) was excised from 
pFLAME-3-ace (Blokpoel et al., 2003) with BamHI and EcoRI, blunted and 
cloned into the ScaI sites of the plasmids containing the lacZ constructs. M. 
smegmatis rpsA promoter with tetO operator (Psmyc) was cut out of pCon3 (Dr 
Paul Carroll, QMUL) with XbaI/BamHI, blunted and cloned into the ScaI sites of 
the plasmids containing the lacZ constructs.  
 
The tetracycline repressors were extracted from pMC1m and pMC1s (Guo et 
al., 2007) with NotI, blunted and cloned into pSC-B. The constructs were 
excised with EcoRI and cloned into the EcoRI sites of pTT1A (Pham et al., 
2007). Successful cloning was confirmed by restriction enzyme digest and 
sequence verification. Primers and plasmids used in this study are provided in 
Appendix 13. 
2.17  Electroporation of mycobacteria 
2.17.1 Electroporation of M. smegmatis and M. marinum 
A 5 mL pre-culture was grown overnight and 1 mL was used to inoculate a 100 
mL culture grown until an OD580 of 0.8-1.0 was reached. The culture was chilled 
on ice for 90 min before pelleting the cells by centrifugation at 2700 x g for 10 
min at 4°C. The pellet was resuspended in 20 mL 10% w/v glycerol and 
washed in 5 mL 10% glycerol. The final pellet was redissolved in 1 mL of 10% 
glycerol, dispensed in 200 µL aliquots and stored at -80°C. Electrocompetent 
cells were thawed on ice. To each vial of cells, 1 µg of salt-free DNA (in a 
volume of ≤5 µL) was added, mixed gently and the sample incubated on ice for 




cuvette (Flowgen Biosciences) and pulsed in an electroporator (Bio-Rad 
Laboratories Ltd.) set at 2.5 kV, 25 µF and 1000 Ω. Cells were incubated on ice 
for 10 min, recovered in 5 mL Lemco or 7H9 broth for M. smegmatis or M. 
marinum respectively and grown at 37°C with shaking at 100 rpm for 2 h. Serial 
dilutions were plated onto Lemco or 7H9 agar plates containing the appropriate 
selection antibiotic. Transformants were picked after 3 to 5 d of growth for M. 
smegmatis and after 7 d of growth for M. marinum. 
2.17.2 Electroporation of M. tuberculosis 
An inoculum of 3 mL was used to seed a 100 mL roller bottle culture which was 
grown for 7 d rolling at 37°C. The culture was treated with 10 mL of 2 M glycine 
24 h before harvesting. Half of the culture was pelleted by centrifugation at 
2700 x g for 10 min. The cells were washed twice in 10% w/v glycerol using 10 
and 5 mL respectively and resuspended in 1 mL of 10% w/v glycerol. 1 µg of 
plasmid DNA (in a volume of ≤ 5 µL) was mixed with 200 µL of cells. Cells were 
transferred into a 2 mm electroporation cuvette and pulsed in an electroporator 
set to 2.5 kV, 25 µF and 1000 Ω. Cells were recovered in 10 mL medium and 
incubated at 37°C for 24 h. Serial dilutions were plated onto 7H10 plates 
containing the appropriate selection antibiotic. Transformants were picked after 
4 weeks of growth.  
2.18 Reporter gene assays 
2.18.1 Preparation of cell-free extracts 
Mycobacterial cells were grown to an OD600 of 0.6-0.8, harvested by 
centrifugation (10 min at 2700 x g), washed in 5 mL of 10 mM Tris-Cl (pH 8) 
and resuspended in 1 mL of 10mM of Tris-Cl. The solution was transferred into 
a 2 mL lysing matrix B tube (MP Biomedicals). Cells were disrupted using a 
FastPrep FP120  set at speed 6.0 for 30 s. Samples were spun at 16 000 x g 
for 4 min and the supernatants were recovered. Cell-free extracts from M. 
tuberculosis cells were filter sterilised through a 0.2 µm filter unit. 
2.18.2 Determination of protein concentration  
Total protein concentration of the samples was determined using the Pierce 
BCA protein assay kit (Fisher). Standards of bovine serum albumin (BSA) were 
prepared using 0.9% w/v NaCl and used at 0, 25, 125, 250, 500, 750, 1000, 
1500 and 2000 µg mL-1. Reagents A and B were mixed at a ratio of 50:1 and 




96-well PVC microtitre plate. Samples were incubated at 37°C for 30 min and 
the OD562 was measured. A standard curve was plotted from which protein 
concentrations of the cell-free extracts were calculated. 
2.18.3 ß-galactosidase activity assays 
β-galactosidase assays were carried out following the method previously 
described by Miller (Miller, 1972). Briefly, 100 µL of cell-free extract was added 
to 900 µL of Z Buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM 
MgSO4, pH 7) and incubated at 37°C for 5 min. 200 µL of 4 mg mL-1 ONPG 
was added and reaction mixtures were incubated at 37°C for a minimum of 60 
min. Reactions were stopped with 500 µL of 1 M NaHCO3. The OD420 was 
measured and β-galactosidase activity, expressed in Miller Units (MU), was 
calculated using the following formula:  
 
 
2.19  Protein-protein interactions assays 
2.19.1 Bacterial two hybrid system 
Genes encoding the proteins of interest were amplified by PCR using the 
primer pairs listed in Appendix 8. The PCR products were cloned into pSC-A 
vector and sequence verified before being subcloned into pKT25 or pUT18 
vectors (Karimova et al., 1998). Plasmids are listed in Appendix 10. Different 
combinations of the resultant constructs were co-transformed into E. coli 
BTH101 and plated onto LB agar plates at 30°C containing X-Gal and 
appropriate selection antibiotics.  
 
To measure interaction between pairs of hybrid proteins, colonies were 
inoculated into 4 mL of LB broth with appropriate antibiotics and IPTG. Cultures 
were diluted to an O.D of 0.5 and 2 mL of M63 medium was added to 0.5 mL of 
bacterial cultures. Cells were permeabilised with 30 µL of toluene and 32 µL of 
0.1% w/v SDS. Tubes were vortexed for 10 s, lightly plugged with cotton and 
incubated at 37°C with shaking at 225 rpm for 35 min. For the enzymatic 
reaction, aliquots of 0.1 to 0.5 ml of the permeabilised cells were added to PM2 
buffer (70 mM Na2HPO4.12H20, 30 mM NaH2PO4 H20, 1 mM MgSO4, 0.2 mM 
MnSO4, 100 mM β-mercaptoethanol, pH 7.0) to a final volume of 1 mL. Tubes 




(pre-equilibrated to 30°C). Tubes were incubated at 37°C for 30 min. The 
reaction was stopped by addition of 0.5 ml of 1 M Na2CO3. The OD420 was 
measured and β-galactosidase activity, expressed in Miller Units, was 





Genes encoding the proteins of interest were amplified by PCR using the 
primer pairs listed in Appendix 9. The PCR products were cloned into pSC-A 
vector and sequence verified before being subcloned into PL240 and PL242 
vectors (O'Hare et al., 2008) between SpeI and HpaI restriction sites (plasmids 
are listed in Appendix 11). The resultant constructs were introduced into M. 
smegmatis ΔhisA and plated on Lemco agar. Three separate co-transformants 
were inoculated into 2 mL LB plus 0.05% Tween 80 and incubated at 37°C with 
shaking at 160 rpm until OD600 reached 1.0. 1 mL of culture was harvested by 
centrifugation at 2700 x g for 1 min. The bacteria were washed in 1 mL SDW 
plus 0.05% Tween 80 and resupended in 1 mL SDW. Drops of 5 µL suspension 
of undiluted, 1/10 and 1/100 dilutions were spotted onto 7H9 agar plates 
lacking tryptophan. The same dilutions were spotted onto plates containing 
tryptophan to check cell numbers. The plates were incubated for 3 weeks at 
25°C. 
2.20  Construction of deletion mutants of M. tuberculosis 
Mutant strains were created using recombineering (van Kessel and Hatfull, 
2007). The flanking regions and the gene of interests were amplified and 
cloned into pGEM vector; the gene was removed by inverse PCR with primers 
carrying BglII restriction sites. The hygromycin cassette with flanking dif sites 
was excised from pAL58 (Cascioferro et al., 2010) using BglII and cloned in 
between the two flanking regions. A linear allelic exchange substrate was 
prepared by digestion with XbaI and HindIII. pJV53 plasmid DNA (van Kessel 
and Hatfull, 2007) was electroporated into M. tuberculosis cells and cells 
carrying pJV53 were inoculated into 100 mL roller bottle of 7H9 induction 
medium (7H9, 10% w/v BSA, Tween 80, 0.2% w/v succinate, kanamycin) and 
incubated at 37°C until an OD580 of 0.4 was reached. 10 mL of 2M glycine and 
0.2% w/v of acetamide were added and the culture was incubated rolling for 24 
OD420 
time (min) 




h at 37°C. 100 ng of linearised DNA were elecroporated and cells were 
recovered in 10 mL medium incubated at 37°C for 2 d before plating. Colonies 
resistant to kanamycin and hygromycin were screened and validated by 
Southern blot analysis. Primers and plasmids used in this study are listed in 
Appendices 14 and 15. 
 
Complementing vectors, carrying smpB or ssrA with their own promoters, were 
constructed by amplifying the corresponding gene sequences and 200 bp of 
upstream sequence from genomic DNA with primers listed in Appendix 14. The 
products were cloned into pGEM and the Gm-int cassette from pUC-Gm-Int 
(Mahenthiralingam et al., 1998) was introduced as a HindIII fragment. The 
resulting vector was introduced in M. tuberculosis smpBΔ (for SmpB 
complementing vector) or cells carrying pJV53 (for SsrA complementing vector) 
and transformants were selected on 7H10 plates containing gentamycin. 
2.21  Southern blotting 
1.5 µg M. tuberculosis genomic DNA was digested overnight with a selected 
restriction enzyme and separated by gel electrophoresis. The DNA gel was 
incubated for 30 min at RT with slow shaking in denaturing buffer (3M NaCl, 1M 
NaOH) followed by 30 min incubation with neutralizing buffer (3M NaCl, 1M 
Tris). DNA was transferred to a Nytran SuPerCharge nylon membrane using a 
turboblotter (Whatman) following manufacturer’s instructions as follows. 20 
sheets of dry GB004 blotting paper (thick) were placed in the stack tray and 
four sheets of dry 3MM Chr blotting paper (thin) were placed on top of stack. 
One sheet of prewet 3MM Chr blotting paper in transfer buffer (3M NaCl, 8 mM 
NaOH) and the transfer membrane was then added. The membrane was 
covered with the agarose gel, making sure there were no air bubbles in 
between. The top surface of the gel was weted with transfer buffer, and three 
sheets of 3MM Chr blotting paper, presoaked in transfer buffer, placed on top of 
the gel. The “buffer tray” of the transfer device was added to the bottom tray 
and filled with transfer buffer. Transfer was carried out overnight. 
 
The membrane was placed in a glass hybridization tube containing 15 mL of 
AlkPhos Direct hybridisation buffer (GE Healthcare) and incubated rolling at 
60°C for 5-6 h. To generate a probe, a DNA fragment was PCR amplified and 
labeled with AlkPhos Direct system (GE Healthcare) according to the 




ng/µL, heated for 5 min in a boiling water bath and immediately cooled on ice 
for 5 min. 10 µL of reaction buffer, 2 µL of labelling reagent, 10 µL of cross 
linker solution were added and the mixture was incubated at 37°C for 30 min. 
The probe was added to the buffer and hybridised overnight at 60°C. Primary 
and secondary post hybridization washes were carried out. 50 mL of pre-
heated primary wash buffer (2M urea, 0.1% SDS, 50 mM NaOH, 150 mM NaCl, 
1mM MgCl2 and 0.2% blocking reagent) was incubated for 30 min with gentle 
agitation at 60°C. The wash step was repeated before placing the blot in a 
clean container containing 100 mL of secondary wash buffer (1M Tris, 2 M 
NaCl, 1M MgCl2) for 5 min at RT with gentle agitation twice. The probe was 
detected by CDP-Star (GE Healthcare) using 1 mL of detection reagent for 5 
min at RT. The blot was wrapped in a detection bag and placed in a film 
cassette. HyperfilmECL autoradiography film (GE Healthcare) was placed on 
top of the blot in a dark room, exposed for minimum 1 h and developed. 
2.22  Macrophage infections 
J774A murine macrophages (derived monocytes from Balb/C) (Rastogi et al., 
1989) were grown in complete medium (Dulbecco's Modified Eagle Medium, 
DMEM) (Invitrogen), supplemented with 10% fetal calf serum (FCS) (Invitrogen) 
and 2 mM L-Glutamine, at 37°C with 5% CO2. Activated macrophages were 
prepared by adding 100 units mL-1 interferon gamma (Invitrogen) for 24 h and 
100 ng ml-1 LPS for 4 h at 37°C. To get a multiplicity of infection of 10, 1 mL of 
an M. tuberculosis culture at O.D=0.05 was spun and resuspended in 10 mL 
complete medium. 100 µL of the suspension was added to 5x105 monocytes 
per well of a 24 well plate and incubated at 37°C with 5% CO2 for 24 h. The 
extracellular bacteria were removed by washing the macrophages three times 
with 1 mL PBS. To determine the number of intracellular bacteria at each time 
point (1, 3 and 7 d), bacteria were harvested using 4 mL of 0.25% SDS and 
serial dilutions of the lysates were plated on plates and incubated at 37°C for 4 
weeks before the colonies were counted. 
2.23  Electrophoretic mobility shift assay  
The Rv2745c coding sequence was PCR amplified and cloned into pET-28a 
(Novagen) using primers to encode mutations V111D and A112D at the C- 
terminus listed in Appendix 5. Protein expression and purification were carried 






PCR products were amplified using primers listed in Appendix 6 with biotin 
modification on one primer. Electrophoretic mobility shift assays (EMSA) were 
carried out using the LightShift Chemiluminescent EMSA Kit (Pierce) according 
to the manufacturer’s instructions as follows. Binding reactions were performed 
with 10X binding buffer, 1 µg poly dI:dC, 15 fmol target DNA, protein extract 
and SDW for 20 min at RT. Samples were electrophoresed in 6% native 
polyacrylamide gel for 2 h in 0.5X TBE buffer. Reactions were transferred to a 
nylon membrane (Thermo Scientific) in an electrophoretic transfer unit with 
0.5X TBE buffer at 100V for 1 h. The membrane was crosslinked in a UV-light 
crosslinking instrument using the auto crosslink function. To block the 
membrane 20 mL of blocking buffer was added and incubated for 15 min with 
gentle shaking. The buffer was replaced by 20 mL blocking buffer containing 
66.7 µL streptavidin-horseradish peroxidase conjugate and incubated for 15 
min at RT. The membrane was washed 4 times for 5 min each in wash solution 
followed by 5 min incubation in 30 mL of substrate equilibration buffer. Excess 
buffer was removed and the membrane was incubated for 5 min with substrate 
solution composed of luminol-enhancer solution mixed with stable peroxide 
solution. The moist membrane was wrapped in plastic wrap and exposed to X-
ray film. 
2.24  Microarray 
RNA was extracted and cDNA was synthesised and labelled using SuperScript 
Indirect cDNA Labeling System (Invitrogen) following manufacturer’s 
instructions as follows. Two µg total RNA was mixed with 5 µg anchored 
oligo(dT)20 primer, 1 µL of random hexamers and SDW in a total volume of 18 
µL. The mixture was heated at 70°C for 5 min and quickly placed on ice; 6 µL of 
5X First Strand Buffer, 1.5 µL 0.1 M dithiothreitol (DTT), 1 µL dNTP mix 
(including amino-modified nucleotides), 1 µL RNaseOUT and 1 µL Superscript 
III Reverse transcriptase were added and incubated at 46°C overnight. The 
synthesis reaction was stopped by adding 10 µL 0.5M EDTA and 10µL 1M 
NaOH and incubated at 65°C for 15 min. 25 µL 1M Tris was added to neutralise 
the pH. In parallel, 4 µg gDNA were digested overnight with EcoRI and cleaned 
DNA was mixed with 10 µg of random hexamers and distilled water in a total 
volume of 39 µL. The mixture was mixed, incubated at 100°C for 10 min and 
chilled on ice for 30 s. Five µL of 10X EcoPol (Klenow) buffer, 2 µL of 5 mM 




added to the mixture and incubated at 37°C overnight. DNA transcription was 
stopped by adding 5 µL of 0.5M EDTA. 
 
Unincorporated aa-dUTP and free amines were removed from gDNA and cDNA 
samples following a modified method from the MinElute PCR purification kit 
(Qiagen). cDNA was vigorously mixed with 400 µL PB buffer before transferring 
to MinElute column and spun for 1 min; 750 µL phosphate wash buffer was 
added to the column and spun for 1 min. The collection tube was emptied and 
the column centrifuged for an additional 1 min. The column was transferred to a 
new 1.5 microfuge tube and 30 µL phosphate elution buffer was added. The 
buffer was eluted by centrifugation and a second elution was repeated with 
another 30 µL of phosphate elution buffer.  
 
The gDNA and cDNA solutions were dried in a vacuum concentrator until the 
volume was reduced to 3 µL and 5 µL of 2X coupling buffer was added. 2 µL of 
DMSO was added to vials of Cy3 or Cy5 Alexa Fluor Reactive dyes (Invitrogen) 
to resuspend the dyes, vortexed thoroughly and added to the relevant gDNA or 
cDNA tubes. The mixes were incubated at RT in the dark for 1-2 h. Free dye 
was removed by purification following a modified method from the MinElute 
PCR purification kit (Qiagen) as previously. cDNA was eluted by adding 30 µL 
EB buffer twice. cDNA concentrations as well as dye incorporations were 
measured on a ND-1000 spectrophometer.  
 
Cy3 and Cy5 probes were mixed together and dry in a speed vac concentrator.  
Microarrays were provided by the Bacterial Microarray Group at St Georges, 
University of London ( BµG@S). Printed slides were incubated at 42°C with 
prehybridisation buffer (5X SSC, 0.1% SDS and 1% BSA) for at least 1 h. The 
buffer was removed and SDW was added and removed until suds could no 
longer be seen. The slides were placed in a slide holder inside a staining dish 
containing water and placed on a rotor shaker. The water was changed every 2 
min until 2 L total of wash water was used. The staining dish was filled with 
isopropyl alcohol for 2 min and the slides were centrifuged at 600 x g for 10 
min. 
 
65 µL of hybridisation buffer (40% formamide, 5X SSC, 0.1% SDS, 0.6 µg.µL-1 
salmon sperm DNA) was added to the Cy3/Cy5 probe mixture and vortexed. 




for 5 min. A clean lifterslip was placed over the prehybridised microarray slide 
and the labelled probe mixture was pipetted onto the lower edge of the lifterslip. 
Slides were placed in a hybridisation chamber and incubated in a 42°C 
waterbath overnight. Slides were removed from the chamber and placed in low 
stringency wash buffer (2X SSC, 0.1% SDS, 0.1 mM DTT) pre-warmed to 
55°C. As the cover slips were removed, the slides were placed in a glass slide 
holder placed into a staining dish containing low stringency wash buffer pre-
heated to 55°C and agitated for 5 min. Slides were transferred to a dish with 
new low stringency buffer and agitated for 5 min; washed twice in medium 
stringency medium (0.1X SSC, 0.1% SDS, 0.1 mM DTT) for 5 min followed by 
2 washes for 5 min in high stringency medium (0.1X SSC, 0.1 mM DTT).  
 
Slides were read with a Genepix scanner and microarray analysis was 
performed by the Bacterial Microarray Group at St. George's, University of 
London (BµG@S). Each experiment was analysed separately and also 
combined as one. GeneSpring v7.3 analysis software was used for statistical 
analysis to identify any significant differences between the expression levels of 
individual genes. Analysis was restricted to only genes with 2-fold expression 
differences. One-way ANOVA was used to select differentially expressed genes 
with a p-value of less than 0.05 using Benjamini and Hochberg false discovery 
rate correction. 
2.25  qRT-PCR 
5 µL of DNA or cDNA was added to a 2X mix composed of 25 µL Taqman 
mastermix (Roche), 9 µL of 5 µM primer mix, 1 µL of 25 µM probe and 10 µL 
SDW. 25 µL of the reaction mix were aliquoted into a 96 well qRT-PCR plate 
and centrifuged briefly. Amplification reactions were monitored with the 7500 
Real Time PCR System (Applied Biosystems). Three biological replicates were 
assayed in duplicate. In order to measure relative gene expression levels, 
standard curves for each primer-probe set were generated using genomic DNA 
and used to calculate copy number for cDNA reactions. Copy number was 
corrected by substractiong background from genomic DNA in the samples (no 
reverse transcription reaction). In order to standardise the samples to ensure 
that equal amounts of cDNA were used each value was standardized to sigA to 




3 Regulation of ClpP1 and ClpP2 expression 
and activity 
3.1 Introduction 
Clp proteases have proteolytic cores capable of cleaving a broad range of 
peptide bonds, and yet their activity is directed against only misfolded or 
aggregated proteins and specific substrate proteins (Thompson et al., 1994). 
The active Clp protease is composed of a proteolytic and a regulatory ATPase 
subunit as the proteolytic subunit is unable to bind and degrade protein without 
an ATPase control partner. Degradation by the Clp complex is a highly 
regulated process and this control is critical for the cell viability. For example 
activation of ClpP activity by ADEPs is lethal in Gram positive bacteria including 
M. tuberculosis (Brotz-Oesterhelt et al., 2005; Ollinger et al., 2011).  
 
Prokaryotic gene expression is controlled mainly at the level of initiation of gene 
transcription (Alberts et al., 2002b). Clp proteases are involved in protein quality 
control by degrading misfolded or aggregated proteins, thus it is not surprising 
that in most bacteria expression of ClpP is induced by conditions which lead to 
protein misfolding, such as heat shock or oxidative stress (Engels et al., 2004; 
Msadek et al., 1998). In M. tuberculosis, the clpP genes are highly expressed 
during aerobic and hypoxic growth and are further up-regulated during 
reaeration following exposure to anaerobic conditions (Muttucumaru et al., 
2004; Sherrid et al., 2010). Additionally, an increase in clpP1 and clpP2 
expression was observed after different stresses such as oxidative shock in M. 
tuberculosis and after vancomycin treatment in M. smegmatis (Barik et al., 
2009; Mehra and Kaushal, 2009). The transcriptional regulator ClgR activates 
ClpP1 and ClpP2 expression in actinobacteria including M. tuberculosis (Bellier 
and Mazodier, 2004; Engels et al., 2004; Sherrid et al., 2010). ClgR-mediated 
up-regulation of the clp genes is required for replication in a macrophage model 
of infection (Estorninho et al., 2010) supporting an important role for the Clp 
proteases during adverse conditions.  
 
Regulation of proteolysis may also occur at the level of substrate selection. The 
Clp ATPase subunits recognise and control substrate entry into the proteolytic 
core for degradation and therefore ensure proteolytic specificity (Hoskins et al., 




example, E. coli ClpXP complex degrades the stationary-phase sigma factor σS 
and Mu transposase, which are not substrates for ClpAP (Levchenko et al., 
1995; Schweder et al., 1996). Conversely, ClpAP, but not ClpXP, degrades 
MazE and HemA (Engelberg-Kulka and Glaser, 1999; Wang et al., 1999).  
 
M. tuberculosis contains three potential ATPase subunits (ClpC1, ClpC2 and 
ClpX) but it is not known how many of them associate with ClpP1 or ClpP2 (Fig 
3.1 A). ClpX and ClpC1 possess ‘LGF’ loops (Fig 3.1 B), a determinant for 
interaction with ClpP (Kim et al., 2001), suggesting there are the only two 
ATPases interacting with ClpP1 and ClpP2. ClpC2 may not be functional since 
it does not have ATPase activity (Benaroudj et al., 2011). Interaction between 
ClpP2 and ClpC1 has been demonstrated (Singh et al., 2006) but this does not 
exclude interaction between ClpP1 and ClpC1; RseA was shown to be 
degraded by the ClpP2-ClpC1 complex (Barik et al., 2009) further 
demonstrating an interaction between ClpP2 and ClpC1.  
 
The presence of two ClpP proteases in M. tuberculosis as well as their 
essentiality is intriguing. One could hypothesise that ClpP1 and ClpP2 are 
present or induced in the cell under different conditions. For example, one ClpP 
subunit could be constitutively expressed while the other one may be induced 
in the presence of stress conditions or alternatively, the two ClpP proteins may 
be induced in response to different environmental conditions. The presence of 
two ClpP proteins suggests that they may target different substrates or be 
involved in different cellular pathways. In order to determine the specific role of 
the two ClpP proteases in M. tuberculosis, the first objective of the project was 
to determine if there was a difference in clpP1 and clpP2 gene expression and 
regulation. ClpP1 and ClpP2 could target different substrates by interacting with 
different ATPase subunits or accessory subunits; thus the next objective was to 
determine protein-protein interaction between the two ClpP subunits, the 
ATPases and the accessory components.  
3.2 Results 
3.2.1 Co-transcription of clpP1 and clpP2  
It seemed likely that clpP1 and clpP2 were co-expressed since they are 





Figure 3.1 ClpP and Clp ATPases present in M. tuberculosis 
A) Genomic organisation of the ClpP and Clp ATPase subunits in M. tuberculosis. The 
genetic coordinates for the H37Rv strain of M. tuberculosis are given.  
B) Overall architecture of the Clp ATPases present in M. tuberculosis. Class I ATPase 
proteins (ClpC1) contain two ATPase (AAA) modules while class II (ClpX) contain only 
one AAA module. The ‘LGF’ loops sequences, predicted to be necessary for interaction 





















and stop codons overlap. In order to determine if clpP1 and clpP2 are co-
transcribed as an operon, semi-quantitative RT-PCR was conducted on RNA 
extracted from M. tuberculosis during late exponentional phase. cDNA was 
synthesised and primers were designed to amplify regions specific to clpP1 
(258 bp) and clpP2 (264 bp), or that spanned clpP1-clpP2 junction (257 bp). To 
determine the relative amounts of each mRNA species, limiting dilution RT-
PCR was used as a semi-quantitative method; sigA, whose expression is 
considered to be constant was used as a control (Manganelli et al., 1999) (Fig 
3.2). Products were identified for all three mRNA species, indicating that the 
two genes are co-transcribed. The relative levels of amplification of clpP2 were 
lower compared to levels of clpP1 mRNA as expected if the gene was at the 3’ 
end of an operon. These data demonstrate that clpP1 and clpP2 are 
transcribed in late exponentional phase and the two clpP genes are co-
expressed under the control of a single promoter. 
3.2.2 Identification of the promoter of the clpP1P2 operon 
In order to identify the promoter of the operon, a 125 bp region (P125) 
encompassing the first two codons of M. tuberculosis clpP1, the intergenic 
region between clpP1 and the upstream gene tig, and the tig stop codon, was 
cloned into pSM128, a plasmid which integrates in a single copy in the genome 
and contains a promoterless lacZ reporter gene (Dussurget et al., 1999). The 
corresponding plasmid was electroporated into M. smegmatis, M. marinum, and 
M. tuberculosis and promoter activity was assayed in aerobic standing cultures. 
Promoter activity, measured by β-galactosidase activity, was detected in all 
three organisms confirming that a functional promoter was present in this 
region (Fig 3.3 B). However, the promoter was much more active in M. 
tuberculosis (106 MU) as compared to M. marinum (12 MU) or M. smegmatis 
(15 MU).  
 
To exclude the possibility of another promoter sequence upstream of clpP2, the 
region encompassing the first two codons of clpP2 and 280 bp upstream of 
clpP2, was cloned upstream of a promoterless lacZ reporter gene. Promoter 
activity was assayed in aerobic standing cultures in M. tuberculosis; no activity 
was detected in this region (Fig 3.3 C) confirming that, at least under aerobic 






Figure 3.2 Co-transcription of clpP1 and clpP2 in M. tuberculosis 
A) Chromosomal organisation of clpP1 and clpP2. Regions amplified for RT-PCR are 
marked. B) Limiting dilution RT-PCR. RNA was extracted from M. tuberculosis grown to 
late exponential phase in liquid cultures and cDNA was synthesised form 1 µg of RNA. 
Serial-four fold dilutions of cDNA were used as a template for PCR using primers 
specific for clpP1 (P1), clpP2 (P2), the spanned clpP1-clpP2 junction (P1P2) and sigA. 
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Figure 3.3 Identification of the promoter of the clpP1P2 operon  
A) Upstream regions of clpP1 or clpP2 tested for promoter activity. B) P125 activity in M. 
smegmatis, M. marinum and M. tuberculosis. C) PclpP2 activity in M. tuberculosis. 
Promoter activity was measured in transformants grown in late exponential phase in 
standing liquid cultures. Results are the average activity ± standard deviation of three 
independent transformants assayed in duplicate. Activity is given in Miller Units (MU)- 
measured as nmol of O-nitrophenol produced per min per mg of protein. The 





Mycobacterial promoters are very diverse although the -10 element is 
frequently similar to the E. coli consensus sequence (TATAAT) (Gomez and 
Smith, 2000). Looking at the sequence data it was possible to identify two 
putative -10 elements in the 125 bp promoter region (Fig 3.4 A). To determine if 
either of these are the genuine -10 element of the promoter, the TAGTGT 
hexamer (10A) was mutated to CAGTGG and the TAGAAG hexamer (10B) 
was mutated to CGGAAG and promoter activity, using lacZ reporter gene, was 
measured in M. marinum and M. tuberculosis (Fig 3.4 B and C). In M. marinum 
and M. tuberculosis, no significant difference in activity was observed when the 
TAGAAG hexamer was mutated to CGGAAG but when the TAGTGT was 
mutated to CAGTGG promoter activity was abolished, indicating that the 
TAGTGT hexamer is the -10 element of the ClpP1P2 operon promoter.  
 
In mycobacteria the -35 region of a promoter is often hard to predict, and it is 
not uncommon for regulated promoters to completely lack a -35 element 
(Gomez and Smith, 2000). Two potential -35 elements were identified (35A and 
35B in Fig 3.4 A) with similarity to the canonical -35 element of E. coli 
promoters (TTGACA), located 17 and 23 nucleotides upstream of the -10 
element respectively. Mutation of each element was conducted and the effect 
on promoter activity measured in M. tuberculosis (Fig. 3.4 D); neither of the 
mutations reduced promoter activity suggesting that they are not functional -35 
elements and that this promoter may lack this region. However, mutation of 
GTGACC (35A) to CCGACC significantly increased promoter activity; a 
possible explanation for this may be that this region may be a binding site for a 
regulator as discussed in a later section (3.2.9). 
3.2.3 Promoter of the clpP1P2 operon is weak 
The frequency of transcription initiation is dependent on the strength of the 
promoter i.e. its affinity for the RNA polymerase, and the action of regulatory 
proteins. In order to determine the intrinsic strength of the ClpP1P2 operon 
promoter, a short upstream region, encompassing the two first ClpP1 codons 
and 86 bp upstream of clpP1 (denoted P92), was cloned upstream of a 
promoterless lacZ and activity was measured in M. tuberculosis. The activity 
was very low (12 MU) demonstrating that the promoter is weak (Fig 3.5). 
Expression of clpP1P2 is induced after addition of vancomycin in M. smegmatis 





Figure 3.4 Identification of the promoter elements of the clpP1P2 operon 
A) Sequence of the upstream region of clpP1P2. Putative -10 elements (10A and 10B) 
and putative -35 elements (35A and 35B) are boxed. Mutated residues are in bold. 
ClpP1 start codon is indicated. B and C) Identification of the -10 element in M. marinum 
and in M. tuberculosis respectively. The following mutations were made- 10A: TAGTGT 
mutated to CAGTGG; 10B: TAGAAG mutated to CGGAAG. D) Absence of a -35 
element. The following mutations were made- 35A: GTGACC to CCGACC; 35B: 
GCGAAA to GCGAGG. 
Promoter activity was measured in transformants grown in late exponential phase in 
standing liquid cultures. Results are the average activity of three independent 
transformants assayed in duplicate ± standard deviation. Activity is given in Miller Units 
(MU)- measured as nmol of O-nitrophenol produced per min per mg of protein. The 
background activity from pSM128 (control vector) was 4 ± 2 MU. A significant 
difference, measured by the student’s t-test (unpaired, two sided), compared to the 










































































































Figure 3.5 Promoter activity of P92 in response to diamide and vancomycin 
M. tuberculosis transformants harbouring the P92 plasmid or the control vector pSM128 
were grown to late exponential phase in standing liquid cultures. Stress treatments 
were 10 mM diamide for 1 h or 6 µg/mL of vancomycin for 90 min. Cell-free extracts 
were prepared after treatment and results are the average activity of three independent 
transformants assayed in duplicate ± standard deviation. Activity is given in Miller Units 
(MU)- measured as nmol of O-nitrophenol produced per min per mg of protein. A 
significant difference compared to the control vector pSM128 is marked by an * (p 















































(Barik et al., 2009; Mehra and Kaushal, 2009). Activity of P92 was tested after 
these treatments but was not induced (Fig 3.5).  
3.2.4 Promoter activity in response to heat and oxidative 
shocks  
Under stress conditions such as high temperature or oxidation, misfolded and 
aggregated proteins can accumulate and are potentially toxic for the cells. Clp 
proteases are involved in the degradation of misfolded or aggregated proteins 
(Kruger et al., 2000; Thomsen et al., 2002) and are heat induced in several 
organisms including B. subtilis and C. glutamicum (Engels et al., 2004; Msadek 
et al., 1998). Promoter activity of P125 in M. smegmatis cultures exposed to 
moderate (42°C) or even severe (50°C) heat shocks were not significantly 
different from the untreated control (Fig. 3.6 A). Moderate heat shock was 
tested in M. tuberculosis, as well as oxidative shock (diamide) to determine if 
the published observations regarding increased RNA expression after oxidative 
stress correlated with increased promoter activity. Promoter activity after heat 
and oxidative stress was not significantly different from the untreated control 
(Fig. 3.6 B) indicating that the promoter was not induced by these conditions. 
3.2.5 Increased promoter activity of a longer fragment  
Since the promoter activity was not increased after oxidative stress despite 
previous published reports of RNA induction, it was considered that the 
intergenic region being examined might not contain all the regulatory sites. A 
longer fragment upstream of clpP1/clpP2 (278 bp) was cloned upstream of a 
promoterless lacZ reporter gene (denoted P278) and promoter activity was 
measured in M. tuberculosis, M. smegmatis and M. marinum (Fig. 3.7). In all 
species the longer fragment had a higher promoter activity than the shorter 
region (Fig 3.3B and Fig 3.7), suggesting that binding sites for regulatory 
elements were missing in the shorter region. Again, promoter activity was much 
lower in M. smegmatis (95 MU) and M. marinum (207 MU), than in M. 
tuberculosis (865 MU). Plasmid instability was noted in M. marinum, since only 
one of the three transformants tested contained the insert.  
 
The longer fragment (P278) was used in all the future studies as the shorter 
fragment misses binding sites for regulatory elements. The effect of heat and 
oxidative stress treatments on promoter activity was first tested in M. 
smegmatis and M. marinum. However, once again promoter activity was not 





Figure 3.6 Promoter activity in response to heat and oxidative stresses in 
M.smegmatis and M. tuberculosis 
Promoter activity of P125 was measured in transformants grown to late exponential 
phase in standing liquid cultures. Stress treatments were 10 mM diamide for 1 h, heat 
shock at 42°C for 1 h, or 50°C for 1 h. Cell-free extracts were prepared after treatment 
and results are the average activity of three independent transformants assayed in 
duplicate ± standard deviation. Activity is given in Miller Units- measured as nmol of O-
nitrophenol produced per min per mg of protein. The background activity from the 






















































Figure 3.7 Promoter activity of P278 in response to stress treatments  
Promoter activity of a 278 bp fragment upstream of clpP1 was measured in A) M. 
smegmatis, B) M. marinum, C and D) in M. tuberculosis in standing or rolling cultures 
respectively. 
Transformants harbouring P278 were grown to late exponential phase in standing liquid 
cultures unless otherwise stated. Treatments were: 42°C for 1 h, 50°C for 1 h, 10 mM 
diamide for 1 h, 50 µg/mL of chlorpromazine for 3 h, 10 µg/mL of menadione for 3 h, 10 
µg/mL of valinomycin for 3h, 6 µg/mL of vancomycin for 90 min. Cell-free extracts were 
prepared after treatment and results are the average activity of three independent 
transformants assayed in duplicate ± standard deviation. Activity is given in Miller Units 
(MU)- measured as nmol of O-nitrophenol produced per min per mg of protein. The 





































































































































valinomycin in M. tuberculosis (Boshoff et al., 2004) and vancomycin treatment 
in M. smegmatis (Barik et al., 2009) have previously been shown to increase 
ClpP expression, these conditions were also examined. Promoter activity was 
tested in M. tuberculosis following these treatments but the promoter was not 
significantly induced or repressed in standing cultures (Fig 3.7 C). To determine 
if the lack of induction was specific to standing cultures, promoter activity was 
also measured in aerated rolling cultures before and after heat and oxidative 
stress treatments in M. tuberculosis. Promoter activity was different in rolling 
cultures (1,380 MU) compared to standing cultures (740 MU) but again was not 
induced after heat or oxidative stress (Fig 3.7 D).  
 
The difference in promoter activity between rolling and standing cultures could 
indicate that the promoter activity is growth dependent. Promoter activity was 
measured from rolling aerated cultures over a time course from O.D580 0.15 to 
O.D580 1.7. The activity was constant from an O.D580 of 0.15 to stationary phase 
at O.D580 1.5 (from 720 to 980 MU) (Fig 3.8). However in late stationary phase, 
at O.D580 of 1.7 to 1.8, promoter activity increased significantly (to 1,050 MU) 
compared to the activity measured at O.D580 0.15 (Fig 3.8). 
3.2.6 The lack of induction is not due to experimental factors 
A series of experiments were designed to try to understand why the lack of 
ClpP induction in this study does not correlate with previous studies (Barik et 
al., 2009; Boshoff et al., 2004; Mehra and Kaushal, 2009).  
 
Microarray data suggested that streptomycin induces clpP1 and clpP2 
expression (Boshoff et al., 2004). However, streptomycin was used throughout 
the culturing to maintain selection of the promoter constructs raising the 
possibility that the lack of induction observed in these studies may result from 
the fact that the promoter was already induced. To determine if this was the 
case, promoter activity was measured in cultures grown with or without 
antibiotic selection for seven days. There was no significant difference in 
promoter activity between cultures grown in presence or absence of antibiotic 
selection and no induction of activity was observed following diamide or 
vancomycin treatment in either condition (Fig 3.9 A). This shows that antibiotic 






Figure 3.8 Promoter activity during aerobic growth in M. tuberculosis 
Transformants harbouring P278 were grown in aerobic cultures. Cell-free extracts were 
prepared and ß-galactosidase activity assayed in duplicate. Results are the average 
activity of three transformants against average OD580. Activity is given in Miller Units 
(MU)- measured as nmol of O-nitrophenol produced per min per mg of protein. The 
background activity from pSM128 (control vector) was 8 ± 3 MU. A significant 
difference, measured by the student’s t-test (unpaired, two sided), compared to 























Figure 3.9 Promoter activity was not induced during experimental conditions 
A) Promoter activity in response to diamide and vancomycin treatments in presence or 
absence of streptomycin selection. B) Promoter activity of cultures processed at 4°C or 
at 25°C. C) Promoter activity in response to diamide treatment in M. tuberculosis 
CDC1551. 
M. tuberculosis transformants were grown to late exponential phase in standing liquid 
cultures. Stress treatments were 10 mM diamide for 1 h or 6 µg/mL of vancomycin for 
90 min. Cell-free extracts were prepared after treatment and results are the average 
activity of three independent transformants assayed in duplicate ± standard deviation. 
Activity is given in Miller Units (MU)- measured as nmol of O-nitrophenol produced per 
min per mg of protein. The background activity from pSM128 was 6 ± 2 MU under the 
different conditions tested. 




































































ClpP1 can be induced by cold shock in cyanobacteria (Porankiewicz et al., 
1998). During the making of cell free extracts, liquid cultures were harvested at 
4°C, raising the possibility that promoter activity may have been induced during 
processing. To address this question, promoter activity was measured in 
cultures harvested at 4°C or at room temperature (25°C) but no significant 
different in activity was noted excluding cold shock induction (Fig. 3.9 B).   
 
Previously, ClpP induction in response to diamide treatment has been 
demonstrated in M. tuberculosis CDC1551 strain (Mehra and Kaushal, 2009). 
To determine whether clpP1P2 induction might be strain-specific, promoter 
activity was compared between M. tuberculosis H37Rv and M. tuberculosis 
CDC1551. The activity of the CDC1551 strain (800 MU) was comparable to that  
observed in H37Rv and was not induced after diamide treatment (Fig 3.9 C) 
demonstrating that promoter induction after diamide treatment was not strain- 
specific.  
3.2.7 Promoter activity during hypoxia and reaeration 
M. tuberculosis has the ability to survive inside the host environment for 
decades in a latent state before reactivation. The Wayne model is frequently 
used to study hypoxia (Wayne and Hayes, 1996), one condition believed to be 
encountered by the bacteria during latency, and inoculating hypoxic cultures 
into aerated medium (reaeration) can be used to mimic reactivation of the 
disease (Sherrid et al., 2010). Promoter activity was measured during 
adaptation to hypoxia and over 12 weeks of survival in hypoxia (Fig 3.10 A). 
Promoter expression was similar between aerated and hypoxic cultures 
(typically around 700-800 MU) for up to 56 days (eight weeks) of hypoxia. 
Promoter activity was reduced to 350 MU between weeks 8 and 12 (84 days) of 
exposure to hypoxia. Hypoxic cultures of 84 days were then inoculated into 
aerated medium, and promoter activities were measured once the cultures 
reached a minimum O.D580 of 0.3. Promoter activity returned to its original 
activity quickly after reaeration (Fig. 3.10 B).  
3.2.8 Mapping of a regulatory sequence  
Higher promoter activity was observed for P278 compared to P125 suggesting 
that the longer fragment contained at least one regulatory element binding site 




   
Figure 3.10 Promoter activity in hypoxic cultures and after reaeration 
A) Promoter activity in the Wayne model of hypoxia. M. tuberculosis liquid cultures 
were inoculated to a theoretical starting OD580 of 0.004 in DTA medium. Results are the 
average activity of three independent transformants assayed in duplicate ± standard 
deviation. Activity is given in Miller Units (MU)- measured as nmol of O-nitrophenol 
produced per min per mg of protein. A significant difference compared to activity at day 
0 is marked by an * (p <0.05) using the student’s t-test (unpaired, two sided). 
B) Promoter activity after reaeration. 84 days hypoxic cultures were used to inoculate 
aerobic rolling cultures. Cell-free extracts were prepared once the cultures reached an 
O.D580 of 0.3 and ß-galactosidase activity in the samples was measured in duplicate. 
Activity is given in Miller Units- measured as nmol of O-nitrophenol produced per min 











































transcriptional regulator ClgR, the palindromic motif CGC-N5-GCG is found in 
the promoter region of clpP (Russo et al., 2009). This motif is found in the 
region upstream of clpP1P2 in M. tuberculosis, approximately 100 bp away of 
ClpP1 start codon (Fig 3.11 A). The first half of the motif (CGC) was mutated to 
‘AAA’ and promoter activity was measured using lacZ as before. Promoter 
activity was significantly reduced after mutation in M. smegmatis (3.6-fold 
reduction), M. marinum (4-fold reduction) and M. tuberculosis (3.4-fold 
reduction) suggesting the possible binding of a regulator at this site, most likely 
to be ClgR (Fig 3.11 B). 
 
To determine the nucleotides in this region that are responsible for the binding 
of a regulatory element, single nucleotide substitutions were created where 
native A/T were mutated to G bases and C/G were replaced by As and activity 
was tested (Figure 3.11 C). Twenty bases were mutated in total and numbered 
1 to 20. Two bases (A1G and C20A) whose mutation had no effect on promoter 
activity were considered to be outside the sequence bound by a regulator. All 
mutations in between these two nucleotides had a significant effect on promoter 
activity and therefore constitute the binding site, which is thus 18 bp long. Two 
mutations induced a higher promoter activity (C5A and G19A) while all other 
mutations induced a significant reduction in promoter activity compared to the 
unmutated plasmid. This regulatory 18 bp sequence 
(TGACGCTGTAAGCGAACG) matches the consensus sequence of ClgR 
binding site in C. glutamicum (Engels et al., 2005). As regulation of clpP1P2 by 
ClgR was previously demonstrated in M. tuberculosis (Sherrid et al., 2010) 
these data strongly suggest that the sequence mapped is the ClgR binding 
sequence.  
 
To determine if the differences in promoter activity following mutagenesis were 
due to alteration in binding of ClgR, a protein-DNA binding assay was used. 
The final two amino acids of ClgR (V111, A112) were mutated to aspartates to 
stabilise the protein as previously described (Sherrid et al., 2010) and the 
protein was purified by affinity chromatography. Using this assay (EMSA), a 
DNA shift demonstrates binding of a selected protein to a DNA sequence. 
However, no DNA shift was observed when the 278 bp promoter region of 
clpP1P2 and purified ClgR (200ng or 500 ng) were used; the addition of MgCl2 
or NP-40 were all found to show no difference, as again there was no 




Figure 3.11 Mapping of a regulator binding site in the clpP1P2 promoter region 
A) Sequence of the region upstream of clpP1P2. Tig stop codon and ClpP1 start codon 
are indicated. Residues that constitute the binding site of a regulator are boxed. B) 
Identification of a putative regulatory site in M. smegmatis, M. marinum and M. 
tuberculosis. CGC (underlined bold) was mutated to AAA. C) Mapping of a regulator 
binding site in M. tuberculosis. Single nucleotide substitutions in P278 were made by 
SDM. Residues A or T were mutated to G or and residues C or G were mutated to A. 
Results are the average activity of three independent transformants assayed in 
duplicate ± standard deviation. Activity is given in Miller Units- measured as nmol of O-
nitrophenol produced per min per mg of protein. A significant difference of activity 
compared to unmutated P278 (control) is marked by an * (p <0.05) using the student’s t-
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Figure 3.12 No interaction detected between ClgR and clpP1P2 upstream regions  
Binding reactions were performed with P278 (Lanes 4 and 5) and a 48 bp sequence 
(P48) upstream of clpP1 (Lanes 6 to 10). DNA fragments were PCR amplified with a 
biotin labeled primer, gel extracted and cleaned. 200 ng of purified ClgR protein 
extracts was used in lanes 7 to 9 while 500 ng was used in lane 10. Epstein Barr 
nuclear antigen (EBNA) system (EBNA) provided in the kit was used as a positive 
control (Lanes 1 to 3). Lane 3 contains excess unlabelled DNA. 
Lane 
Protein extract (ng) 
NP-40 (0.05 %) 













to have prevented ClgR binding, thus binding of ClgR to a shorter DNA 
fragment was tested. This fragment of 48 bp (P48) contained the predicted 18 
bp ClgR binding site from the mutagenesis study and 15 bp on each side. 
However, no shift was observed with this fragment either (Fig 3.12). As 
expected, a shift was observed for the positive control reaction provided with 
the kit (Fig 3.12).   
3.2.9 Identification of a second regulatory sequence  
An increase in promoter activity was noticed when the GTGACC hexamer was 
mutated to CCGACC (Fig 3.4 D), suggesting that other regulator(s) besides 
ClgR may bind in the upstream region of clpP1P2. The presence of inverted 
repeats is an indication for possible regulator binding sites and the imperfect 
complementary inverted repeat sequence ‘GTTTCAGGG-N58-CAGGTGCCCC’ 
was found upstream of clpP1P2 (Fig 3.13 A). The last three nucleotides of the 
first part of the motif were mutated to A’s by SDM and activities measured using 
lacZ in M. tuberculosis. Promoter activities of P125 and P278 were found to be 
significantly reduced (4.6 fold reduction) compared to the wild-type sequence, 
suggesting that this motif may be the binding region of a second positive 
regulator (Fig 3.13 B).  
3.2.10 Protein-protein interactions  
ClpP1 and ClpP2 are co-expressed and therefore are present in the cell under 
the same conditions. However, even though ClpP1 and ClpP2 are active under 
the same conditions they may be performing different functions by interacting 
with different ATPase subunits. Indeed, ClpP subunits need to associate with 
an ATPase partner to be able to degrade substrate proteins. The ATPase 
proteins can enlarge the number of substrates they can recognise by 
interacting with adaptor proteins such as ClpS, which is involved in recognition 
of substrates harbouring a N-degron. The presence of ClpP1 and ClpP2 in 
addition to multiple ATPase subunits in M. tuberculosis (ClpC1, ClpC2 and 
ClpX) suggests that several possible Clp protease complexes could form. 
ClpP1 and ClpP2 may have different affinities for different ATPases or different 
adaptors in order to recognise various substrates. Protein-protein interactions 
between the two ClpP proteins with ATPases and adaptor proteins were 
investigated using two independent methods. ClpB was also included in the 






Figure 3.13 Identification of a second regulatory sequence 
A) Sequence of the upstream region of clpP1P2. Sequence of a second putative 
regulatory site is indicated in bold. Putative ClgR binding site and -10 element are 
indicated. The three G residues (underlined bold) were mutated to AAA. B) Effect of 
GGG mutation on promoter activity. M. tuberculosis transformants harbouring the 
mutated or unmutated plasmid (control) were grown to late exponential phase in 
standing liquid cultures. Results are the average activity of three independent 
transformants assayed in duplicate ± standard deviation. Activity is given in Miller Units 
(MU)- measured as nmol of O-nitrophenol produced per min per mg of protein. The 
background activity from pSM128 (control vector) ranged from 5 to 8 MU. A significant 
difference compared to the unmutated plasmid (control) is marked by an * (p <0.05) 



























3.2.10.1 Detection of interactions using the bacterial two-hybrid 
system  
Interactions between the different Clp components proteins were studied with 
the bacterial two hybrid (BACTH) system (Karimova et al., 1998) (Fig 3.14). 
This system uses the fast growing organism E. coli and interactions between M. 
tuberculosis proteins have been previously demonstrated using this method 
(Klepp et al., 2009). In this assay, the proteins of interest are fused to two 
fragments (T25 and T18) of the catalytic domain of Bordetella pertussis 
adenylate cyclase (CyaA) and co-expressed in an adenylate cyclase deficient 
E. coli strain. Interaction between the two hybrid proteins results in functional 
complementation between the T25 and T18 fragments, leading to cAMP 
synthesis. cAMP binds to the catabolite gene activator protein CAP leading to 
transcription of lacZ. Thus, bacteria expressing interacting proteins form blue 
colonies on LB medium in presence of X-Gal whereas cells expressing non- 
interacting proteins remain white; in addition the strength of interaction can be 
quantified by measuring β-galactosidase activity. 
 
In order to investigate interactions between the ClpP proteins, ClpP1 and 
ClpP2, the different ATPases ClpB, ClpC1, ClpC2, ClpX, and the accessory 
proteins, ClpS and SmpB, the bacterial two-hybrid system was used. DNA 
fragments encoding ClpP1, ClpP2, ClpC1, ClpS and SmpB were cloned into 
vectors as fusions to the C-terminal or N-terminal regions of the T25 domains 
(T25 or NT25) while DNA fragments encoding ClpB, ClpC1, ClpC2 and ClpX 
were cloned into vectors as fusions to the T18 domains (T18 or T18C) of 
adenylate cyclase (Karimova et al., 1998). Pairs of recombinant plasmids were 
co-transformed into the E. coli adenylate cyclase deficient strain BTH101 
(Karimova et al., 1998). Interaction between the different proteins was 
determined by colour of the colonies formed on LB agar in the presence of X-
Gal (white for non-interacting proteins, blue for interacting proteins) and the 
results were confirmed by measuring β-galactosidase activity (Table 1 and 2). 
The GCN4 leucine zipper motifs were used as a positive control for 
complementation (Karimova et al., 1998). The level of β-galactosidase activity 
in liquid cultures for bacteria expressing the positive controls was typically 
5,000 units per mg of dry weight bacteria while the background levels were 
around 80 units per mg of dry weight bacteria, confirming a strong interaction 





Figure 3.14 Principle of the E. coli two hybrid system based on a functional 
complementation of CyaA fragments 
The T25 and T18 fragments correspond to amino acids 1–224 and 225–399 of the 
CyaA protein. If the two fragments, fused to two interacting proteins (X and Y), are 
brought into close proximity cAMP is produced. cAMP, bound to the transcriptional 
activator CAP, is a regulator of the expression of various genes including lacZ. Bacteria 
expressing interacting proteins form blue colonies on LB medium in the presence of X-
Gal. Cells expressing non-interacting proteins remain white. The level of β-
galactosidase activities, taken as an indicator of the strength of the interaction, can be 










Table 1 Detection of protein-protein interactions between A) ClpP1, B) ClpP2, and 
C) ClpC1 with the different Clp subunits  
Transformants harbouring T25 (T25 or NT25) and T18 (T18 or T18C) fusion proteins 
were grown in presence of 0.5 mM of IPTG for 16h. The cells were permeabilised and 
ß-galactosidase activity was measured. Results are the average activity of three 
independent transformants assayed in duplicate ± standard deviation and are given in 
units per mg of dry weight bacteria. One unit of activity corresponds to 1 nmol of ONPG 
hydrolysed per min at 28°C. Values significantly different from the empty vectors 
(approximately 80 units/mg of dry weight bacteria) using the student’s t-test (unpaired, 
two sided) are indicated in bold (p<0.05). /: Non-tested combinations. 
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Table 2 Detection of protein-protein interaction, between A) ClpS and B) SmpB 
with the different Clp subunits; C) between Esat6 with Cfp10; D) between the E. 
coli ClpP and ClpX proteins.  
Transformants harbouring the T25 (T25 or NT25) and T18 (T18 or T18C) fusion 
proteins were grown in presence of 0.5 mM of IPTG for 16h. The cells were 
permeabilised and ß-galactosidase activity was measured. Results are the average 
activity of three independent transformants assayed in duplicate ± standard deviation 
and are given in units per mg of dry weight bacteria. One unit of activity corresponds to 
1 nmol of ONPG hydrolysed per min at 28°C. Values significantly different from the 
empty vectors (approximately 80 units/mg of dry weight bacteria) using the student’s t-
test (unpaired, two sided) are indicated in bold (p<0.05). /: Non-tested combinations. 
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Since the ClpP tetradecameric complex is formed by two ClpP heptamers, it 
was predicted that interaction between ClpP1 and ClpP1 or ClpP2 would be 
observed. However, no interaction between ClpP1 and ClpP1 or ClpP2 was 
observed (Table 1A). In addition no interaction between ClpP1 and ClpC1, 
ClpC2, ClpX, ClpS or SmpB was seen, as all the measured activities were 
similar from the activity detected for the empty vectors (approximately 80 units) 
(Table 1A). ClpP2 interacted with itself (346 units), but did not interact with 
ClpP1, ClpB, ClpC1, ClpC2, ClpX, ClpS or SmpB (Table 1B). ClpP2 self-
interaction was seen in one combination only (ClpP2-NT25 + ClpP2-T18C) 
suggesting that orientation of the fusion protein may influence protein folding. 
Similar observations were made during interaction analysis of E. coli FtsW and 
FtsI where interaction was seen in one configuration only (FtsI-T18 + FtsW-
T25) (Karimova et al., 2005).  
 
Singh et al., (2006) previously demonstrated that ClpC1 interacts with ClpP2, 
thus it was expected to see an interaction between these two proteins. To 
determine if the lack of interaction could be due to the vector used (T18 or T25) 
clpC1 was cloned into the T25 vectors (T25 and NT25) and co-transformed with 
ClpP1, ClpP2, ClpC1, ClpC2, ClpX, ClpS or SmpB fused to T18 domains (T18 
or 18C). All the resulting strains appeared white on LB medium containing X-
Gal and no activity was detected demonstrating that there was no interaction 
between ClpC1 and the other members of the complex in this assay (Table 
1C).  
 
ClpS is involved in recognition of substrates harbouring a N-degron, while 
SmpB participates in the formation of SsrA-tagged proteins. It was expected 
that interaction would be detected between ClpS and at least one ATPase for 
the degradation of proteins tagged at their N-terminus; and protein-protein 
interaction with SmpB was also tested to determine if SmpB had a role in 
substrate recognition. ClpS and SmpB were cloned into T25 vectors and tested 
for interaction with the different ATPases and ClpP proteins cloned in the T18 
domains. ClpS and SmpB were not found to interact with any of the Clp 
proteins tested (Table 2 A and B). 
 
To try to understand the lack of interactions described above it was decided to 
test if the interaction between two mycobacterial proteins could be detected 




filtrate protein 10) secreted antigens interact in M. tuberculosis and form a tight 
1:1 complex (Renshaw et al., 2002). ESAT-6 was cloned into the T18 vectors 
and CFP-10 was cloned into the T25 vectors. The plasmids were transformed 
into E. coli BTH101 and blue colonies were observed. β-galactosidase activity 
in liquid cultures was approximately 8,000 units per mg of dry weight bacteria 
(Table 2C). As previously seen with ClpP2-ClpP2 interaction, the interaction 
only occurred in one combination (CFP10-T25 + ESAT6-T18). The high level of 
activity indicates that ESAT-6 and CFP-10 proteins interact strongly and 
confirms that the system can be used to detect interaction between M. 
tuberculosis proteins. However, these proteins are monomers and do not reflect 
the complex structure of ClpP and ATPase proteins.  
 
To see if the lack of interactions was due to the complex structure of the Clp 
proteins, interaction between E. coli ClpP and ClpX proteins, known to interact 
(Grimaud et al., 1998), was tested. E. coli clpP was cloned into the T25 vectors 
while clpX was cloned into T18 vectors. E. coli BTH101 was co-transformed 
with the corresponding fusion proteins and plated on LB X-Gal medium. The 
bacterial colonies that were obtained were white and exhibited a β-
galactosidase activity similar to the negative controls (Table 2D). This result 
shows that the interaction between E. coli Clp proteins could not be detected 
with this method. 
3.2.10.2 Assay of interactions using Split-Trp 
Many genes from mycobacteria yield folded proteins and active enzymes when 
expressed in M. smegmatis, whereas the same genes yield neither folded 
proteins or active enzymes in E. coli (Garbe et al., 1993; Thangaraj et al., 1990; 
Zhang et al., 1991). It was therefore decided to use a second two-hybrid 
system, based on a mycobacterial species. Split-protein sensors are an 
important tool for studying protein interactions in living cells (Piehler, 2005). The 
Split-Tryptophan (Split-Trp) method uses a simple growth assay to detect 
protein-protein interactions (O'Hare et al., 2008). In this assay, the proteins of 
interest are fused to two fragments of Saccharomyces cerevisiae Trp1p 
involved in tryptophan (Trp) biosynthesis, and are co-expressed in a 
tryptophan-auxotroph M. smegmatis strain. Interaction between the two hybrid 
proteins results in reconstitution of active Trp1p and rescue of tryptophan 




previously demonstrated with this method using M. smegmatis as a bacterial 
host (O'Hare et al., 2008; Sacco et al., 2007).   
 
clpP1, clpP2, clpB, clpC1, clpC2, clpX, clpS and smpB genes were cloned into 
PL240 and PL242 vectors to generate fusion proteins with the N-terminal and 
C-terminal fragments of Saccharomyces cerevisiae Trp1p protein (O'Hare et 
al., 2008). Pairs of plasmids were electroporated into M. smegmatis ΔhisA and 
recombinant bacteria were grown in parallel on solid medium lacking or 
supplemented with tryptophan. If an interaction occurs between the proteins 
encoded by a pair of plasmids, Trp1p function is restored and the recombinant 
strain is able to grow in absence of exogenous Trp. Esat6-Cfp10 and C2-C1 
plasmid pairs were used as positive controls. As expected, the two positive 
controls grew on medium lacking tryptophan, demonstrating interaction 
between the corresponding proteins (Fig 3.15). All strains harbouring Clp 
proteins grew readily on medium supplemented with tryptophan but could not 
grow on medium lacking tryptophan demonstrating there were no interactions 
between the different Clp proteins (Fig 3.15).  
3.3 Discussion  
The functional significance of the presence of two ClpP proteases in M. 
tuberculosis is currently unknown. clpP1 and clpP2 are co-expressed, thus 
excluding the possibility they are present under different conditions (Fig 3.2). 
ClpP1 and ClpP2 co-expression suggest a coordinated function for the two 
proteins, and ClpP1 and ClpP2 heptameric rings have been found to form a 
ClpP1P2 tetradecamer complex (Akopian et al., 2012). Presence of a mixed 
complex was reported previously in Listeria monocytogenes (Zeiler et al., 2011) 
and Synechococcus elongatus	  (Stanne et al., 2007). The presence of a mixed 
complex could allow the possibility of degrading a large subset of protein 
substrates simultaneously if ClpP1 and ClpP2 recognise different substrates. 
 
The promoter of the clpP1/clpP2 operon was identified. Interestingly its activity 
was significantly higher in M. tuberculosis compared to the model organisms M. 
smegmatis or M. marinum, which are often used as genetic hosts for M. 
tuberculosis studies. A possible explanation for this may be the absence of 
regulatory control elements in the model organisms. The -10 sequence was 
identified (Fig 3.4 C) and found to match the consensus sequence for the 





Figure 3.15 Split-Trp growth assay in M. smegmatis ΔhisA 
Pairs of proteins were fused to Ntrp and Ctrp and co-expressed in M. smegmatis ΔhisA 
grown at 25°C on 7H9 agar in presence or absence of tryptophan. Undiluted and serial 
dilutions 1/10 and 1/100 were plated (from left to right). 
-Trp: Medium lacking tryptophan; + Trp: Medium containing tryptophan, (+): Positive 













(Gomez et al., 1998). No -35 element was identified (Fig 3.4 D), however this is 
not uncommon in mycobacteria. Several promoters that do not require a -35 
region for activity have been identified but they typically contain a TGN motif 
immediately upstream of the -10 region described as an extended -10 element 
(Bashyam et al., 1996). Since the clpP1P2 promoter does not have this TGN 
motif and does not possess a -35 element, it is possible that a regulator makes 
contact with a subunit of the RNA polymerase to facilitate the polymerase 
binding. 
 
The -10 element sequence of the clpP1P2 operon (TAGTGT) has three 
nucleotides in common with the E. coli consensus sequence (TATAAT), 
however the intrinsic promoter activity is weak (Fig 3.5). High promoter activity 
is therefore dependent on the binding of regulator (s). A regulatory region was 
mapped: the 18 bp sequence identified forms an imperfect palindromic 
sequence (Fig 3.11) and matches the ClgR binding site in C. glutamicum 
(Engels et al., 2005). This regulatory region is present in P125 and P278 but 
binding of the regulator may be reduced in the shorter region due to presence 
of a terminator in the pSM128 plasmid close to the cloning site. Binding of ClgR 
in the upstream region of clpP1P2 was previously demonstrated but could not 
be repeated in this study (Sherrid et al., 2010). The main difference with the 
previous study was the use of biotin labelled DNA while cy3 labelling was used 
previously. The presence of a binding site for a second regulator was 
suggested (Fig 3.13), however two positive regulators of ClpP1P2 activity 
would be surprising; thus it may be possible that the introduced mutations 
induced a conformational change in the sequence allowing a stronger binding 
of ClgR.  
 
A knockdown strain of ClpP1P2 showed reduced growth (Carroll et al., 2011) 
suggesting that a high promoter activity is necessary for optimal growth 
conditions. Promoter activity was slightly increased in late stationary phase 
(after an OD580 of 1.7) (Fig 3.8) suggesting that an increase in the Clp protease 
activity is necessary to degrade the accumulation of misfolded proteins 
emerging during stationary phase (Kwiatkowska et al., 2008). The importance 
of the Clp proteases in stationary phase was previously demonstrated as E. coli 
and B. subtilis clpP mutants have a loss of viability during stationary phase 





Promoter activity during hypoxia was high and constant for up to eight weeks 
(Fig 3.10 A). Promoter activities are generally reduced during hypoxia as 
metabolic activity is greatly reduced, thus the high level of the ClpP1P2 
promoter activity demonstrates an essential role for the Clp protease in this 
condition and suggests an important activity of the Clp proteases during 
infection. This confirms a previous report of high clpP expression in a hypoxic 
environment (Muttucumaru et al., 2004) thus this illustrates the importance of 
the Clp protease in conditions where oxygen is limited, such as within a 
macrophage and this may explain why the ΔclgR strain was not able to 
replicate during macrophage infection (Estorninho et al., 2010). In addition, a 
ClpP1P2 knockdown strain displayed a reduction of virulence in macrophages 
further confirming their importance during infection (Carroll et al., 2011). 
Promoter activity was reduced between eight to 12 weeks of hypoxia but 
returned to its original activity quickly after reaeration (Fig 3.10 B) confirming 
previous reports of clpP induction during reaeration (Sherrid et al., 2010). 
Reaeration is used to mimic reactivation of the disease and the quick return of 
promoter activity after hypoxia may suggest a role for the Clp proteases during 
reactivation of the disease. Targeting Clp activity, either directly or via ClgR, 
could therefore be a novel and attractive approach to prevent M. tuberculosis 
survival during infection and avoid reactivation of the disease.  
 
The role of proteases is particularly vital during stresses that increase the 
occurrence of damaged proteins. clpP induction under heat shock conditions is 
variable among actinomycetes: while clpP1P2 expression is induced upon 
severe heat stress in C. glutamicum (Engels et al., 2004), none of the clpP 
genes are heat induced in S. lividans (Bellier and Mazodier, 2004). Promoter 
activity was not increased at 42°C in M. tuberculosis (Fig 3.7) consistent with 
microarray studies which did not detect any transcript increase for either clpP1 
or clpP2 following heat shock (45°C for 30 min) (Stewart et al., 2002). 
Altogether this suggests that ClpP1 and ClpP2 are not involved in the heat 
shock response in M. tuberculosis.  
  
The lack of induction after stress treatments demonstrates that the ClpP 
proteases are constitutively expressed. Since clpP1P2 induction was previously 
demonstrated at the mRNA level after diamide or vancomycin treatment (Barik 




transcription and degradation, expression of the two ClpP may be controlled by 
mRNA degradation.  
 
ClpP1 and ClpP2 not being differentially expressed transcriptionally suggests 
that they may be regulated post-transcriptionally. To determine if regulation of 
activity was occurring at the level of substrate selection, interactions between 
all of the Clp proteins were examined. Two methods were used: the E. coli 
bacterial two-hybrid system and the Split-Trp systems. In the bacterial two- 
hybrid system, ClpP2 was found to interact with itself but not with any other 
members of the Clp system (Table 1) and no interactions were detected with 
the Split-Trp method (Fig 3.15). This was surprising since ClpX and ClpC1 both 
possess ‘LGL’ loops, a determinant for interaction, and interaction of ClpC1 
with ClpP2 was previously demonstrated (Singh et al., 2006). One plausible 
explanation for the lack of interaction in these systems may be that the 
structure of the Clp complex, made of two heptameric rings binding to a 
hexameric ATPase, is too complex to be detected with these methods as 
suggested by the lack of interaction between E. coli ClpP and ClpX proteins 
tested. For example, the adenylate cyclase fragments might be trapped inside 
the barrel structure of the ClpP proteins or the hybrid proteins might not fold 
properly.  
 
However Singh et al. (2006) demonstrated interaction between ClpC1 and 
ClpP2 using the mycobacterial protein fragment complementation (M-PFC), a 
two-hybrid system based in M. smegmatis such as the Split-Trp. The size of the 
protein mDHFP used for M-PFC is about 21 kDa while the fusion protein Trp1P 
used for the Split-Trp studies is 25 kDA so the size of the fusion protein does 
not explain the difference of results obtained. The reason for the detection of 
interaction with this system but not with the BACTH or Split-Trp is still unknown.  
 
The Clp proteins were expressed from multicopy plasmids and therefore their 
expression levels were elevated. Clp over-expression could be toxic to the cell 
and the fusion proteins might aggregate into inclusion bodies. In addition, 
toxicity of over-expression of ClpP2 has been demonstrated in M. tuberculosis 
partially supporting this hypothesis (Ollinger et al., 2011).  
 
It is also possible that the E. coli or M. smegmatis endogenous Clp proteins 




interaction in the assays. The use of ClpP deletion strains may be an 
alternative for future studies to counteract this issue. It is important to note that 
when ClpP1 and ClpP2 were previously expressed in E. coli, the proteins were 
enzymatically inactive (Akopian et al., 2012; Benaroudj et al., 2011; Ingvarsson 
et al., 2007). Proteolytic activity was detected only when the two ClpP proteins 
were present together in presence of small activating molecules (Akopian et al., 
2012). This demonstrates that ClpP1 and ClpP2 form a mixed complex in order 
to become active, thus it is possible that association of ClpP1 and ClpP2 with 
each other induce a conformational change that enable them to bind to the 
ATPases, which would explain the lack of interaction observed in the assays. 
 
To conclude, data gained from this study showed that there is no difference in 
regulation of transcription of clpP1 and clpP2 as the two genes are co-
expressed. The promoter region of clpP1P2 was identified and the binding site 
for a positive regulator, most likely to be ClgR was mapped. The results 
generated also suggest that clpP1 and clpP2 are constitutively expressed and 
the levels of expression remain high during hypoxia indicating the Clp 
proteases are important for bacterial survival inside the host environment. 





4 Substrate specificities of ClpP1 and ClpP2  
4.1 Introduction 
Bacterial proteins are usually targeted for degradation when they harbour a 
sequence tag. One such degradation tag, encoded by ssrA, is added to the C-
terminus of a nascent polypeptide in a trans-translation reaction (Keiler et al., 
1996). SsrA-tagged proteins are subsequently degraded by proteases including 
the Clp proteases (Gottesman et al., 1998). Proteolytic degradation directed by 
tmRNA can be exploited experimentally to produce proteins with altered half-
lives. The E. coli ssrA tag has the sequence AANDENYALAA (Keiler et al., 
1996) but alternative degradation tags that vary in the final three amino acids 
(e.g. AAV, ASV) alter protein stability (Andersen et al., 1998). The C-terminal 
end of the tag (LAA) is recognised by ClpX and degradation is enhanced by the 
adaptor protein SspB, which recognises the AANDENY portion of the tag (Flynn 
et al., 2001; Levchenko et al., 2000). The M. tuberculosis SsrA tag sequence 
has been identified and consists of a ten amino acids portion (AADSHQRDYA) 
and a terminal LAA sequence. SsrA-tagged GFP proteins are degraded in M. 
smegmatis (Blokpoel et al., 2003; Triccas et al., 2002), but a direct role of the 
Clp proteases in the degradation of SsrA-tagged proteins in M. tuberculosis has 
not been demonstrated and M. tuberculosis does not have a SspB homolog 
(Kim et al., 2010). Since M. tuberculosis has two ClpP, it is possible that only 
one of them is involved in the degradation of SsrA-tagged proteins or that the 
two ClpP recognise different tag sequences. 
 
One of the most common methods to investigate gene function is to create a 
deletion mutant. Since essential genes cannot be deleted, over-expression in 
combination with microarray profiling provides an alternative approach for 
investigating their role (Stewart et al., 2004). Microarrays are commonly used 
for analysis or to identify global patterns of gene expression and offer the 
possibility to monitor the expression level of thousands of genes in parallel.  
 
Expression of genes of interest can be inducible. Conditional gene expression 
systems generally consist of an inducible promoter that can be turned on and 
off in a controlled manner, so gene expression can be up or down-regulated. 
The acetamidase system was one of the earliest inducible promoter systems 




M. smegmatis by acetamide through a complex mechanism involving several 
promoters, two positive regulators of gene expression (AmiC and AmiD) and 
one repressor (AmiA) are involved (Draper, 1967; Mahenthiralingam et al., 
1993; Narayanan et al., 2000; Parish et al., 1997; Parish and Stoker, 1997; 
Roberts et al., 2003). The system has been used for conditional over-
expression of various genes of interest (Brown and Parish, 2006; Brown et al., 
2010; Kang et al., 2005; Manabe et al., 1999; Parish et al., 1997; Park et al., 
2008). In addition, several tetracycline-inducible promoter systems have also 
been used to express foreign and native genes in both fast and slow-growing 
mycobacteria (Blokpoel et al., 2005; Carroll et al., 2005; Ehrt et al., 2005; Guo 
et al., 2007). They are based on regulation of expression from a promoter 
through a tetracycline-responsive repressor (TetR). The repressors and the 
promoters used to express TetR vary between the systems, but the general 
principle of tetracycline-inducible gene expression is the same. In the absence 
of inducer, TetR binds to the operator region of the promoter, blocks 
transcription, and promoter activity is switched off. In the presence of 
tetracycline or anhydrotetracycline, a conformational change in the regulator 
prevents binding and the promoter is available for RNA polymerase to bind and 
start gene transcription (Klotzsche et al., 2009). 
 
B. thuringiensis has two ClpP proteins involved in different cellular pathways: 
ClpP1 is essential for normal cell division at low temperature whereas ClpP2 is 
required for motility and sporulation (Fedhila et al., 2002). Thus one could 
hypothesise that the two ClpP proteins of M. tuberculosis also have different 
substrate specificities. clpP1 is essential for mycobacterial growth and clpP2 is 
predicted to be essential (Ollinger et al., 2011; Sassetti et al., 2003), their 
deletion is therefore not possible. To determine if ClpP1 and ClpP2 have 
different regulatory functions, one objective of the project was to analyse the 
effect of ClpP1 and ClpP2 over-expression on the transcriptome. It may be 
possible that ClpP1 and ClpP2 exhibit different proteolytic activities and have a 
separate range of protein substrates; one could be involved in general protein 
turnover while the other one may be involved in the degradation of specific 
substrate proteins and therefore ClpP1 or ClpP2 over-expression could have 
distinct effects on the transcriptome. One of the main substrates of the Clp 
proteases is the SsrA-tagged proteins. To determine which of the Clp proteases 
degrade SsrA-tagged proteins in M. tuberculosis, SsrA-tagged LacZ was used 




substrate specificities their affinity with different SsrA tag sequences was 
measured. 
4.2 Results 
4.2.1 Effect of ClpP1 and ClpP2 over-expression on the 
mycobacterial transcriptome 
Clp proteolysis contributes to a variety of functions in many bacteria, varying 
their levels may therefore have a serious effect on the transcriptome of the cell. 
Microarrays were used to analyse the global transcriptional response of M. 
tuberculosis to over-expression of both clpP1 and clpP2. M. tuberculosis 
ClpP1-ClpP2 over-expressing strain (pOPPY7), under the control of the 
constitutive hsp60 promoter, was obtained from Dr J. Ollinger (Ollinger et al., 
2011). The over-expressing strain and a strain carrying the empty vector 
(pSMT3) were grown to late exponential phase in rolling cultures and total RNA 
was extracted (Rustad et al., 2009b). cDNA was synthesised, labelled with 
fluorescent dye, and hybridised against labelled M. tuberculosis genomic DNA; 
to avoid variation coming from dye incorporation the dyes were swapped. 
Genes whose expression differed by at least two-fold were identified using one- 
way ANOVA (Table 3). It is to note that the expression data was of low 
intensity, thus explaining the low number of differentially expressed genes and 
limiting their reliability. 
 
As expected, clpP1 (5.1-fold) and clpP2 (5.7-fold) were up-regulated and, in 
addition, six genes were found to be up-regulated in the ClpP1-ClpP2 over-
expressing strain. These genes are responsible for various functions: Rv2205c 
encodes a hypothetical protein, Rv2526 encodes an antitoxin, DevB is involved 
in the pentose phosphate pathway, HemD is involved in the biosynthesis of 
siroheme and cobalamin; Wbbl2 is possibly involved in cell wall 
arabinogalactan linker formation and FadD13 is involved in lipid degradation. 
This suggests that the Clp proteases are involved in regulation of multiple 
cellular pathways. 
 
Quantitative real-time PCR (qRT-PCR) was used to validate the results 
obtained from the microarray study (Fig 4.1). As Rv2526 antitoxin forms a 
complex with toxin Rv2527, the associated toxin was added to the qRT-PCR 
analysis to determine the effect of the over-expression of ClpP1 and ClpP2 on 









p value Product 




clpP1 5.1 0.016 Clp protease proteolytic 
subunit 1 
Rv2205c  2.1 0.044 Hypothetical protein 
Rv1445c devB 2.1 0.044 6-phosphogluconolactonase 
Rv0511 hemD 2.0 0.044 uroporphyrin-III C-
methyltransferase 
Rv1525 wbbL2 2.1 0.044 Rhamnosyl transferase  
Rv2526  2.3 0.044 Antitoxin 
Rv3089 fadD13 2.5 0.016 Fatty-acid-CoA ligase 
 
Table 3 Differentially expressed genes in the ClpP1-ClpP2 over-expressing strain 
Total RNA was extracted from three M. tuberculosis liquid cultures, grown until late 
exponential phase, carrying pSMT3 (empty vector) or the plasmid over-expressing 
clpP1 and clpP2 (pOPPY7). cDNA was synthesised and labelled with Cy3 or Cy5 dyes 
and hybridised against genomic DNA. Genepix software was used for image reading 
and analysis was performed using GeneSpring v7.3 software. Genes which were more 
than two-fold up-regulated in the over-expressing strain with a p value of less than 0.05 





Figure 4.1 mRNA levels of target genes in strains over-expressing ClpP1 and/or 
ClpP2  
Total RNA was extracted from three independent M. tuberculosis liquid cultures grown 
until late exponential phase and levels of mRNA were measured using qRT-PCR. A) 
Levels of mRNA of clpP1 and clpP2. B) Levels of mRNA of target genes. The amount 
of mRNA is given as an arbitrary value standardised to sigA expression values. The 
mean ± standard deviation of three biological samples assayed in duplicate is given. A 
significant difference, measured by Student’s t-test (unpaired, two sided), compared to 
the control is marked by an * (p <0.05). 
Strains are- Control: empty vector (pSMT3); P1: over-expressing ClpP1; P2: over-














































and ClpP2 together or independently in order to differentiate specific effect of 
the over-expression of each protease. The results generated were normalised 
to sigA, whose expression is considered to be constant (Manganelli et al., 
1999). 
 
As expected, clpP1 and clpP2 were both over-expressed in the double over-
expressing strain (5.6-fold increase in clpP1 and 12-fold increase in clpP2). A 
7.8-fold increase of clpP1 expression was measured in the ClpP1 over-
expressing strain and a 3.4-fold increase was measured for clpP2 expression in 
the ClpP2 over-expressing strain (Fig 4.1 A). 
 
HemD expression was significantly increased in the ClpP1 and the ClpP1-
ClpP2 over-expressing strains, but no significant difference of expression was 
noted in the ClpP2 over-expressing strain. There was no significant difference 
in the expression levels of devB, Rv2205c, wbbl2, Rv2526, Rv2527 and fadD13 
between the control wild-type and all the over-expressing ClpP strains (Fig 4.1 
B). The expression levels of the genes were very low compared to sigA 
showing that the selected genes are expressed at low levels. Overall, the 
microarray experiment did not show an important effect of ClpP1 and ClpP2 
over-expression on the transcriptome.  
4.2.2 Reporter system of ClpP1 and ClpP2 proteolytic activity 
In order to assay ClpP1 and ClpP2 enzymatic activities, a LacZ based reporter 
incorporating an SsrA tag was developed. AANDENYA-LAA and AANDENYA-
ASV protein tags were added to the C-terminal end of LacZ (referred as LacZ-
LAA and LacZ-ASV respectively) and expressed under the control of the 
inducible acetamidase promoter (Pami) from M. smegmatis (Parish et al., 1997). 
These tags have previously been used to target protein for degradation in M. 
smegmatis and differ in the half-life of the tagged protein; GFP-LAA has a half-
life of 165 minutes while GFP-ASV has a half-life of 110 minutes (Blokpoel et 
al., 2003).  
 
Plasmids harbouring untagged or tagged LacZ were co-transformed in M. 
tuberculosis harbouring clpP1, clpP2 or clpP1P2 over-expressing plasmids and 
steady state levels of LacZ proteins were measured. Over-expression of ClpP1 
or ClpP2 was used to determine if SsrA-tagged LacZ was degraded by one 




transformants were grown under induced (presence of acetamide) or non-
induced conditions, cell-free extracts were prepared and LacZ activity was 
determined using the β-galactosidase assay. The steady state level reflects a 
balance between protein synthesis and protein degradation, consequently if 
degradation of LacZ is performed by the ClpP proteases, a strain over-
expressing the protease would have a higher protein turnover rate than the 
wild-type and therefore the steady state level of a substrate protein would be 
reduced. A reduction of the steady state level of LacZ will be visible by a 
reduction of its activity.  
  
Under non-induced conditions untagged LacZ, LacZ-ASV, and LacZ-LAA were 
expressed at a similar level (approximately 2,000 Miller units) in the wild-type 
and the different over-expressing strains (Fig 4.2). This suggests that protein 
degradation by the Clp proteases was not occurring for untagged and SsrA-
tagged LacZs when they were produced at low level.  
 
There was a significant difference in LacZ activity between cells grown in 
induced conditions (acetamide) compared to cells grown in non-induced 
conditions for untagged (4.1-fold induction), ASV-tagged (4.8-fold induction) 
and LAA-tagged LacZ (2-fold induction), confirming that induction of the 
acetamidase promoter in M. tuberculosis was occurring and resulting in 
increase in LacZ levels (Fig 4.2).  
 
No difference in the steady state levels of untagged LacZ activity was observed 
when ClpP1 was over-expressed (Fig 4.2 A). However, there was a significant 
decrease in the steady state levels of untagged LacZ when ClpP2 or ClpP1-
ClpP2 were over-expressed (2.3-fold and 1.6-fold reduction respectively). This 
indicates that the rate of degradation of untagged LacZ was not increased 
when ClpP1 was over-expressed but the rate of degradation was increased 
when ClpP2 was over-expressed suggesting that ClpP2 degrades untagged 
LacZ but ClpP1 does not.   
 
Incorporation of the ASV tag changed the dynamics of protein turnover. There 
was a significant decrease in steady state levels of LacZ-ASV when either 
ClpP1 or ClpP2 were over-expressed independently or together (1.3-fold 
reduction in all over-expressing strains) (Fig 4.2 B). This demonstrates that 





Figure 4.2 Activity of LacZ variants in over expressing ClpP strains  
M. tuberculosis transformants were grown to late exponential phase in standing liquid 
cultures in presence of succinate +/- acetamide (0.1 % w/v) and cell-free extracts were 
prepared. Results are the average activity of three independent transformants assayed 
in duplicate ± standard deviation. Activity is given in Miller Units- measured as nmol of 
O-nitrophenol produced per min per mg of protein. A significant difference measured by 
the student’s t-test (unpaired, two sided) compared to the induced LacZ level in the WT 
strain is marked by an * (p <0.05). 
Empty bars: uninduced conditions (succinate); Grey striped bars: induced conditions 
(succinate + acetamide). Strains are- WT: wild-type; P1: over-expressing ClpP1; P2: 
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LacZ-ASV. This shows that this tag sequence directs protein degradation by 
both ClpP1 and ClpP2 in M. tuberculosis. 
 
Similarly to E. coli, the last three residues of the M. tuberculosis SsrA tag 
sequence are LAA. Tagging LacZ with LAA had a profound effect on protein 
activity. A reduction in steady state quantities of LacZ-LAA was seen in all 
strains, even in the WT as compared to untagged LacZ (Fig 4.2 C); LacZ-LAA 
activity was about 5,200 Miller units in induced conditions in all strains while 
untagged and LacZ-ASV activity was about 10,000 Miller units in the WT strain. 
This demonstrates that LacZ-LAA is degraded quickly in the cell, thus the tag 
ending with LAA is more efficient at directing protein degradation compared 
with the tag ending with ASV. Over-expression of ClpP1 and ClpP2 did not 
have an effect on steady state levels of LacZ-LAA as the quantities were similar 
in all strains confirming that degradation does not occur when LacZ levels are 
low. 
 
The E. coli ClpXP complex recognises the last three amino acids of the ssrA 
tag (AANDENYALAA) (Flynn et al., 2001; Karzai et al., 2000). To determine if 
the last three amino acids of the tag were also the determinant for recognition 
in mycobacterial degradation, the last three residues were mutated to GGG. 
Interestingly, the uninduced level of LacZ-GGG (7,400 MU) was higher 
compared to untagged and LacZ-ASV and LacZ-LAA (around 2,000 MU) (Fig 
4.2 D). The steady state levels of LacZ-GGG were similar between the wild-
type and over-expressing ClpP1 strains demonstrating that the protein was not 
recognised by ClpP1 for degradation; this indicates that the last three residues 
are the determinant for degradation by ClpP1. LacZ-GGG steady state levels 
were significantly reduced when ClpP2 was over-expressed (2.5-fold reduction) 
confirming that ClpP2 degrades proteins in the absence of a C-terminal 
degradation signal. However when both clpP1 and clpP2 were over-expressed 
the steady state levels were not significantly different from the wild-type. 
4.2.2.1 Steady state levels of LacZ-ASV were not reduced after 
stress treatments 
Since LacZ-ASV appeared to be a good indicator of ClpP1 and ClpP2 activity, 
LacZ-ASV steady state levels were measured after heat shock (42°C), 
oxidative shock (addition of diamide), or vancomycin treatment in order to 





Figure 4.3 LacZ-ASV activity after heat and oxidative shocks  
Three M. tuberculosis transformants carrying LacZ-ASV were grown to late exponential 
phase in standing liquid cultures in presence of acetamide (0.1 % w/v) and cell-free 
extracts were prepared. Treatments were 10 mM diamide for 1 h or 6 µg/mL of 
vancomycin for 90 min. Results are the average activity of three independent 
transformants assayed in duplicate ± standard deviation. Activity is given in Miller Units- 
measured as nmol of O-nitrophenol produced per min per mg of protein. A significant 
difference from untreated WT is marked by an * (p <0.05). 












































tuberculosis transformants carrying LacZ-ASV were grown in presence of 
acetamide to induce synthesis and steady state levels of LacZ were measured 
after stress treatments. There was no significant difference in LacZ-ASV steady 
state levels between untreated and stressed cultures suggesting that protein 
turnover was not increased in these conditions. LacZ-ASV levels were reduced 
when ClpP1 was over-expressed, as observed previously. However an 
increase in LacZ-ASV degradation in the ClpP1 over-expressing strain was not 
observed between untreated and stressed cultures suggesting that degradation 
by ClpP1 was not induced by these conditions, supporting evidence from the 
promoter data on the lack of induction of the Clp proteases. 
4.2.2.2 Degradation kinetics 
To verify that ClpP2 was degrading untagged LacZ and to measure the kinetics 
of degradation, untagged LacZ levels were measured in WT and over-
expressing ClpP2 strains. Pami is always expressed at a low level, even in the 
absence of acetamide (Parish et al., 1997; Roberts et al., 2003), thus this 
system is not suitable to follow protein turnover over time where a strict on/off 
switch is required. Therefore untagged LacZ was expressed under the control 
of an anhydrotetracycline (ATc) inducible promoter (Psmyc-tetO) (Ehrt et al., 2005). 
Transformants were grown to late exponential phase in rolling cultures in 
presence of ATc to induce LacZ expression. Cultures were then washed and 
inoculated into new rolling cultures without ATc to follow LacZ turnover. In 
presence of 150 ng/mL ATc the level of LacZ was around 238 MU and in 
presence of 300 ng/mL ATc the level of LacZ was around 362 MU, confirming 
increased levels of LacZ in presence of increasing concentrations of ATc (Fig 
4.4). Protein stability following the removal of ATc was measured, the level of 
LacZ was reduced from 238 MU to 30 and from 362 MU to 60 MU after two 
days, thus removal of ATc lead to a rapid decrease in untagged LacZ levels in 
the wild- type strain. Over-expression of ClpP2 was found to have no effect on 
the turnover rates observed (Fig 4.4). 
4.3 Discussion 
To determine if ClpP1 and ClpP2 were targeting different substrate proteins, 
the effect of their over-expression on the transcriptome was analysed. 
Antitoxins have previously been shown to be degraded by Clp protease 
complexes in E. coli and Staph. aureus (Aizenman et al., 1996; Donegan et al., 





Figure 4.4 Untagged LacZ turnover in WT and ClpP2 over-expressing strains 
M. tuberculosis transformants carrying untagged LacZ were grown to late exponential 
phase in rolling cultures in the presence of 150 ng/mL (A) or 300 ng/mL of ATc (B) and 
cell free extracts were prepared from 10 mL. Cultures were washed three times to 
remove ATc and new rollers were inoculated, cell-free extracts were prepared after 1 
and 2 days of incubation. Results are the average activity of three independent 
transformants assayed in duplicate ± standard deviation. Activity is given in Miller Units- 
measured as nmol of O-nitrophenol produced per min per mg of protein. 





















































be the case in M. tuberculosis. Microarray analysis showed that six genes were 
up-regulated when ClpP1 and ClpP2 were over-expressed including antitoxin 
Rv2526 but over-expression of the toxin or antitoxin was not confirmed when 
the corresponding RNA levels were measured by qPCR (Fig 4.1). Despite the 
use of a strong constitutive promoter (Phsp60), there was only a 3-fold up-
regulation of clpP2 expression in the ClpP2 over-expressing strain; toxicity of 
over-expression of ClpP2 has been reported for mycobacterial cells suggesting 
that the plasmid used may be unstable (Ollinger et al., 2011). Over-expression 
of ClpP1 resulted in increased hemD expression while over-expression of 
ClpP2 had no detectable effect on transcription of the genes measured (Fig 
4.1). HemD is involved in the biosynthesis of siroheme and cobalamin (vitamin 
B12). Over-expression in HemD expression suggests that ClpP1 may degrade 
a negative transcriptional regulator of HemD. Interestingly, a potential ClgR 
binding site was identified upstream of hemD (Sherrid et al., 2010). ClgR is a 
positive transcriptional regulator, which is induced and degraded by the Clp 
proteases (Bellier and Mazodier, 2004; Engels et al., 2004). Degradation of 
ClgR in S. lividans is dependent on C-terminal sequence (AA) (Bellier et al., 
2006), which has similarity to the M. tuberculosis ClgR C-terminus (AVA), 
suggesting that ClgR may be degraded by ClpP1 and/or ClpP2 in M. 
tuberculosis. ClpP1 and ClpP2 may be competing for ATPase binding so when 
ClpP1 is over-expressed it occupies most of the ATPases reducing ClpP2 
activity. If ClgR is a ClpP2 substrate, a reduction in ClpP2 activity may result in 
ClgR over-expression which in turn activates hemD expression. 
 
In order to determine if the Clp proteases were involved in the degradation of 
SsrA-tagged proteins in M. tuberculosis and if a difference in tag recognition 
was seen between the two ClpP proteins, unstable LacZ variants were used, 
which had different degradation tags. The first eight amino acids of the tags 
were similar (AANDENYA) and the last three residues differed (LAA, ASV, 
GGG). No LacZ degradation was observed in the non-induced conditions 
suggesting that degradation occurs only when protein concentration reaches a 
threshold level. When ClpP1 and ClpP2 were over-expressed individually or 
together, LacZ-ASV steady levels were significantly reduced, demonstrating 
that both ClpP1 and ClpP2 degrade LacZ-ASV (Fig 4.2 B). However 
degradation was not increased during heat or oxidative stresses (Fig 4.3). This 
demonstrates that the M. tuberculosis Clp proteases are involved in the 




increased after stress. When the ASV residues were mutated to GGG, ClpP1 
degradation was not observed, demonstrating that the final three amino acids 
are the recognition signal for degradation by ClpP1 (Fig 4.2 D). M. tuberculosis 
SsrA tag sequence ends with LAA and LacZ-LAA was degraded faster than 
LacZ-ASV confirming the importance of the last three residues for proteolytic 
degradation (Fig 4.2 C).   
 
Untagged LacZ and LacZ-GGG were not targeted by ClpP1 but were degraded 
by ClpP2 (Fig 4.2 A). Protein degradation of untagged LacZ in the cell was 
confirmed using a different promoter (Psmyc-tetO); degradation was occurring 
quickly as difference in protein levels was observed after one day (Fig 4.4). No 
difference in protein turnover was visible after one or two days when ClpP2 was 
over-expressed probably due to the fast turnover. One strategy to follow protein 
degradation within hours would be to use a fluorescent protein such as GFP for 
example. The difference in substrate degradation by ClpP1 and ClpP2 
suggests that ClpP1 might be involved in the degradation of specific substrates 
while ClpP2 might be responsible for a general and central housekeeping 
function. The apparent lack of sequence determinant for ClpP2 degradation 
may explain the toxicity when ClpP2 is over-expressed, which may result in 
degradation of proteins necessary for growth for example.  
 
In E. coli, ClpAP, ClpXP and Tsp protease complex preferentially target 
proteins which contain small and uncharged residues (Ala, Cys, Ser, Thr, and 
Val) in the last three positions of their sequence (Keiler et al., 1996; Keiler and 
Sauer, 1996). A search of the M. tuberculosis genome for proteins whose last 
two residues consisted of any combination of the residues Ala, Cys, Ile, Leu, 
Ser, Thr, and Val and whose third-to-last residue was not Asp, Gly, Glu, or His, 
(found to be stabilising residues) revealed that 10% of the proteins encoded by 
essential genes may be susceptible to C-terminal proteolysis (Chang et al., 
2008). This high number of potentially short-lived proteins indicates that ClpP1 
and ClpP2 may be involved in the regulation of a large range of pathways; most 
proteins identified in the study were hypothetical reflecting a lack of knowledge 
regarding these short-lived proteins. Functions of these short-lived proteins 
may be unravelled by studying regulatory proteolysis by the Clp proteases. 
 
Protein degradation by the Clp proteases is dependent on ClpP proteins 




detected when the ClpP subunits were over-expressed suggesting that the 
number of ClpP subunits is the limiting factor for formation of the complex in the 
cell. The excess of Clp ATPase subunits in the cell is probably due to the fact 
that besides participating in protein degradation they also exhibit chaperone 
activity for refolding misfolded proteins (Wawrzynow et al., 1996).  
 
Accumulation of incorrectly folded SsrA-tagged proteins may be toxic for the 
cells. In E. coli, Clp, Lon, FtsH, and Tsp proteases are involved in the 
degradation of tagged proteins (Choy et al., 2007; Gottesman et al., 1998; 
Herman et al., 1998; Spiers et al., 2002). Since M. tuberculosis does not have 
Lon or Tsp homologs, FtsH and the Clp proteases may be the only proteases 
involved in the degradation of SsrA-tagged proteins. Both ClpAP and ClpXP 
complexes can recognise SsrA-tagged proteins in E. coli suggesting that 
different ATPases can be involved in their degradation although ClpXP is the 
major complex that degrades SsrA-tagged proteins in the cell (Gottesman et 
al., 1998). The last three residues of the tag sequence, identified as the 
recognition motif for degradation by ClpP1, are recognised by ClpX in E. coli 
suggesting that ClpX is involved in the degradation of SsrA-tagged proteins in 
M. tuberculosis. Given that ClpP1 and ClpP2 can degrade SsrA-tagged 
proteins it is likely that they both interact with ClpX. ClpP2 is also able to 
degrade untagged protein demonstrating that, in addition to ClpX, ClpP2 can 
interact with another ATPase.  
 
ClpX is able to interact with SsrA-tagged proteins and deliver them for 
degradation to ClpP. However the adaptor protein SspB enhances degradation 
of SsrA-tagged proteins in E. coli; SspB recognises the AANDENY portion of 
the tag which is different from the M. tuberculosis sequence (Flynn et al., 2001; 
Levchenko et al., 2000). M. tuberculosis does not have a SspB homolog (Kim 
et al., 2010) and ClpP1 and ClpP2 proteases recognise E. coli tag sequences 
suggesting that an accessory protein may not be necessary for degradation in 
M. tuberculosis.  
 
To conclude, data gained from this study showed that both ClpP1 and ClpP2 
are involved in degradation of SsrA-tagged proteins. ClpP2 is also involved in 
the degradation of untagged proteins demonstrating that ClpP1 and ClpP2 
have different substrate specificities. ClpP1 may degrade SsrA-tagged proteins 




recognition by ClpP1 is dependent on the final three amino acids of the tag 





5 Accessory components for Clp activity 
5.1 Introduction 
Interplay between the Clp ATPases, adaptor proteins and degradation signals 
ensure substrate recognition for degradation by the Clp proteases. Degrons 
can be encoded in the protein sequence or added post-transcriptionally and are 
located near the C- or N-terminus of the sequence. ClpS is involved in 
recognition of substrates harbouring a N-degron, while tmRNA and SmpB 
contribute in the addition of the SsrA tag at a protein C-terminus. 
 
The adaptor protein ClpS directly interacts with destabilising N-terminal 
residues in E. coli and transfers substrate proteins to the ClpAP complex for 
degradation (Erbse et al., 2006; Schmidt et al., 2009). In E. coli the loss of ClpS 
does not have phenotypic consequences but a clpS mutant in Pseudomonas 
aeruginosa was found to have increase sensitivity to β-lactams and exhibited 
defects in swarming motility and biofilm formation (Fernandez et al., 2011; 
Schmidt et al., 2009). The presence of ClpS in M. tuberculosis indicates that 
this pathway is conserved in this species, but to date no mycobacterial 
substrates have been identified. ClpS is not predicted to be essential for 
mycobacterial growth (Sassetti et al., 2003) but is predicted to be required for 
survival in primary murine macrophages (Rengarajan et al., 2005). 
 
Ribosomes can become stalled in the presence of a cluster of rare codons or in 
mRNA lacking a stop codon for example (Keiler et al., 1996). The accumulation 
of stalled ribosomes can stop protein synthesis and prevent bacterial growth. 
tmRNA (encoded by ssrA) and its associated protein SmpB are employed in a 
trans-translation process to rescue stalled ribosomes and add a C-terminal tag 
to the incomplete nascent protein that will serve as a signal for proteolysis 
(Himeno et al., 1997; Keiler et al., 1996). Clp proteases are involved in the 
degradation of SsrA-tagged proteins (Gottesman et al., 1998). tmRNA levels in 
M. smegmatis are high (Andini and Nash, 2011) suggesting a high rate of trans-
translation in mycobacteria. Besides its role in ribosome rescue and signalling 
for protein clearance, tmRNA can play a regulatory role in gene expression 
(Ranquet and Gottesman, 2007) and acts as an antisense RNA to regulate 





tmRNA is not essential for viability of many bacteria such as E. coli or B. 
subtilis, but it is important for cell growth and resistance to adverse conditions 
(Abo et al., 2002; Komine et al., 1994; Yang and Glover, 2009). smpB mutants 
have the same phenotype as ssrA mutants in E. coli indicating that SmpB is 
essential for trans-translation (Karzai et al., 1999). SmpB is responsible for a 
variety of actions: it binds to tmRNA, protects it from degradation, enhances its 
aminoacylation efficiency and is required for stable association of tmRNA with 
the stalled ribosomes (Barends et al., 2001; Hallier et al., 2006; Karzai et al., 
1999). In M. tuberculosis smpB is not predicted to be essential whilst no data 
are available for ssrA (Sassetti et al., 2003).  
 
Clp proteases are involved in degradation of N and C-terminal tagged proteins 
which are recognised or generated by ssrA, smpB and clpS. To determine the 
importance and investigate the role of these three genes, construction of 
deletion mutants was attempted.  
5.2 Results 
The construction of clpS, smpB, and ssrA unmarked deletion mutants was 
attempted through recombineering (Fig 5.1). Allelic exchange by homologous 
recombination allows specific genes to be targeted for mutagenesis. Allelic 
exchange substrates (AES) were constructed to contain approximately 500 bp 
of DNA flanking each targeted gene, surrounding a hygromycin resistance 
cassette which possesses terminal dif sites (Cascioferro et al., 2010) (Fig 5.1 
B). Linear AES were electroporated in M. tuberculosis cells expressing the 
Che9 phage recombinases gp60 and gp61 to facilitate DNA recombination, 
conferring kanamycin resistance (van Kessel and Hatfull, 2007). The 
endogenous recombinases XerC and XerD recognise and resolve the dif sites 
so the resistance cassette is quickly excised from the chromosome. Following 
excision, one dif site of 28 bp is left at the chromosomal site. The strategy of 
replacing a gene of interest by a dif site allows the construction of an unmarked 
(no antibiotic marker) and in-frame deletion mutant.  
5.2.1 Construction of a SsrA deletion mutant 
An attempt to construct a ssrA deletion mutant in M. tuberculosis was made. 
The AES, containing a hygromycin resistance cassette flanked by dif sites, 500 





Figure 5.1 Method for construction of the mutant strains 
A) Chromosomal organisation of clpS, ssrA and smpB in M. tuberculosis. 
Regions used for construction of the allelic exchange substrate are indicated. 
B) Method for construction of mutant strains. First, a linear AES recombines 
with the chromosomal region of the gene of interest by homologous 
recombination. The hygromycin (Hyg) cassette is incorporated into the 
chromosome and is then excised due to recombination between the dif sites. 


















electroporated into M. tuberculosis cells encoding phage recombinases; 
recombinants were then selected on hygromycin and kanamycin containing 
plates. To verify that the ssrA AES inserted into the correct chromosomal locus, 
48 hygromycin resistant recombinants were isolated, DNA was extracted and 
Southern blotting was carried out. All the transformants screened contained the 
ssrA chromosomal band (1.8 kb) but also contained other bands at 2.4, 2.8 or 4 
kb (Fig 5.2 A and B). The presence of the chromosomal ssrA copy and the 
presence of a second fragment of varying size suggest illegitimate 
recombination between the AES and the chromosomal DNA. Since none of the 
transformants lost the ssrA chromosomal copy, it is possible that ssrA is 
essential in M. tuberculosis.  
 
To determine if ssrA is essential, a merodiploid strain was constructed by 
inserting an integrating vector, containing ssrA gene sequence and around 200 
bp of the upstream region, into the chromosome at the mycobacteriophage L5 
attB site (Lee et al., 1991). The SsrA AES was then electroporated into the 
merodiploid strain and recombinants were selected on hygromycin, kanamycin 
and gentamicin (complementing vector marker). DNA was extracted from 16 
transformants and Southern blotting was carried out. Twelve out of the 16 
recombinants screened had the expected hybridisation pattern for a ssrA 
chromosomal replacement: the deletion band (1.2 kb) and the DNA cassette 
band (2.9 kb), while four recombinants (number 7, 8, 11 and 14) had the ssrA 
wild-type copy (1.8 kb band) (Fig 5.2 C). An additional band of approximately 4 
kb indicates the presence of the complementing vector (Fig 5.2 C). Thus the 
chromosomal copy of ssrA could be deleted when a second functional copy 
was provided and it was not possible to do so in absence of a second copy (Fig 
5.2 B); this demonstrates that ssrA is essential in M. tuberculosis.  
 
tmRNA has two functions: rescue of stalled ribosomes and marking of the 
associated nascent polypeptides for clearance (Withey and Friedman, 1999). 
To determine which function is essential in M. tuberculosis, a second 
merodiploid strain was constructed where the integrated copy encoded a SsrA 
variant in which the last two codons of the tag reading frame (AA) were 
changed to DD (ssrA-DD). This variant enables the stalled ribosomes to be 
rescued but the resulting tagged proteins are not recognised by the proteolytic 















Figure 5.2 Demonstration of the essentiality of ssrA in M. tuberculosis 
A) Expected sizes for Southern analysis. Region used as the probe for Southern 
blotting is indicated. B) Southern analysis of 16 ssrA recombinants. SsrA::hyg AES was 
electroporated in M. tuberculosis and 16 SsrA recombinants were isolated in presence 
of hygromycin, DNA was extracted and Southern blotting was carried out. Genomic 
DNA from wild-type (WT) H37Rv and ssrA recombinants was digested with NcoI and 
hybridised with the ssrA probe. C) Southern analysis of 16 recombinants in SsrA 
merodiploid strains. D) Southern analysis of 16 recombinants in SsrA-DD merodiploid 
strains. 
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(Gottesman et al., 1998; Herman et al., 1998; Keiler et al., 1996). The SsrA 
AES was electroporated into this merodiploid strain and recombinants were 
selected on hygromycin, kanamycin and gentamicin.  In this background, all the 
16 recombinants screened had the WT band and an additional band at 
approximately 2.7 kb (Fig 5.2 D). This indicates that SsrA-DD is unable to 
functionally compensate for the loss of ssrA. The additional band (~2.7 kb) 
indicates where the AES inserted into the chromosome, the signal of the bands 
was faint on this blot which explains why the band of the complementing vector 
is absent. 
5.2.2 Construction of a SmpB deletion mutant 
To construct a SmpB deletion mutant the SmpB AES was constructed with a 
hygromycin resistance cassette flanked by dif sites, 500 bp of the smpB 
flanking regions and 47 bp of the gene. The AES was electroporated into M. 
tuberculosis cells encoding gp60 and gp61, and recombinants were selected on 
hygromycin and kanamycin. Eight recombinants were isolated and further 
grown on plates containing hygromycin to maintain presence of the resistance 
hygromycin cassette or on plates without antibiotic selection to allow excision of 
the hygromycin cassette. DNA was extracted and Southern blot analysis was 
carried out to determine the site of insertion of the AES. Out of the eight 
recombinants, seven of them had the WT copy of the gene while one 
recombinant (number 2) had the expected hybridisation pattern for a deletion 
strain: the deletion band (1.5 kb) and the DNA cassette band (3.1 kb) (Fig 5.3 A 
and B). When the same recombinant was grown without antibiotic selection the 
proportion of cells that lost the resistance cassette was higher showing a rapid 
excision of the hygromycin cassette, indicated by a stronger deletion band (1.5 
kb) on the Southern blot (Fig 5.3 B). Recombinant number 2 was further grown 
in liquid cultures without antibiotic selection and serial dilutions were plated on 
no antibiotic plates to allow dif excision. Transformants were then isolated in 
presence or absence of antibiotics in order to identify a sensitive recombinant 
that lost the hygromycin selection marker. DNA was extracted from one 
hygromycin sensitive transformant and analysed by Southern blot analysis. The 
expected genotype of the deletion mutant was confirmed; the deletion band of 
1.5 kb was present while the 1.8 kb WT and 3.1 kb DNA cassette bands were 
lost (Fig 5.3 C). The mutant strain conserved 45 bp of the smpB original 





Figure 5.3 Construction of a mutant strain of SmpB  
A) Expected sizes for Southern analysis. Region used as the probe for Southern 
blotting is indicated. B) Southern analysis of 16 smpB recombinants. SmpB::hyg AES 
was electroporated in M. tuberculosis and eight SmpB recombinants were grown in 
presence (+) or absence (-) of hygromycin, DNA was extracted and Southern blotting 
was carried out. Genomic DNA from wild-type (WT) H37Rv and smpB recombinants 
was digested with XhoI and hybridised with the smpB probe. C) Southern analysis of 
genomic DNA from WT and smpBΔ strains. 
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smpB deletion mutant was obtained demonstrating that SmpB is not essential 
for viability of M. tuberculosis in vitro. 
 
A complementing vector was created containing the smpB sequence and its 
predicted promoter region (200 bp of the upstream region) and inserted into the 
chromosome at the mycobacteriophage L5 attB site (Lee et al., 1991) in the 
SmpB mutant strain to create a complemented strain.  
5.2.2.1 Phenotypic analysis of the SmpB mutant strain 
A deletion mutant of SmpB was obtained but the loss of SmpB could have 
serious physiological consequences. To determine if loss of smpB had any 
effect on the growth of M. tuberculosis, growth of WT and the SmpB mutant 
strain (smpBΔ) was monitored in aerobic conditions. The deletion strain did not 
show any defect in growth demonstrating that SmpB is not required for aerobic 
growth in M. tuberculosis (Fig 5.4 A). 
 
The SmpB-SsrA system is thought to play an important role in tolerance to sub-
lethal concentrations of translation-specific antibiotics (Abo et al., 2002), most 
likely by rescuing stalled ribosomes and targeting the associated protein 
fragments for proteolytic degradation. Thus growth of the WT, mutant, and 
complemented strain (smpB C’), was assayed in the presence of sub-lethal 
concentrations of antibiotics targeting ribosome function such as 
chloramphenicol and erythromycin. Both antibiotics target the 50S ribosomal 
subunit preventing protein synthesis.  
 
Growth of the smpBΔ mutant was compromised in the presence of both 
chloramphenicol and erythromycin. smpBΔ mutant cells were able to grow in 
presence of 1 µg/mL of chloramphenicol but were unable to grow in 2.5 µg/mL, 
while the WT cells were able to grow with up to 5 µg/mL of chloramphenicol 
(Fig 5.4). There was a partial restoration of WT growth in the complemented 
strain as this strain was able to grow in presence of 2.5 µg/mL of 
chloramphenicol but not in 5 µg/mL. The growth of the smpBΔ strain was 
significantly reduced in the presence of 2.5, 5 and 10 µg/mL of erythromycin 
compared to WT strain (Fig 5.5). Once again, growth pattern of the 
complemented strain displayed an intermediate phenotype between the results 





Figure 5.4 Deletion of SmpB leads to chloramphenicol sensitivity in M. 
tuberculosis   
M. tuberculosis WT, smpBΔ and smpB C’ strains were cultured in aerobic conditions in 
7H9-Tw-AD medium in 16 mm diameter glass tubes and stirred at 120 rpm for 14 days. 
Results are the mean OD580 of three biological replicates ± standard deviation. 
A) No antibiotics; B) 1 µg/mL of chloramphenicol; C) 2.5 µg/mL of chloramphenicol D) 5 
µg/mL of chloramphenicol. 





























































Figure 5.5 Deletion of SmpB leads to erythromycin sensitivity in M. tuberculosis 
M. tuberculosis WT, smpBΔ and smpB C’ strains were cultured in aerobic conditions in 
7H9-Tw-AD medium in 16 mm diameter glass tubes and stirred at 120 rpm for 14 days. 
Results are the mean OD580 of three biological replicates ± standard deviation. 
A) No antibiotics; B) 2.5 µg/mL of erythromycin; C) 5 µg/mL of erythromycin at D) 10 
µg/mL of erythromycin. 




























































To determine if the smpBΔ growth defect was specific to the presence of 
translation inhibitors, the effect of rifampicin, an antibiotic that interferes with 
transcription and RNA elongation, was tested. There was no significant 
difference in rifampicin susceptibility between WT and smpBΔ strains for up to 
4 ng/mL of rifampicin (Fig 5.6) and none of the strains were able to grow in 5 
ng/mL. This shows that deletion of SmpB does not lead to rifampicin 
sensititvity, thus the growth defect of the mutant strain was specific for 
translation inhibitors. 
 
Recent work has suggested that pyrazinamide targets RpsA which is involved 
in trans-translation (Shi et al., 2011). Since SmpB is also involved in tmRNA 
activity, the effect of sub-lethal concentrations of pyrazinamide was tested on 
growth of the WT and the smpBΔ mutant. Since pyrazinamide is only effective 
at acidic pH, growth was assayed at pH 5.5. smpBΔ cells were able to grow at 
pH 5.5; thus SmpB is not necessary for growth under these conditions (Fig 5.7). 
The minimal inhibitory concentration (MIC) of PZA for M. tuberculosis varies 
from 6.25 to 50 µg/ml at pH 5.5 (Heifets, 2002; Mc Dermott and Tompsett, 
1954; Stottmeier et al., 1967). Growth of WT and smpBΔ were similarly affected 
with concentrations of up to 25 µg/mL of pyrazinamide (Fig 5.7) showing that 
sensitivity to pyrazinamide does not increase in the absence of SmpB. 
 
The SmpB-SsrA system plays a crucial role in bacterial survival in hostile 
environments, it may therefore be essential inside a macrophage where the 
bacteria are subjected to adverse concentrations, e.g. limited concentrations of 
iron and magnesium, changes in pH, exposure to toxic nitrogen and oxygen 
species (Appelberg, 2006). For example, it was reported that Salmonella 
smpBΔ or Yersinia pseudotuberculosis smpB-ssrAΔ strains showed a defect in 
survival within macrophages (Baumler et al., 1994; Okan et al., 2006). 
Therefore the ability of M. tuberculosis smpBΔ to survive and replicate in 
murine macrophages was assessed.  
 
Resting macrophages were used to mimic initial or latent infection, and 
activated macrophages were used to model an active immune response. In 
resting macrophages, mutant and complemented strains both replicated and 
grew to the same level (Fig 5.8 A); in activated macrophages, both mutant and 





Figure 5.6 Deletion of SmpB does not lead to rifampicin sensitivity in M. 
tuberculosis 
M. tuberculosis WT and the smpBΔ mutant strain were cultured in aerobic conditions in 
7H9-Tw-AD medium in 16 mm diameter glass tubes and stirred at 120 rpm for 14 days. 
Results are the mean OD580 of three biological replicates ± standard deviation. 
A) No antibiotics; B) 2 ng/mL of rifampicin; C) 3 ng/mL of rifampicin; D) 4 ng/mL of 
rifampicin. 



























































Figure 5.7 Deletion of SmpB does not lead to pyrazinamide sensitivity in M. 
tuberculosis   
M. tuberculosis WT and the smpBΔ strain were cultured in aerobic conditions in 7H9-
Tw-AD medium in 16 mm diameter glass tubes and stirred at 120 rpm for 14 days. 
Results are the mean OD580 of three biological replicates ± standard deviation. 
A) No antibiotics; B) 15 µg/mL of pyrazinamide, C) 20 µg/mL of pyrazinamide; D) 25 
µg/mL of pyrazinamide. 

























































Figure 5.8 Growth of smpBΔ and complemented strains in macrophages  
J774A murine macrophages were activated by the addition of 100 units/ml of IFN-γ 24 
h prior to infection. Macrophages were infected with smpBΔ and smpBΔ C’ strains with 
a multiplicity of infection of 1:10. Bacteria were harvested and CFU were determined. 
Results are the mean and standard deviations from three independent samples. The 
inoculum was 4x105 CFU for smpBΔ and 6x105 CFU for the smpBΔ C’.  































similar to what would be expected for the WT strain but in this experiment the 
CFU of the starting inoculum for the WT was significantly lower than the 
inoculum of the other strains, and therefore the data was not included. These 
data suggest that SmpB is not involved in the ability of M. tuberculosis cells to 
survive and replicate into macrophages. 
5.2.3 Construction of a ClpS deletion mutant 
An attempt to construct a clpS deletion mutant in M. tuberculosis was made 
using the same strategy as previously described for ssrA and smpB. The AES, 
containing a hygromycin resistance cassette flanked by dif sites, 500 bp of the 
clpS flanking regions and 50 bp of the gene sequence, was electroporated into 
M. tuberculosis. DNA was extracted from 32 transformants in total (from two 
different electroporations) selected on hygromycin and kanamycin containing 
plates and Southern blotting was carried out to confirm the correct 
recombination of the AES into the chromosome (Fig 5.9). All the tested 
transformants had the WT allele of clpS (indicated by the presence of a 3 kb 
band, Fig 5.9 A and B) with an additional band of ~9 kb (Fig 5.9 B). The 
membrane was re-probed with a probe designed to anneal to the hygromycin 
cassette. The wild-type band was no longer visible but the faint 9 kb band was 
present (Fig 5.9 C). This suggests that the AES did not integrate into the clpS 
locus but into another region of the chromosome by illegitimate recombination 
which occurs at high frequency in M. tuberculosis (Kalpana et al., 1991). No 
deletion strains were obtained possibly due to the fact that ClpS is essential or 
due to the presence of another chromosomal region similar to the AES where it 
could recombine.  
5.3 Discussion 
tmRNA is thought to play a critical role in bacterial physiology but ssrA 
essentiality varies among bacterial species. In E. coli, where the tmRNA is not 
essential, other rescue pathways (ArfA and YaeJ) are present to recycle stalled 
ribosomes (Chadani et al., 2011b; Chadani et al., 2010). In M. tuberculosis, 
ssrA could only be deleted from the chromosome when a second functional 
copy was provided demonstrating that ssrA is essential and that it is the only 
pathway responsible for ribosome rescue in M. tuberculosis (Fig 5.2). 
 
A SsrA-DD variant rescues stalled ribosomes but addition of the peptide tag to 





Figure 5.9 Analysis of ClpS recombinants 
A) Expected sizes for Southern analysis. Region used as the probe for Southern 
blotting is indicated. B) Southern analysis of 15 ClpS recombinants. ClpS::hyg AES was 
electroporated in M. tuberculosis and 15 ClpS recombinants were isolated in presence 
of hygromycin, DNA was extracted and Southern blotting was carried out. Genomic 
DNA from wild-type (WT) H37Rv and ClpS recombinants was digested with KpnI and 
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tuberculosis it was possible to delete ssrA from the chromosome when a WT 
copy was provided but the ssrA-DD allele could not substitute for WT ssrA (Fig 
5.2 C and D). This suggests that both ribosome rescue and clearance of 
truncated polypeptides functions are essential in M. tuberculosis. This is 
unusual as clearance of these polypeptides was not essential in N. 
gonorrhoeae where tmRNA is essential (Huang et al., 2000) and phenotypes in 
E. coli and B. subtilis were complemented by SsrA-DD (Muto et al., 2000; 
Withey and Friedman, 1999). However, motility in Y. pseudotuberculosis and 
DNA replication control in C. crescentus are not complemented by the SsrA-DD 
variant, suggesting that tagging with the wild-type sequence is important in 
these species (Keiler and Shapiro, 2003; Okan et al., 2006) similarly to the 
results obtained for M. tuberculosis.  
 
Besides its function as tmRNA, SsrA was also shown to act as an antisense 
RNA to regulate expression of CrtM/N and influence the pigment synthesis of 
Staph. aureus (Liu et al., 2010) and this function is independent of SmpB. It is 
not known if SsrA has a regulatory role in M. tuberculosis at this time but if ssrA 
acts as an antisense RNA it may be involved in the reduction of translation of a 
protein, such as toxin, whose elevated expression is toxic for the cell; this could 
explain the essentiality of ssrA in M. tuberculosis. 
 
SmpB is usually essential for tmRNA activity and smpB mutant cells have the 
same phenotype as ssrA mutants (Karzai et al., 1999). However, a smpB 
deletion mutant was viable in M. tuberculosis. Growth was not impaired under 
normal conditions or during a macrophage model of infection suggesting that 
SmpB may not be essential in vivo (Fig 5.8). In the presence of sub-lethal 
concentrations of chloramphenicol and erythromycin growth was inhibited but 
not in presence of rifampicin, indicating that the defect is specific to translation 
inhibitors (Fig 5.4, 5.5 and 5.6). Erythromycin was previously shown to increase 
the synthesis of tmRNA in M. smegmatis by inducing the ssrA promoter, which 
confirms that tmRNA activity is very important in response to ribosome 
inhibitors in mycobacteria (Andini and Nash, 2011). Pyrazinamide did not affect 
growth of SmpB mutant cells (Fig 5.7) confirming reports that this antibiotic is 
specific to RseA and does not target other components of the tmRNA system 





tmRNA stability depends on SmpB (Hallier et al., 2004; Hong et al., 2005) so it 
is likely that in the absence of SmpB the level of tmRNA in the cell is reduced. 
The low level of tmRNA in the SmpB mutant may be sufficient to clear stalled 
ribosomes occurring in normal growth conditions. However tmRNA may be 
overwhelmed in conditions of stress when the number of stalled ribosomes 
increases and explains the growth defect observed in presence of antibiotics 
targeting the ribosome function.  
 
The phenotype observed for smpBΔ in the presence of antibiotics targeting 
ribosomes was not completely restored in the complemented strain (Fig 5.4 and 
5.5). This could be due to the fact that the upstream region cloned did not 
contain the full promoter region or not the true promoter if the gene is part of an 
operon for example.  
 
ClpS is essential for the degradation of proteins harbouring a N-degron in E. 
coli (Schmidt et al., 2009). The construction of a clpS deletion mutant would 
have helped to determine if Clp proteases participate in the N-end rule pathway 
in M. tuberculosis. The presence of two ClpP proteases allows the possibility 
that only one of them is involved in clearance of proteins harbouring a N-
degron. However construction of a clpS mutant was not achieved due to 
technical difficulties (AES inserting into another locus due to illegitimate 
recombination) or due to the fact that ClpS is essential. Introducing the ClpS 
AES into a merodiploid strain would establish if ClpS is essential in M. 
tuberculosis.  
 
To conclude, data gained from this study showed that SmpB is not essential in 
M. tuberculosis but deletion of smpB does have profound phenotypic 
consequences in presence of antibiotics targeting ribosomes. In contrast, the 
tmRNA mutagenesis study showed that ssrA is essential for in vitro growth of 
M. tuberculosis and its two functions, ribosome rescue and clearance of 
truncated polypeptides, are both important, which is unusual for bacterial cells. 




6 General discussion 
Clp proteases are involved in protein quality control by degrading misfolded or 
aggregated proteins, and contribute to the maintenance of cellular functions 
during normal and stress conditions. Clp are two component proteases 
composed of a proteolytic component associated with ATPase subunits and 
Clp ATPases can interact with accessory proteins for targeting additional 
substrates. The number of Clp proteins and composition of the complexes, as 
well as adaptor proteins that regulate them, vary between organisms. 
Deregulation of ClpP function is an effective way to induce bacterial death and 
could potentially be used in the treatment for tuberculosis (Brotz-Oesterhelt et 
al., 2005; Ollinger et al., 2011).  
 
Although the majority of bacteria contain only one ClpP M. tuberculosis has two 
ClpP homologues, with at least one of them known to be essential for 
mycobacterial growth (Carroll et al., 2011; Ollinger et al., 2011). The overall aim 
of this work was to determine why two ClpP proteins are present and essential 
in this pathogenic organism. The main findings were that there is no difference 
in transcriptional regulation of clpP1 and clpP2 as the two subunits are co-
expressed. The levels of expression were high and remained constant up to 
eight weeks of hypoxia. Using two different two-hybrid systems, I was unable to 
determine any interaction between ClpP1, ClpP2 and the different ATPase 
subunits ClpX, ClpC1 and ClpC2. A difference in proteolytic activity was found, 
which suggests that the two ClpP subunits actively target different substrates. 
The role of the accessory components was investigated: although construction 
of a ClpS deletion mutant was not achieved, tmRNA was found to be essential, 
and SmpB was not required for aerobic growth but was important for growth in 
presence of translation inhibitors.  
 
The functional significance of having two ClpP subunits is not clear. Data 
gained from this study showed that ClpP1 and ClpP2 proteins are not 
expressed under different conditions, therefore excluding the possibility they 
may respond to different stress conditions (Chapter 3; 3.2.1). Instead they form 
a mixed tetradecameric complex (Akopian et al., 2012) as also is the case in 
Listeria monocytogenes (Zeiler et al., 2011) and Synechococcus elongatus	  
(Stanne et al., 2007). The M. tuberculosis tetradecameric complex is made of 




Synechococcus ClpP complex where each ring contains a mixture of ClpP3 
and ClpPR subunits (Akopian et al., 2012; Andersson et al., 2009). The 
formation of a mixed complex may be beneficial if ClpP1 and ClpP2 interact 
with different ATPase subunits targeting different substrates, in order to allow 
degradation of varied substrates simultaneously.  
 
The level of expression of clpP1 and clpP2 is high and ClpP1 and ClpP2 are 
constitutively expressed as demonstrated by the lack of induction after different 
stress treatments that induce protein misfolding (Chapter 3, 3.2.5). The 
constitutive expression of the two subunits associated with reports of ClpP1 
and ClpP2 induction at the mRNA level, after diamide treatment for example 
(Mehra and Kaushal, 2009),  suggests that ClpP1 and ClpP2 are regulated 
post-transcriptionally by RNA degradation. However, further regulation by 
protein degradation or post- translational modification cannot be excluded. 
 
M. tuberculosis can survive within macrophages, believed to be deficient in 
oxygen and nutrient supply, and cause latent TB infection (Wayne and 
Sohaskey, 2001). Following changes in immunocompetency, due to HIV for 
example, the bacilli can be reactivated and cause active TB. Latent infection 
and reactivation are major problems for TB eradication but remain poorly 
understood. Oxygen depletion is commonly studied in vitro using the Wayne 
model (Wayne and Hayes, 1996). ClpP1 and ClpP2 were highly expressed for 
up to eight weeks of hypoxia, promoter activity was reduced between week 8 
and 12 of hypoxia, and re-induced quickly following reaeration (Chapter 3, 
3.2.7). The high level of promoter activity during hypoxia is unusual, as many 
genes are typically down-regulated, and may suggest that the Clp proteases 
are involved in degradation of proteins that become toxic after damage during 
infection or in the infection environment. Additionally, it has been shown that 
the Clp proteases regulate expression of stress response factors in numerous 
bacteria, such as sigma B in B. subtilis (Reeves et al., 2007), so it is could be 
expected that they regulate factors which may be involved in M. tuberculosis 
colonisation, such as survival or virulence factors. Clp proteases were 
previously reported to be induced during reaeration, which is used to mimic 
reactivation of the disease (Sherrid et al., 2010). Clp proteases are likely to 
control regulation of transcription factors necessary for the bacteria to 




these factors. Targeting the Clp proteases may therefore be a successful 
approach to treat latent TB and to prevent reactivation of the disease.  
 
The binding site for a transcriptional positive regulator of clpP1P2 was mapped 
by SDM (Chapter 3, 3.2.8), this is likely to be the binding site for ClgR, which 
also positively regulates the ClpP proteins in S. lividans and C. glutamicum 
(Bellier and Mazodier, 2004; Engels et al., 2004). ClgR binding in the upstream 
region of clpP1P2 and activation of clpP1P2 transcription was previously 
demonstrated in M. tuberculosis (Mehra and Kaushal, 2009; Sherrid et al., 
2010) but the binding site had not been previously mapped. The sequence 
determined in this study is a perfect match to the ClgR consensus sequence in 
C. glutamicum suggesting a conserved mode of action for ClgR in 
actinobacteria (Engels et al., 2005). ClgR binding is required for full promoter 
activity of ClpP1P2 expression, so targeting its activity may be an alternative 
approach to reduce Clp activity. A mutant of ClgR was found to be viable but 
had limited survival into macrophages (Estorninho et al., 2010). A knockdown 
strain of ClpP1-P2 also had reduced growth and virulence in macrophages, 
confirming the importance of ClpP1 and ClpP2 for growth and infection (Carroll 
et al., 2011)  
 
Ribosomes decode information from messenger RNA but can stall in the 
absence of a stop codon on a defective mRNA. An accumulation of stalled 
ribosomes results in a shortage in the number of active ribosomes, leading to 
an arrest in protein translation and eventually to cell death. The tmRNA system, 
encoded by ssrA, has a dual role in rescuing the stalled ribosomes and tagging 
the incomplete nascent polypeptides (Huang et al., 2000; Withey and 
Friedman, 1999). The presence of ssrA in M. tuberculosis was previously 
detected but the pathway has not as yet been characterised (Tyagi and Kinger, 
1992). It was only possible to delete ssrA in the presence of an additional copy 
of the gene, thus ssrA is essential for M. tuberculosis growth (Chapter 5, 5.2.1). 
E. coli, whose tmRNA tagging system is non essential, has alternative rescue 
pathways (Chadani et al., 2010; Chadani et al., 2011b); as ssrA was found to 
be essential it indicates that M. tuberculosis only has this single pathway for 
ribosome rescue and tagging of nascent proteins; tmRNA is therefore an 





The ribosome rescue function of tmRNA is believed to be physiologically more 
important than its other function, which is to destabilise the nascent incomplete 
protein as a SsrA-DD variant can complement phenotypes associated with the 
loss of SsrA in most organisms (Huang et al., 2000; Muto et al., 2000; Withey 
and Friedman, 1999). Ribosome rescue and clearance of SsrA-tagged proteins 
are both essential in M. tuberculosis (Chapter 5, 5.2.1), which is unusual as 
only the ribosome rescue function has been previously found to be essential in 
N. gonorrhoeae where tmRNA is essential (Huang et al., 2000). The 
accumulation of SsrA-tagged proteins may be toxic for the cell, possibly due to 
an inappropriate cellular activity or their accumulation may congest the 
proteolysis pathways; this would emphasize the importance of the proteolysis 
function in M. tuberculosis. 
 
SmpB is required for tmRNA stability and interaction with the ribosomes (Karzai 
et al., 2000), but interestingly SmpB was not found to be essential in M. 
tuberculosis (Chapter 5, 5.2.2). A deletion mutant was more sensitive to 
antibiotics which target ribosomes but was not affected for survival in 
macrophages. E. coli tmRNA half life exceeds the doubling time of the 
bacterium (Hallier et al., 2004) but tmRNA stability depends on the presence of 
sufficient SmpB (Hallier et al., 2004; Hanawa-Suetsugu et al., 2002). It is likely 
that in absence of SmpB the number of SsrA molecules present in the cell are 
sufficient to clear stalled ribosomes occurring in normal growth conditions but 
they may be overwhelmed when the number of stalled ribosomes increases in 
conditions of stress. tmRNA can act as an antisense RNA in absence of SmpB, 
so the essentiality of tmRNA may be due to this function which would allow the 
possibility of having a second putative ribosome rescue system. SmpB function 
seems therefore only required during conditions that block the ribosome. 
Characterisation of the mutant may however be useful to dissect the tmRNA 
pathway in M. tuberculosis. 
 
Using a reporter of activity both ClpP1 and ClpP2 were found to degrade SsrA-
tagged proteins in M. tuberculosis (Chapter 4, 4.2.2). Even though the Clp 
proteases are involved in degradation of SsrA-tagged proteins in many 
organisms, a direct role was not previously shown in M. tuberculosis. 
Accumulation of SsrA-tagged proteins may be toxic in M. tuberculosis cells, as 
the SsrA-DD strain could not be created, thus clearance of these proteins by 




adaptor protein promotes degradation in E. coli but there are no homologs in M. 
tuberculosis. In S. pneumoniae SsrA-tagged proteins are degraded without 
adaptor protein (Ahlawat and Morrison, 2009); it is not known if an adaptor 
protein is necessary for degradation in M. tuberculosis.  
 
ClpP proteins cannot degrade proteins on their own but form complexes with 
Clp ATPases, which regulate substrate entry into the proteolytic compartment. 
ClpX is the Clp ATPase usually involved in the degradation of SsrA-tagged 
proteins (Ahlawat and Morrison, 2009; Gottesman et al., 1998), and as ClpP1 
and ClpP2 degrade these proteins, both ClpP subunits are likely to interact with 
ClpX. Mutation of the last three residues of the SsrA tag prevented recognition 
by ClpP1, demonstrating that these residues were the determinant for 
identification, similarly to the residues recognised by ClpXP in E. coli (Flynn et 
al., 2001) and further suggesting that ClpP1 interacts with ClpX. Additionally to 
SsrA-tagged LacZ, ClpP2 was shown to degrade untagged LacZ, and LacZ-
GGG, demonstrating that ClpP2 was recognising LacZ, present in excess, 
independently of the tag sequence. ClpP2 is therefore involved in a general and 
central housekeeping function as opposed to ClpP1, which may be more 
specific to a particular set of substrates such as proteins harbouring the SsrA 
degradation tag.   
 
The difference in substrate recognition between ClpP1 and ClpP2 may be due 
to their association with different ATPase subunits, suggesting that besides 
ClpX, ClpP2 could interact with an additional ATPase (s). There are three 
potential Clp ATPases in M. tuberculosis; but only ClpX and ClpC1 contain the 
‘LGL’ loop, an essential motif for interaction (Kim et al., 2001), leaving the 
possibility that ClpP2 interacts with ClpC1 and ClpX, whilst ClpP1 interacts with 
ClpX only. M. tuberculosis ClpP2 interaction with ClpC1 has been previously 
demonstrated, and RseA was shown to be targeted by the ClpC1P2 complex, 
both confirming the formation of this complex in the cell and also its ability to 
degrade specific untagged proteins (Barik et al., 2009; Singh et al., 2006). 
Altogether the data were used to make a model of protein degradation by the 
Clp proteases in M. tuberculosis (Fig 6.1). It was not possible to verify this 
model by protein-protein interaction studies between the two ClpP and different 
ATPase subunits, despite using two different methods (Chapter 3, 3.2.10). The 






Figure 6.1 Model of ClpP1 and ClpP2 activities in M. tuberculosis 
ClpP1 and ClpP2 form a mixed tetradecameric complex. ClpP1 and ClpP2 degrade 
SsrA-tagged proteins by interacting with ClpX. In addition, ClpP2 can degrade specific 
untagged proteins by interacting with ClpC1. ClpC1 can further recognise proteins 
harbouring a N-degron by interacting with ClpS. Overall ClpP1 and ClpP2 have distinct 
functional roles, proteolysis by ClpP1 is specific to the particular set of substrates 
recognised by ClpX only while ClpP2 is involved in the degradation of proteins 
recognised by both ClpX and ClpC1. 
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hexameric ATPase, may be too complex to be detected with the technologies 
used.  
 
Adaptor proteins enhance substrate recognition of the Clp ATPases. In bacteria 
the ClpS adaptor protein binds N-end rule substrates and delivers them for 
degradation by the ClpAP protease complex (Erbse et al., 2006). ClpS normally 
associates with ClpA but since ClpA is absent in Gram positive organisms ClpS  
may co-operate with ClpC (Dougan et al., 2002). No N-end rule substrates 
have been identified in M. tuberculosis to date, and construction of a deletion 
mutant was not successful (Chapter 5, 5.2.3). If ClpS interacts with ClpC1 for 
clearance of proteins harbouring destabilising residues in their N-terminus; 
ClpP2 is likely to be the ClpP subunit involved in their degradation; these 
substrates would be specific to ClpP2 given that ClpP1 does not interact with 
ClpC1 (Fig 6.1).  
 
Further work on Clp proteases could include new protein-protein interaction 
studies to verify the model described above. Protein affinity chromatography or 
pull down assays could be used, or immunoprecipitation if ClpP1 or ClpP2 
specific antibodies are available. To fully elucidate ClpP1 and ClpP2 function it 
is essential to discover the cellular protein substrates targeted by each, 
preferentially under a range of different conditions such as exponential and 
stationary phase growth, or during hypoxia and starvation. Protein studies, such 
as 2D gel electrophoresis followed by mass spectrophotometry, on the ClpP1 
and ClpP2 over-expressing strains under the control of a tightly inducible 
expression system, could be used for the identification of cellular substrates. 
Once identified, sequence comparison between the different substrates would 
allow the determination of the recognition signals used by the different Clp 
complexes in M. tuberculosis.  
 
Further work on the tmRNA system could be done by replacing the native 
promoter for an inducible expression system, which would allow the regulation 
of expression in different environmental conditions and therefore determine 
ssrA requirement and function; and it would be interesting to determine if ssrA 
acts as an antisense RNA in M. tuberculosis, as it is the case in Staph. aureus 
(Liu et al., 2010). It would be important to see if another protein can substitute 
SmpB activity in the binding of tmRNA to stalled ribosomes and determine if 




the role of the Clp proteases in degradation of SsrA-tagged proteins an 
unstable fluorescent protein could be used, and more studies are also needed 
to determine if an accessory protein is involved in the recognition of SsrA-
tagged proteins in M. tuberculosis. More importantly, the identification of 
compounds that inhibit the tmRNA pathway would determine if this pathway 
could be a used as a target for the development of new TB drugs.  
 
The identification and characterisation of a N-end rule pathway remains to be 
examined in mycobacteria. The creation of a ClpS deletion mutant could be 
carried out in M. tuberculosis if ClpS is not essential, as predicted by TraSH 
data (Sassetti et al., 2003), and over-expression studies could give more 
insights into ClpS function. Microarray or 2D gel electrophoresis followed by 
mass spectrophotometry on mutant and over-expressing ClpS strains would be 
possible ways to identify substrates of the potential mycobacterial N-end rule 
pathway. Since ClpS is conserved in M. smegmatis and M. marinum, similar 
experiments could be carried out in the model organisms. The discovery of 
substrates would determine the physiological role of the N-end rule pathway in 
M. tuberculosis. The discovery of substrates and accessory components would 
help to establish a clear N-end rule in M. tuberculosis and will determine the 
destabilising residues. Protein-protein interaction studies between ClpS and the 
different Clp ATPases would determine which ClpP-ATPase complex-(es) are 
involved in the degradation of potential N-end substrates. Regulation of 
proteolysis of a specific protein can be used to determine its function and 
proteins sequences are commonly modified by altering their C-terminal 
sequences but modifying the N-terminal sequence may become a novel 
approach to target protein for degradation.  
 
To conclude, the collective data show that ClpP1 and ClpP2 have distinct 
functional roles as they have a different proteolytic profile; ClpP1 seems to be 
involved in degradation of SsrA-tagged proteins only while ClpP2 seems to be 
involved in general proteolysis. The difference in activity between the two 
subunits is not due to a difference in transcription as they are co-expressed, but 
is likely to come from their interaction with different ATPase subunits, which in 
turn may be interacting with different accessory proteins. Protein tagging 
through tmRNA is essential for mycobacterial growth and clearance by the Clp 
proteins of these SsrA-tagged proteins may explain the essentiality of the Clp 




consequences. Proteolysis is an important activity in replicating and possibly 
resting cells so Clp protease activators or inhibitors may become new actors in 
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Appendix 1. Primers used for RT-PCR in this study 
 
Primer name Sequence (5’ to 3’) Purpose 
sigAF CAGGACACTACGACCAGCAC 
sigAR CTCACGTTCGAGGTCTTCGT 








Amplification of clpP1/clpP2 
junction (264 bp) 
P2F AAGGAGTCCAATCCATAC 
P2R GCAGCCGCCGAGGCGGCC 






Appendix 2. Primers used for identification and 
characterisation of the clpP1P2 promoter  
Name  Sequence (5’ to 3’) Purpose 
PclpF1 GAGTACTTTCAGGGGGTGCGTGAC Amplification of 92 bp upstream of clpP1P2 
PclpF2  AGTACTTGACCGTATGACGCTGTA Amplification of 125 bp upstream of clpP1P2 
PclpF3  AGTACTCAGGGCCGCAGTGGAGGC Amplification of 278 bp upstream of clpP1P2 
PclpR AGTACTGCTCACAGTGGGGCACCT Amplification of upstream regions of clpP1P2 
SDM10AF   GCCAGCCTGGTTGGTCAGTGGCGGAGCATAGAAG 
SDM on putative -10 
element from TAGTGT to 
CAGTGG 
SDM10AR CTTCTATGCTCCGCCACTGACCAACCAGGCTGGC 
SDM on putative -10 
element from TAGTGT to 
CAGTGG 
SDM10BF   GTTAGTGTCGGAGCACGGAAGAACTCGAGG 
SDM on putative -10 
element from TAGAAG to 
CGGAAG 
SDM10BR   CCTCGAGTTCTTCCGTGCTCCGACACTAAC 
SDM on putative -10 
element from TAGAAG to 
CGGAAG 
SDM35AF GGTTTCAGGGGGTGCCCGACCGCGAAACAGCCAGCC 
SDM on putative -35 
element from GTGACC to 
CCGACC 
SDM35AR GGCTGGCTGTTTCGCGGTCGGGCACCCCCTGAAACC 
SDM on putative -35 
element from GTGACC to 
CCGACC 
SDM35BF GGGGTGCGTGACCGCGAGGCAGCCAGCCTGGTTGG 
SDM on putative -35 
element from GCGAAA to 
GCGAGG 
SDM35BR CCAACCAGGCTGGCTGCCTCGCGGTCACGCACCCC 
SDM on putative -35 
element from GCGAAA to 
GCGAGG 
PclpP2F GCAGTACTGTACCAAGGGCAAGCGCTAC 
Amplification of 280 bp 
upstream of clpP1P2 
Pclp2R  GCAGTACTATTCACTGTGCTTCTCCATTG 
Amplification of 280 bp 
upstream of clpP1P2 
RegF  CAACGTGACCGTATGAAAATGTAAGCGAACGCGCC 
RegR   GGCGCGTTCGCTTACATTTTCATACGGTCACGTTG 
SDM of putative regulatory 




SDM of putative regulatory 
region from GGG to AAA in 




Appendix 3. Primers used for SDM in clpP1P2 promoter 
regulatory region  
  Name Sequence Mutation 
Reg1F  GACAACGTGACCGTGTGACGCTGTAAGC  
Reg1R GTTACAGCGTCACACGGTCACGTTGTC 
A1G 
Reg2F CAACGTGACCGTAGGACGCTGTAAGCG      



























































Appendix 4. Plasmids and vectors used for identification 
and characterisation of the clpP1P2 promoter 
Plasmid 
name Description  Source 
pSC-A PCR cloning vector, AmpR Stratagene 
pSC-B PCR cloning vector, AmpR Stratagene 
pSM128 LacZ promoter probe vector, integrating, SmR Dussurget et al., 1999 
pPclp1 125 bp upstream of clpP1P2 in pSM128 This study 
pPclp3 pPclp1 with putative -10 element mutated from TAGTGT to CAGTGG This study 
pPclp4 pPclp1 with putative -10 element mutated from TAGAAG to CGGAAG This study 
pPclp5 pPclp1 with putative -35 element mutated from GTGACC to CCGACC This study 
pPclp6 278 bp upstream of clpP1P2 in pSM128 This study 
pPclp7 pPclp6 with CGC motif mutated to AAA This study 
pPclp8 pPclp1 with putative -35 element mutated from GCGAAA to GCGAGG This study 
pPclp32 pPclp6 with SDM A1G This study 
pPclp31 pPclp6 with SDM T2G This study 
pPclp9 pPclp6 with SDM G3A This study 
pPclp10 pPclp6 with SDM A4G This study 
pPclp11 pPclp6 with SDM C5A This study 
pPclp12 pPclp6 with SDM G6A This study 
pPclp13 pPclp6 with SDM C7A This study 
pPclp14 pPclp6 with SDM T8G This study 
pPclp15 pPclp6 with SDM G9A This study 
pPclp16 pPclp6 with SDM T10G This study 
pPclp17 pPclp6 with SDM A11G This study 
pPclp18 pPclp6 with SDM A12G This study 
pPclp19 pPclp6 with SDM G13A This study 
pPclp20 pPclp6 with SDM C14A This study 
pPclp21 pPclp6 with SDM G15A This study 




pPclp23 pPclp6 with SDM A17G This study 
pPclp24 pPclp6 with SDM C18A This study 
pPclp27 pPclp6 with SDM G19A This study 
pPclp28 pPclp6 with SDM C20A This study 
pPclp25 92 bp upstream of clpP1P2 in pSC-A This study 
pPclp26 92 bp upstream of clpP1P2 in pSM128 This study 
pPclp33 pPclp6 with GGG motif mutated to AAA This study 
pPclp34 pPclp1 with GGG motif mutated to AAA This study 
pPclp35 pPclp26 with GGG motif mutated to AAA This study 
pPclp36 280 bp upstream of clpP2 in pSC-B This study 










name Sequence (5’ to 3’) 
ClgRDD-F GCCATATGGCGGCTTTGGTGCGTGAG clgR 
ClgRDD-R  ATGGATCCTTAGTCATCCGCCAGCGACACCACCGGC 
 
Plasmid 
name  Characteristics Source 
pET-28a Expression vector, N-terminal His tag, KanR Novagen 
pPclp38 ClgR-DD in pGEM, AmpR This study 




Appendix 6. EMSA primers and products  
 
Primer 
name Sequence (5’ to 3’) Purpose 
P278F  CAGGGCCGCAGTGGAGGC 
P278R  GCTCACAGTGGGGCACCT [biotin] 
Amplification of 278 bp 
upstream of clpP1 
P48F CGACAACGTGACCGT 
P48R CCCTGAAACCGGC [biotin] 
Amplification of 48 bp 
regulatory region 




name  Characteristics Source 
P278 278 bp upstream of clpP1, biotin labelled This study 
P48 
48 bp regulatory region upstream of clpP1, 





Appendix 7. Method for ClgR purification 
ClgR-DD was purified by Dr Ruth Rose at the Queen Mary University protein 
purification facility. ClgR-DD plasmid was transformed in BL21 (DE3) Codon 
plus competent cells. Cells were grown in one litre LB medium at 37 ºC to an 
OD600 of approximately 0.9, induced with 1mM IPTG, and grown overnight at 18 
ºC. Culture cells were harvested by centrifugation at 3,315 x g, re-suspended in 
50 mL buffer (20 mM Tris pH 7.0, 500 mM NaCl, 10 mM imidazole) and lysed 
by two passages through an Emusiflex (lys); cell debris (pel) were removed by 
centrifugation at 35,000 x g for 20 min. Soluble fraction (s/n) was incubated 
with 1 ml of Ni-NTA sepharose (Sigma) for 1 h at 4 ºC on a rotator. The 
contents were poured into a column and unbound material removed under 
gravity (f/t). The sepharose was washed (wash) in 20 mL buffer (20 mM Tris 
pH 7.0, 500 mM NaCl, 10 mM imidazole). The protein was eluted in elution 
buffer (20 mM Tris pH 7.0, 500 mM NaCl, 500 mM imidazole) into 1.5 ml 
eppendorfs. The protein was buffer exchanged in storage buffer (20 mM Tris 
pH 7.4, 10 % glycerol) using a PD10 column (GE Healthcare), eluted into 3.5 
ml storage buffer, and stored at -20 ºC.  Fractions that were not exchanged 
were kept in elution buffer at 4 ºC. 
 
Figure 8.1 SDS gel of purified ClgR-DD 
The samples were boiled at 100 ºC for 10 min. 10 µl of sample was loaded on to a 15 
% SDS gel run at 200 V for 1 h and stained in coomassie stain. 
lys, s/n, pel, f/t, wash = 40 µl sample buffer + 10 µl sample (see text for description) 
Elution fractions = 20 µl sample + 20 µl sample buffer 

















































Appendix 8. Primers used for cloning into the bacterial two 



































cfp10R GGGTACCGAAGCCCATTTGCGAGGA  
EcClpXF GACTCTAGAGACAGATAAACGCAAAGATGGC E. coli 
clpX EcClpXR GGGTACCTTCACCAGATGCCTGTTGCGC 
EcclpPF GACTCTAGAGTCATACAGCGGCGAACGAGAT E. coli 









gene Name Primer Sequences (5’ to 3’) 
spltP1F GCACTAGTGTGAGCCAAGTGACTG AC 
clpP1 
spltP1R GCGTTAACCTGTGCTTCTCCATTGAC 
spltP2F GCACTAGTGTGAATTCCCAAAATTCT clpP2 
 spltP2R GCGTTAACGGCGGTTTGCGCGGAGAG 
spltBF GCACTAGTGTGGACTCGTTTAACCCG clpB 
 spltBR GCGTTAACGCCCAGGATCAGCGAGTC 





spltC2F GACTAGTATGCCGGAGCCCACACCCAC CGCCTACCCC clpC2 
 
spltC2R GGTTAACGCCGGCATCGGTTGCGCCGGCATCGGTTGC 
spltclpXF GCACTAGTATGGCGCGCATAGGAGAC clpX 











Appendix 10. Vectors and plasmids used in the bacterial 
two-hybrid system 
 
Name Characteristics Source 
pUT18 T18 fragment B. pertussis adenylate cyclase 
subdomain with a multicloning sequence at the 5’ 
end, AmpR 
Karimova et al., 
1998 
pUT18C T18 fragment B. pertussis adenylate cyclase 
subdomain with a multicloning sequence at the 3’ 
end, AmpR 
Karimova et al., 
1998 
pKT25 T25 fragment of B. pertussis adenylate cyclase 
subdomain with a multicloning sequence at the 3’ 
end, KanR 
Karimova et al., 
1998 
pKNT25 T25 fragment of B. pertussis adenylate cyclase 
subdomain with a multicloning sequence at the 5’ 
end, KanR 
Karimova et al., 
1998 
pUT18C zip GCN4 leucine zipper motifs cloned into pUT18C, 
AmpR 
Karimova et al., 
1998 
pKNT25 zip GCN4 leucine zipper motifs cloned into pKNT25, 
KanR 
Karimova et al., 
1998 
pClp1 ClpP1 in pSC-A, AmpR This study 
pClp2 ClpP1 in pKT25, KanR This study 
pClp3 ClpP1 in pKNT25, KanR This study 
pClp4 ClpP1' in pSC-A, AmpR This study 
pClp5 ClpP1 in pUT18C, AmpR This study 
pClp6 ClpP1 in pUT18, AmpR This study 
pClp7 ClpP2 in pSC-A, AmpR This study 
pClp8 ClpP2 in pKT25, KanR This study 
pClp9 ClpP2 in pKNT25, KanR This study 
pClp10 ClpP2' in pSC-A, AmpR This study 
pClp11 ClpP2 in pUT18C, AmpR This study 
pClp12 ClpP2 in pUT18, AmpR This study 
pClp13 ClpB in pSC-A, AmpR This study 
pClp14 ClpB in pUT18C, AmpR This study 
pClp15 clpB in pUT18, AmpR This study 
pClp16 ClpX in pSC-A, AmpR This study 
pClp17 ClpX in pUT18C, AmpR This study 
pClp18 ClpX in pUT18, AmpR This study 
pClp19 ClpC1 in pSC-A, AmpR This study 
pClp20 ClpC1 in pUT18C, AmpR This study 
pClp21 ClpC1 in pUT18, AmpR This study 
pClp22 ClpC2 in pSC-A, AmpR This study 
pClp23 ClpC2 in pUT18C, AmpR This study 
pClp24 ClpC2 in pUT18, AmpR This study 
pClp25 ClpS in pSC-A, AmpR This study 




pClp27 ClpS in pKNT25, KanR This study 
pClp28 SmpB/pSC-A, AmpR This study 
pClp29 SmpB in pKT25, KanR This study 
pClp30 SmpB in pKNT25, KanR This study 
pClp31 ClpC1 in pKT25, KanR This study 
pClp32 ClpC1 in pKNT25, KanR This study 
pClp44 Esat6 in pSC-A, AmpR This study 
pClp33 Esat6 in pUT18C, AmpR This study 
pClp34 Esat6 in pUT18, AmpR This study 
pClp35 Cfp10 in pSC-A, AmpR This study 
pClp36 Cfp10 in pKT25, KanR This study 
pClp37 Cfp10 in pKNT25, KanR This study 
pClp38 E. coli ClpP in pSC-A, AmpR This study 
pClp39 E. coli ClpX in pSC-A, AmpR This study 
pClp40 E. coli ClpP in pKT25, KanR This study 
pClp41 E. coli ClpP in pKNT25, KanR This study 
pClp42 E. coli ClpX in pUT18, AmpR This study 





Appendix 11. Vectors and plasmids used in Split-Trp 
 
Plasmid name Characteristics Source 
PL240 Ntrp fusions of Trp1p, GmR O’Hare et al., 2008 
PL242 Ctrp fusions of Trp1p, AmpRHygR O’Hare et al., 2008 
PL186 Esat6 in PL240, GmR O’Hare et al., 2008 
PL339 Cfp-10 into PL242, AmpR, HygR O’Hare et al., 2008 
PL425 C2 into PL240, GmR O’Hare et al., 2008 
PL426 C1 in PL242, AmpR, HygR O’Hare et al., 2008 
pSplt1 ClpP1 in pSC-A, AmpR This study 
pSplt2 ClpP2 in pSC-A, AmpR This study 
pSplt3 ClpB in pSC-A, AmpR This study 
pSplt4 ClpC1 in pSC-A, AmpR This study 
pSplt5 ClpC2 in pSC-A, AmpR This study 
pSplt6 ClpX in pSC-A, AmpR This study 
pSplt7 ClpP1 in PL240, GmR This study 
pSplt8 ClpP2 in PL240, GmR This study 
pSplt9 ClpB in PL240, GmR This study 
pSplt10 ClpC1 in PL240, GmR This study 
pSplt11 ClpC2 in PL240, GmR This study 
pSplt12 ClpX in PL240, GmR This study 
pSplt13 ClpP1 in PL242, AmpR, HygR This study 
pSplt14 ClpP2 in PL242, AmpR, HygR This study 
pSplt15 ClpB in PL242, AmpR, HygR This study 
pSplt16 ClpC1 in PL242, AmpR, HygR This study 
pSplt17 ClpC2 in PL242, AmpR, HygR This study 
pSplt18 ClpX in PL242, AmpR, HygR This study 
pSplt19 SmpB in pSC-A, AmpR This study 
pSplt20 SmpB in PL240, GmR This study 
pSplt21 SmpB in PL242, AmpR, HygR This study 
pSplt22 ClpS in pSC-A, AmpR This study 
pSplt23 ClpS in PL240, GmR  This study 





Appendix 12. qRT-PCR primer and probe sequences used 
in this study 
 
Target gene Name Sequence (5’ to 3’) 
SigA probe CCTCCGGTGATTTC 
SigA-F CCGATGACGACGAGGAGATC sigA 
SigA-R GGCCTCCGACTCGTCTTCA 
ClpP1 probe TGTTCCGGCTCAACG 
ClpP1-qF TCGCCGTGATCAAGAAAGAA clpP1 
ClpP1-qR GGCTGGCCGGTGAATTC 
ClpP2 probe TGGCGATCTACGACACC 
ClpP2-qF GCGATATCACCATGTACATCAACTC clpP2 
ClpP2-qR GGCCCGCACGTATTGC 
HemD probe ACGCCGTCGCACGCACCCA 
HemD-qF GGATGCGGTAATCAGCGAGGTG hemD 
HemD-qR CCGGGCACGATTTCGATGTG 
FadD13 probe TGGCGCCGTGCCGGCGAT 
FadD13-qF ATCTCGATGCCGCAGTTCGAT fadD13 
FadD13-qR ACCTGGCGCATGAAGTTGA 
Rv2205c probe CCGGGCTCGGCAACCGCGT 
Rv2205-qF GTTTGCGGGCCACTGAACAC Rv2205c 
Rv2205c-qR CAAGCCTGCGCACACTCCAA 
DevB probe TGAGCAACGCCCGCCGGGC 
DevB-qF CGAACGCTACGTTCCCGAAGAC devB 
DevB-qR GGTGCACCTGGTTCGATGGA 
Wbbl2 probe TCGCGGCTACCGGCCGACG 
Wbbl2-qF CTCCCACGCAATGACGCTCAAC wbbl2 
Wbbl2-qR CAAACATCGGCCCGACCATTCC 
Rv2526 probe CGGGCAGCCCAGGCCGTCA 
Rv2526-qF GAGGACCACGATTGAGCTGGAC Rv2526 
Rv2526-qR GACCGTCGCTCGCAATGTTTCC 
Rv2527 probe ACGCCGCCAGCCGGCATCG 






Appendix 13. Primers and plasmids used for reporter 
system experiments   
 
Primer Name Sequence Purpose 
GGG -F CGACGAAAACTACGCTGGAGGAGGATAATAATAACCGGGC 
GGG-R GCCCGGTTATTATTATCCTCCTCCAGCGTAGTTTTCGTCG 




Plasmid name Description Source 
pFLAME-3-ace GFP promoter probe vector (LAA), Pami, kanR Blokpoel et al., 2003 
pCon3 PsmyctetO promoter in pGEM, AmpR Dr P. Carroll, QMUL 
pMC1m WT TetR, Psmyc-tetO Guo et al., 2007 
pMC1s Reverse TetR, PsmyctetO Guo et al., 2007 
pTT1A Tweety derivative, AmpR, KanR Pham et al., 2007 
pDS176 pSM128 with AANDENYA-LAA tag on LacZ Dr D. Schuessler, NIMR 
pDS178 pSM128 with AANDENYA-ASV tag on LacZ, Pami promoter, SmR 
Dr D. Schuessler, 
NIMR 
pDS179 pSM128, Pami promoter, SmR 
Dr D. Schuessler, 
NIMR 
pAMIL1 pDS176, Pami promoter, SmR This study 
pRep1 pDS178 with AANDENYA-ASV tag mutated to AANDENYA-GGG This study 
pRep7 Untagged LacZ in pSM128, Psmyc-tetO promoter, SmR This study 
pRep9 WT TetR in pGEM This study 
pRep10 Reverse TetR in pGEM This study 
pRep11 WT TetR in pTT1A, KanR This study 
pRep12 Reverse TetR in pTT1A, KanR This study 
pOPPY1 clpP1 in pSMT3, hsp60 promoter, HygR Ollinger et al., 2011 
pOPPY2 clpP2 in pSMT3, hsp60 promoter, HygR Ollinger et al., 2011 





Appendix 14. Primers used for recombineering in this 
study 
 
















SmpB-compF  CATCGCCGTAGCGGGCT 
smpB 
SmpB-compR  GCAAGCTTTCAGGTCATGCCCTTAGC 
ssrA-compF  CATCCGCGTTTCCGTGGAC 
ssrA 








Appendix 15. Plasmids used for recombineering  
 
Plasmid 
name  Characteristics Source 
pAL58 Dif-Hyg-dif construct in pCR-Blunt II-TOPO, KanR, HygR 
Cascioferro et al., 
2010 
pUC-Gm-Int HindIII-excisable Gm




pJV53 Chec9 genes gp60_61 under control of the acetamidase promoter in pLAM12, KanR 
van Kessel and 
Hatfull, 2007 
pStar7 
Dif-Hyg-dif cassette flanked with ssrA 
upstream and downstream regions in pGEM, 
AmpR, HygR 
 This study 
pStar9 
Dif-Hyg-dif cassette flanked with smpB 
upstream and downstream regions in pGEM, 
AmpR, HygR 
 This study 
pStar17 ClpS upstream and downstream regions in pGEM, AmpR  This study 
pStar18 
Dif-Hyg-dif cassette flanked with clpS 
upstream and downstream regions in pGEM, 
AmpR, HygR 
 This study 
pStar10 ssrA and 201 bp of upstream region in pGEM, AmpR  This study 
pStar11 smpB and 198 bp of upstream region in pGEM, AmpR  This study 
pStar12 clpS and 198 bp of upstream region in pGEM, AmpR  This study 
pStar13 pStar10 with Gm cassette inserted, Amp
R, 
GmR  This study 
pStar14 pStar10 with Gm cassette inserted, Amp
R, 
GmR  This study 
pStar15 pStar10 with Gm cassette inserted, Amp
R, 
GmR  This study 
pStar16 pStar10 with  the last two residues of ssrA (AA) mutated to DD   This study 
 
